{"3ce12a09c5f0d5e8e7d5d8f6d9cc467e9ae34005": [["uveitis is usually called chorioretinitis.", [["uveitis", "DISEASE", 0, 7], ["chorioretinitis", "DISEASE", 26, 41], ["uveitis", "PROBLEM", 0, 7], ["chorioretinitis", "PROBLEM", 26, 41], ["chorioretinitis", "OBSERVATION", 26, 41]]], ["Other anatomic classifications include panuveitis (inflammation of the choroid, iris and ciliary body), and pars planitis or intermediate uveitis (inflammation of the posterior ciliary body, or pars plana, and anterior choroid).", [["choroid", "ANATOMY", 71, 78], ["iris", "ANATOMY", 80, 84], ["ciliary body", "ANATOMY", 89, 101], ["pars planitis", "ANATOMY", 108, 121], ["posterior ciliary body", "ANATOMY", 167, 189], ["pars", "ANATOMY", 194, 198], ["anterior choroid", "ANATOMY", 210, 226], ["panuveitis", "DISEASE", 39, 49], ["inflammation", "DISEASE", 51, 63], ["pars planitis", "DISEASE", 108, 121], ["uveitis", "DISEASE", 138, 145], ["inflammation", "DISEASE", 147, 159], ["choroid", "MULTI-TISSUE_STRUCTURE", 71, 78], ["iris", "TISSUE", 80, 84], ["ciliary body", "MULTI-TISSUE_STRUCTURE", 89, 101], ["ciliary body", "MULTI-TISSUE_STRUCTURE", 177, 189], ["anterior choroid", "MULTI-TISSUE_STRUCTURE", 210, 226], ["panuveitis", "PROBLEM", 39, 49], ["inflammation of the choroid, iris and ciliary body)", "PROBLEM", 51, 102], ["pars planitis", "PROBLEM", 108, 121], ["intermediate uveitis", "PROBLEM", 125, 145], ["inflammation of the posterior ciliary body", "PROBLEM", 147, 189], ["pars plana", "PROBLEM", 194, 204], ["panuveitis", "OBSERVATION", 39, 49], ["inflammation", "OBSERVATION", 51, 63], ["choroid", "ANATOMY", 71, 78], ["iris", "ANATOMY", 80, 84], ["ciliary body", "ANATOMY", 89, 101], ["pars planitis", "OBSERVATION", 108, 121], ["intermediate uveitis", "OBSERVATION", 125, 145], ["inflammation", "OBSERVATION", 147, 159], ["posterior", "ANATOMY_MODIFIER", 167, 176], ["ciliary body", "ANATOMY", 177, 189], ["pars plana", "OBSERVATION", 194, 204], ["anterior", "ANATOMY_MODIFIER", 210, 218], ["choroid", "ANATOMY", 219, 226]]]], "PMC7161747": [["INTRODUCTIONCoronaviruses (CoVs) are a large family of enveloped RNA viruses with positive\u2010sense single\u2010stranded RNA genome, affecting a wide range of animal species.", [["CoVs", "GENE_OR_GENE_PRODUCT", 27, 31], ["CoVs", "PROTEIN", 27, 31], ["single\u2010stranded RNA genome", "DNA", 97, 123], ["enveloped RNA viruses", "PROBLEM", 55, 76], ["positive\u2010sense single\u2010stranded RNA genome", "PROBLEM", 82, 123], ["RNA genome", "OBSERVATION", 113, 123]]], ["Some widely spread human coronaviruses (HCoVs, i.e., strains 229E, OC43, NL63, and HKU1) are the etiologic agents in 15\u201330% of common cold disease,1 a relatively benign yet highly contagious respiratory illness that can possibly be complicated by virus\u2010induced asthma or exacerbations of chronic obstructive pulmonary disease.2 These HCoVs can also cause high\u2010morbidity lower respiratory tract conditions, such as pneumonia, bronchiolitis, and croup, especially in immunocompromised patients, the elderly and young children.3, 4, 5 Besides, two highly pathogenic CoVs originating from animal reservoirs have had a major medical and socio\u2010economic impact.", [["respiratory", "ANATOMY", 191, 202], ["pulmonary", "ANATOMY", 308, 317], ["lower respiratory tract", "ANATOMY", 370, 393], ["cold disease", "DISEASE", 134, 146], ["respiratory illness", "DISEASE", 191, 210], ["asthma", "DISEASE", 261, 267], ["chronic obstructive pulmonary disease", "DISEASE", 288, 325], ["respiratory tract conditions", "DISEASE", 376, 404], ["pneumonia", "DISEASE", 414, 423], ["bronchiolitis", "DISEASE", 425, 438], ["croup", "DISEASE", 444, 449], ["human", "ORGANISM", 19, 24], ["coronaviruses", "ORGANISM", 25, 38], ["HCoVs", "CANCER", 40, 45], ["OC43", "GENE_OR_GENE_PRODUCT", 67, 71], ["NL63", "GENE_OR_GENE_PRODUCT", 73, 77], ["HKU1", "GENE_OR_GENE_PRODUCT", 83, 87], ["pulmonary", "ORGAN", 308, 317], ["HCoVs", "GENE_OR_GENE_PRODUCT", 334, 339], ["tract", "ORGANISM_SUBDIVISION", 388, 393], ["patients", "ORGANISM", 483, 491], ["children", "ORGANISM", 515, 523], ["CoVs", "ORGANISM", 563, 567], ["human", "SPECIES", 19, 24], ["patients", "SPECIES", 483, 491], ["children", "SPECIES", 515, 523], ["human coronaviruses", "SPECIES", 19, 38], ["Some widely spread human coronaviruses", "PROBLEM", 0, 38], ["HCoVs", "TEST", 40, 45], ["strains", "TEST", 53, 60], ["OC43", "TEST", 67, 71], ["NL63", "TEST", 73, 77], ["common cold disease", "PROBLEM", 127, 146], ["contagious respiratory illness", "PROBLEM", 180, 210], ["virus\u2010induced asthma", "PROBLEM", 247, 267], ["chronic obstructive pulmonary disease", "PROBLEM", 288, 325], ["high\u2010morbidity lower respiratory tract conditions", "PROBLEM", 355, 404], ["pneumonia", "PROBLEM", 414, 423], ["bronchiolitis", "PROBLEM", 425, 438], ["croup", "PROBLEM", 444, 449], ["two highly pathogenic CoVs", "PROBLEM", 541, 567], ["a major medical and socio\u2010economic impact", "PROBLEM", 612, 653], ["widely", "OBSERVATION_MODIFIER", 5, 11], ["spread", "OBSERVATION_MODIFIER", 12, 18], ["human coronaviruses", "OBSERVATION", 19, 38], ["common cold", "ANATOMY", 127, 138], ["disease", "OBSERVATION", 139, 146], ["contagious", "OBSERVATION_MODIFIER", 180, 190], ["respiratory illness", "OBSERVATION", 191, 210], ["asthma", "OBSERVATION", 261, 267], ["chronic", "OBSERVATION_MODIFIER", 288, 295], ["obstructive", "OBSERVATION_MODIFIER", 296, 307], ["pulmonary", "ANATOMY", 308, 317], ["disease", "OBSERVATION", 318, 325], ["respiratory tract", "ANATOMY", 376, 393], ["pneumonia", "OBSERVATION", 414, 423], ["bronchiolitis", "OBSERVATION", 425, 438], ["highly", "OBSERVATION_MODIFIER", 545, 551], ["pathogenic CoVs", "OBSERVATION", 552, 567], ["animal", "OBSERVATION_MODIFIER", 585, 591], ["reservoirs", "OBSERVATION_MODIFIER", 592, 602], ["major", "OBSERVATION_MODIFIER", 614, 619]]], ["In 2003, the newly discovered SARS\u2010CoV6 responsible for the severe acute respiratory syndrome, suddenly emerged in South\u2010East Asia, after which it caused 8096 infections worldwide with a case\u2010fatality (CFR) rate of 9.6% and a total societal cost estimated at 40 billion USD.7 In 2012, the thus far unknown Middle East Respiratory Syndrome virus (MERS\u2010CoV) appeared6 which, to date, caused 2249 cases with a CFR of 36%.8 The high virulence of SARS\u2010 and MERS\u2010CoVs, combined with their sudden emergence and clear pandemic potential, has boosted the development of preventive (i.e., vaccines) or therapeutic (i.e., antiviral drugs) interventions to address serious CoV infections in humans.", [["SARS", "DISEASE", 30, 34], ["acute respiratory syndrome", "DISEASE", 67, 93], ["infections", "DISEASE", 159, 169], ["Respiratory Syndrome", "DISEASE", 318, 338], ["SARS", "DISEASE", 442, 446], ["CoV infections", "DISEASE", 661, 675], ["CoV6", "GENE_OR_GENE_PRODUCT", 35, 39], ["Middle East Respiratory Syndrome virus", "ORGANISM", 306, 344], ["MERS\u2010CoV", "ORGANISM", 346, 354], ["CoV", "ORGANISM", 661, 664], ["humans", "ORGANISM", 679, 685], ["humans", "SPECIES", 679, 685], ["Middle East Respiratory Syndrome virus (MERS\u2010CoV", "SPECIES", 306, 354], ["humans", "SPECIES", 679, 685], ["the severe acute respiratory syndrome", "PROBLEM", 56, 93], ["rate", "TEST", 207, 211], ["Middle East Respiratory Syndrome virus", "PROBLEM", 306, 344], ["a CFR", "TEST", 405, 410], ["SARS", "PROBLEM", 442, 446], ["preventive (i.e., vaccines", "TREATMENT", 561, 587], ["antiviral drugs", "TREATMENT", 611, 626], ["interventions", "TREATMENT", 628, 641], ["serious CoV infections in humans", "PROBLEM", 653, 685], ["severe", "OBSERVATION_MODIFIER", 60, 66], ["acute", "OBSERVATION_MODIFIER", 67, 72], ["respiratory syndrome", "OBSERVATION", 73, 93], ["Middle", "ANATOMY_MODIFIER", 306, 312], ["Respiratory Syndrome", "OBSERVATION", 318, 338], ["high virulence", "OBSERVATION_MODIFIER", 424, 438], ["infections", "OBSERVATION", 665, 675]]], ["Thus far, except for quarantine measures, no effective intervention exists.INTRODUCTIONIn our laboratory, we initiated a small\u2010molecule screening program in HCoV\u2010infected cells, aimed at identifying new chemical entities and CoV targets with relevance for antiviral drug development.", [["cells", "ANATOMY", 171, 176], ["HCoV\u2010infected cells", "CELL", 157, 176], ["CoV", "ORGANISM", 225, 228], ["HCoV\u2010infected cells", "CELL_LINE", 157, 176], ["quarantine measures", "TREATMENT", 21, 40], ["effective intervention", "TREATMENT", 45, 67], ["a small\u2010molecule screening program", "TREATMENT", 119, 153], ["CoV targets", "TREATMENT", 225, 236], ["antiviral drug development", "TREATMENT", 256, 282]]], ["In the present report, we describe the identification of a new class of CoV inhibitors carrying a 1\u2010thia\u20104\u2010azaspiro[4.5]decan\u20103\u2010one scaffold (Scheme 1).", [["thia\u20104\u2010azaspiro[4.5]decan\u20103\u2010one", "CHEMICAL", 100, 131], ["1\u2010thia\u20104\u2010azaspiro[4.5]decan\u20103\u2010one", "CHEMICAL", 98, 131], ["CoV", "ORGANISM", 72, 75], ["thia\u20104\u2010azaspiro[4.5]decan\u20103\u2010one", "SIMPLE_CHEMICAL", 100, 131], ["CoV inhibitors", "TREATMENT", 72, 86], ["decan\u20103\u2010one scaffold (Scheme", "TREATMENT", 120, 148]]], ["Intriguingly, the same scaffold is present in a class of H3 hemagglutinin\u2010specific influenza virus fusion inhibitors that was discovered by our team some time ago.9 This points to the 1\u2010thia\u20104\u2010azaspiro[4.5]\u2010decan\u20103\u2010one scaffold as a versatile chemical structure with high relevance for antiviral drug development.Chemistry ::: RESULTS AND DISCUSSIONHydrazides (3, 4) were obtained by stepwise reactions, firstly by esterification of acids in methanol in the presence of H2SO4 to give esters (1, 2), and secondly hydrazinolysis of 1, 2 to give 3, 4.103, 4 were reacted with cyclic ketones to afford corresponding derivatives 5, 6 that are commercially available or recorded earlier, except 5a and 6a.11, 12 Spectral and analytical data of 5a and 6a are given under \u201cGeneral procedure for the synthesis of N'\u2010(cycloalkylidene)\u20102\u2010phenoxyacetohydrazides (5) or N'\u2010(cycloalkylidene)\u20103\u2010phenylpropanehydrazides (6)\u201d.", [["\u2010azaspiro", "CHEMICAL", 192, 201], ["esterification of acids", "CHEMICAL", 415, 438], ["methanol", "CHEMICAL", 442, 450], ["H2SO4", "CHEMICAL", 470, 475], ["1, 2)", "CHEMICAL", 492, 497], ["cyclic ketones", "CHEMICAL", 573, 587], ["N'\u2010", "CHEMICAL", 804, 807], ["cycloalkylidene", "CHEMICAL", 808, 823], ["\u20102\u2010phenoxyacetohydrazides", "CHEMICAL", 824, 849], ["cycloalkylidene", "CHEMICAL", 861, 876], ["1\u2010thia\u20104\u2010azaspiro[4.5]\u2010decan\u20103\u2010one", "CHEMICAL", 184, 218], ["DISCUSSIONHydrazides", "CHEMICAL", 339, 359], ["methanol", "CHEMICAL", 442, 450], ["H2SO4", "CHEMICAL", 470, 475], ["esters", "CHEMICAL", 484, 490], ["cyclic ketones", "CHEMICAL", 573, 587], ["N'\u2010(cycloalkylidene)\u20102\u2010phenoxyacetohydrazides", "CHEMICAL", 804, 849], ["N'\u2010(cycloalkylidene)\u20103\u2010phenylpropanehydrazides", "CHEMICAL", 857, 903], ["H3 hemagglutinin\u2010specific influenza virus", "ORGANISM", 57, 98], ["3, 4)", "SIMPLE_CHEMICAL", 361, 366], ["methanol", "SIMPLE_CHEMICAL", 442, 450], ["H2SO4", "SIMPLE_CHEMICAL", 470, 475], ["esters", "SIMPLE_CHEMICAL", 484, 490], ["1, 2)", "SIMPLE_CHEMICAL", 492, 497], ["cyclic ketones", "SIMPLE_CHEMICAL", 573, 587], ["N'\u2010(cycloalkylidene)\u20102\u2010phenoxyacetohydrazides (5)", "SIMPLE_CHEMICAL", 804, 853], ["N'\u2010(cycloalkylidene)\u20103\u2010phenylpropanehydrazides (6)\u201d", "SIMPLE_CHEMICAL", 857, 908], ["hemagglutinin\u2010specific influenza virus", "SPECIES", 60, 98], ["H3 hemagglutinin\u2010specific influenza virus", "SPECIES", 57, 98], ["H3 hemagglutinin\u2010specific influenza virus fusion inhibitors", "TREATMENT", 57, 116], ["\u2010decan\u20103\u2010one scaffold", "TREATMENT", 206, 227], ["antiviral drug development", "TREATMENT", 286, 312], ["DISCUSSIONHydrazides", "TEST", 339, 359], ["acids in methanol", "TREATMENT", 433, 450], ["esters", "TEST", 484, 490], ["secondly hydrazinolysis", "TEST", 503, 526], ["cyclic ketones", "TEST", 573, 587], ["analytical data", "TEST", 719, 734], ["General procedure", "TREATMENT", 765, 782], ["the synthesis of N'\u2010(cycloalkylidene)", "TREATMENT", 787, 824], ["phenoxyacetohydrazides", "TREATMENT", 827, 849], ["N'\u2010(cycloalkylidene)", "TREATMENT", 857, 877], ["influenza virus", "OBSERVATION", 83, 98], ["antiviral drug", "OBSERVATION", 286, 300]]], ["Cyclocondensation of 5 or 6 with sulphanylacetic acid or 2\u2010sulphanylpropanoic acid led to N\u2010(substituted 3\u2010oxo\u20101\u2010thia\u20104\u2010azaspiro[4.4]non\u20104\u2010yl/[4.5]dec\u20104\u2010yl/[4.6]undec\u20104\u2010yl)\u20102\u2010phenoxyacetamide (7) or N\u2010(substituted 3\u2010oxo\u20101\u2010thia\u20104\u2010azaspiro[4.4]non\u20104\u2010yl/[4.5]decan\u20104\u2010yl)\u20103\u2010phenylpropanamides (8).", [["sulphanylacetic acid", "CHEMICAL", 33, 53], ["2\u2010sulphanylpropanoic acid", "CHEMICAL", 57, 82], ["N\u2010", "CHEMICAL", 90, 92], ["\u20102\u2010phenoxyacetamide", "CHEMICAL", 172, 191], ["N\u2010", "CHEMICAL", 199, 201], ["3\u2010oxo\u20101\u2010thia\u20104\u2010azaspiro[4.4]non\u20104\u2010yl/[4.5]decan\u20104\u2010yl)\u20103\u2010phenylpropanamides", "CHEMICAL", 214, 288], ["sulphanylacetic acid", "CHEMICAL", 33, 53], ["2\u2010sulphanylpropanoic acid", "CHEMICAL", 57, 82], ["N\u2010(substituted 3\u2010oxo\u20101\u2010thia\u20104\u2010azaspiro[4.4]non\u20104\u2010yl", "CHEMICAL", 90, 141], ["[4.5]dec\u20104\u2010yl", "CHEMICAL", 142, 155], ["[4.6]undec\u20104\u2010yl", "CHEMICAL", 156, 171], ["2\u2010phenoxyacetamide", "CHEMICAL", 173, 191], ["N\u2010(substituted 3\u2010oxo\u20101\u2010thia\u20104\u2010azaspiro[4.4]non\u20104\u2010yl", "CHEMICAL", 199, 250], ["[4.5]decan\u20104\u2010yl)\u20103\u2010phenylpropanamides", "CHEMICAL", 251, 288], ["sulphanylacetic acid", "SIMPLE_CHEMICAL", 33, 53], ["2\u2010sulphanylpropanoic acid", "SIMPLE_CHEMICAL", 57, 82], ["N\u2010(substituted 3\u2010oxo\u20101\u2010thia\u20104\u2010azaspiro[4.4]non\u20104\u2010yl/[4.5]dec\u20104\u2010yl/[4.6]undec\u20104\u2010yl)\u20102\u2010phenoxyacetamide (7)", "SIMPLE_CHEMICAL", 90, 195], ["N\u2010(substituted 3\u2010oxo\u20101\u2010thia\u20104\u2010azaspiro[4.4]non\u20104\u2010yl/[4.5]decan\u20104\u2010yl)\u20103\u2010phenylpropanamides", "SIMPLE_CHEMICAL", 199, 288], ["Cyclocondensation", "TREATMENT", 0, 17], ["sulphanylacetic acid", "TREATMENT", 33, 53], ["2\u2010sulphanylpropanoic acid", "TREATMENT", 57, 82], ["N\u2010(substituted 3\u2010oxo\u20101", "TREATMENT", 90, 112], ["azaspiro", "TEST", 120, 128], ["undec\u20104\u2010yl)", "TREATMENT", 161, 172], ["phenoxyacetamide", "TREATMENT", 175, 191], ["N\u2010(substituted 3\u2010oxo\u20101", "TREATMENT", 199, 221], ["azaspiro", "TEST", 229, 237], ["decan\u20104\u2010yl)", "TREATMENT", 256, 267]]], ["The first evidence for the formation of 7 and 8 was the observation of a new band between 1728\u20131697 cm\u22121 in their IR spectra due to 3\u2010carbonyl group.", [["\u2010carbonyl", "CHEMICAL", 133, 142], ["3\u2010carbonyl", "CHEMICAL", 132, 142], ["3\u2010carbonyl", "SIMPLE_CHEMICAL", 132, 142], ["new", "OBSERVATION_MODIFIER", 73, 76]]], ["The C=O stretching band of the carboxamide moiety was also observed at 1660\u20131693 cm\u22121.", [["carboxamide", "CHEMICAL", 31, 42], ["C=O", "CHEMICAL", 4, 7], ["carboxamide", "CHEMICAL", 31, 42], ["carboxamide moiety", "SIMPLE_CHEMICAL", 31, 49], ["The C=O stretching band of the carboxamide moiety", "TREATMENT", 0, 49]]], ["Bands between 3468\u20133167 cm\u22121 region confirmed the presence of NH stretching bands.", [["NH", "CHEMICAL", 62, 64], ["Bands", "TEST", 0, 5], ["NH stretching bands", "PROBLEM", 62, 81], ["stretching bands", "OBSERVATION", 65, 81]]], ["In the 1H\u2010NMR spectra of 7, CONH protons were observed at \u03b4 9.91\u201310.59 ppm as singlets.", [["1H", "CHEMICAL", 7, 9], ["CONH", "CHEMICAL", 28, 32], ["CONH protons", "SIMPLE_CHEMICAL", 28, 40], ["NMR spectra", "TEST", 10, 21]]], ["C2\u2013methylene protons of 7a\u2013g and 8a\u2013h resonated at \u03b4 3.52\u20133.64 ppm as singlets, while C2\u2010methine protons of 7h\u2013n and 8i\u2013p gave quartets at \u03b4 3.80\u20133.93 ppm.", [["C2\u2013methylene", "CHEMICAL", 0, 12], ["C2\u2010methine", "CHEMICAL", 86, 96], ["C2\u2013methylene", "CHEMICAL", 0, 12], ["C2\u2010methine", "CHEMICAL", 86, 96], ["7h\u2013n", "CHEMICAL", 108, 112], ["C2\u2013methylene protons", "SIMPLE_CHEMICAL", 0, 20], ["7a\u2013g", "SIMPLE_CHEMICAL", 24, 28], ["C2\u2010methine protons", "SIMPLE_CHEMICAL", 86, 104], ["7h\u2013n", "SIMPLE_CHEMICAL", 108, 112], ["8i\u2013p", "SIMPLE_CHEMICAL", 117, 121], ["C2\u2013methylene protons", "TREATMENT", 0, 20]]], ["The 13C\u2010NMR spectra of 7a\u2013m and 8j showed spirothiazolidinone C2 carbon (\u03b4 27.76\u201338.08 ppm) and spirothiazolidinone C=O carbon (\u03b4 167.59\u2013170.77 ppm) resonances as another evidence for the formation of a ring system.", [["spirothiazolidinone C2 carbon", "CHEMICAL", 42, 71], ["spirothiazolidinone", "CHEMICAL", 96, 115], ["13C", "CHEMICAL", 4, 7], ["spirothiazolidinone C2 carbon", "CHEMICAL", 42, 71], ["spirothiazolidinone C=O carbon", "CHEMICAL", 96, 126], ["13C", "SIMPLE_CHEMICAL", 4, 7], ["7a\u2013m", "SIMPLE_CHEMICAL", 23, 27], ["spirothiazolidinone C2 carbon", "SIMPLE_CHEMICAL", 42, 71], ["spirothiazolidinone C=O carbon", "SIMPLE_CHEMICAL", 96, 126], ["NMR spectra", "TEST", 8, 19], ["7a\u2013m", "TEST", 23, 27], ["spirothiazolidinone C2 carbon", "TREATMENT", 42, 71], ["spirothiazolidinone C=O carbon", "TREATMENT", 96, 126], ["a ring system", "TREATMENT", 201, 214], ["ring system", "OBSERVATION", 203, 214]]], ["Molecular weights (for the group coded as 7) were verified by taking mass spectra to get another proof.", [["Molecular weights", "TEST", 0, 17]]], ["ESI method was applied in positive or negative modes and [M+H]+ or [M\u2010H]\u2212 ions formed confirmed the molecular weights.Biological activity ::: RESULTS AND DISCUSSIONThe compounds were evaluated for antiviral activity against human coronavirus 229E in HEL 299 fibroblast cells, and against influenza A/H1N1, A/H3N2, and B viruses in MDCK cells.", [["HEL 299 fibroblast cells", "ANATOMY", 250, 274], ["MDCK cells", "ANATOMY", 331, 341], ["[M+H]+", "CHEMICAL", 57, 63], ["[M\u2010H]\u2212", "CHEMICAL", 67, 73], ["[M+H]+", "SIMPLE_CHEMICAL", 57, 63], ["[M\u2010H]\u2212 ions", "SIMPLE_CHEMICAL", 67, 78], ["human", "ORGANISM", 224, 229], ["coronavirus 229E", "ORGANISM", 230, 246], ["HEL 299 fibroblast cells", "CELL", 250, 274], ["influenza A/H1N1", "ORGANISM", 288, 304], ["A/H3N2", "ORGANISM", 306, 312], ["B viruses", "ORGANISM", 318, 327], ["MDCK cells", "CELL", 331, 341], ["HEL 299 fibroblast cells", "CELL_LINE", 250, 274], ["MDCK cells", "CELL_LINE", 331, 341], ["human", "SPECIES", 224, 229], ["coronavirus", "SPECIES", 230, 241], ["human coronavirus", "SPECIES", 224, 241], ["influenza A/H1N1", "SPECIES", 288, 304], ["A/H3N2", "SPECIES", 306, 312], ["B viruses", "SPECIES", 318, 327], ["ESI method", "TREATMENT", 0, 10], ["M+H", "TEST", 58, 61], ["\u2212 ions", "TEST", 72, 78], ["antiviral activity", "TREATMENT", 197, 215], ["human coronavirus", "PROBLEM", 224, 241], ["fibroblast cells", "TEST", 258, 274], ["influenza", "PROBLEM", 288, 297], ["H1N1", "PROBLEM", 300, 304], ["H3N2", "PROBLEM", 308, 312], ["B viruses in MDCK cells", "PROBLEM", 318, 341], ["fibroblast cells", "OBSERVATION", 258, 274], ["MDCK cells", "OBSERVATION", 331, 341]]], ["The test compounds can be classified in either Group 7, carrying a phenoxyethyl side chain, or Group 8, with a phenethyl side chain.", [["phenethyl", "CHEMICAL", 111, 120], ["phenoxyethyl", "CHEMICAL", 67, 79], ["phenethyl", "CHEMICAL", 111, 120], ["phenoxyethyl side chain", "SIMPLE_CHEMICAL", 67, 90], ["phenethyl side chain", "SIMPLE_CHEMICAL", 111, 131], ["The test compounds", "TEST", 0, 18], ["a phenoxyethyl side chain", "TREATMENT", 65, 90], ["a phenethyl side chain", "TREATMENT", 109, 131]]], ["Our previously discovered H3 hemagglutinin\u2010specific influenza virus fusion inhibitors9 have the same scaffold but carry an imidazo[2,1\u2010b]thiazole or o\u2010hydroxyphenyl side chain.", [["imidazo[2,1\u2010b]thiazole", "CHEMICAL", 123, 145], ["o\u2010hydroxyphenyl", "CHEMICAL", 149, 164], ["imidazo[2,1\u2010b]thiazole", "CHEMICAL", 123, 145], ["o\u2010hydroxyphenyl", "CHEMICAL", 149, 164], ["H3 hemagglutinin\u2010specific influenza virus", "ORGANISM", 26, 67], ["imidazo[2,1\u2010b]thiazole", "SIMPLE_CHEMICAL", 123, 145], ["o\u2010hydroxyphenyl side chain", "SIMPLE_CHEMICAL", 149, 175], ["H3", "PROTEIN", 26, 28], ["hemagglutinin\u2010specific influenza virus", "SPECIES", 29, 67], ["H3 hemagglutinin\u2010specific influenza virus", "SPECIES", 26, 67], ["H3 hemagglutinin\u2010specific influenza virus fusion inhibitors9", "TREATMENT", 26, 86], ["an imidazo", "TREATMENT", 120, 130], ["thiazole", "TREATMENT", 137, 145], ["o\u2010hydroxyphenyl side chain", "TREATMENT", 149, 175], ["influenza virus", "OBSERVATION", 52, 67]]], ["The current series of molecules show no activity against influenza viruses at concentrations up to 100 \u00b5M (data not shown), probably phenoxymethyl and phenethyl side chains are not suitable for binding to influenza virus hemagglutinin.Biological activity ::: RESULTS AND DISCUSSIONSeven compounds, i.e. 7m, 7n, 8k, 8l, 8m, 8n, and 8p, were found to inhibit human coronavirus 229E with low cytotoxicity (Table 1).", [["influenza viruses", "DISEASE", 57, 74], ["phenoxymethyl", "CHEMICAL", 133, 146], ["phenethyl", "CHEMICAL", 151, 160], ["phenoxymethyl", "CHEMICAL", 133, 146], ["phenethyl", "CHEMICAL", 151, 160], ["influenza viruses", "ORGANISM", 57, 74], ["phenoxymethyl", "SIMPLE_CHEMICAL", 133, 146], ["phenethyl side chains", "SIMPLE_CHEMICAL", 151, 172], ["influenza virus hemagglutinin", "ORGANISM", 205, 234], ["8p", "SIMPLE_CHEMICAL", 331, 333], ["human", "ORGANISM", 357, 362], ["coronavirus 229E", "ORGANISM", 363, 379], ["influenza virus hemagglutinin", "PROTEIN", 205, 234], ["influenza virus hemagglutinin", "SPECIES", 205, 234], ["human", "SPECIES", 357, 362], ["coronavirus", "SPECIES", 363, 374], ["influenza virus", "SPECIES", 205, 220], ["human coronavirus", "SPECIES", 357, 374], ["influenza viruses", "PROBLEM", 57, 74], ["phenoxymethyl and phenethyl side chains", "TREATMENT", 133, 172], ["influenza virus hemagglutinin", "TREATMENT", 205, 234], ["human coronavirus", "TEST", 357, 374], ["low cytotoxicity", "PROBLEM", 385, 401], ["no", "UNCERTAINTY", 37, 39]]], ["The compounds showing activity all carry a methyl substituent at the C\u20102 position of the azaspiro[4.5]decane (R1), whereas the unmethylated analogs (i.e., 7e, 7f, 8c, 8d, 8e, 8f, 8h) were devoid of antiviral activity.", [["methyl substituent", "CHEMICAL", 43, 61], ["azaspiro[4.5]decane", "CHEMICAL", 89, 108], ["methyl", "CHEMICAL", 43, 49], ["C\u20102", "CHEMICAL", 69, 72], ["azaspiro[4.5]decane", "CHEMICAL", 89, 108], ["methyl substituent", "SIMPLE_CHEMICAL", 43, 61], ["C\u20102", "SIMPLE_CHEMICAL", 69, 72], ["azaspiro[4.5]decane", "SIMPLE_CHEMICAL", 89, 108], ["a methyl substituent", "TREATMENT", 41, 61], ["antiviral activity", "OBSERVATION", 198, 216]]], ["The same observation was previously made for the structurally related influenza virus fusion inhibitors.9 In addition, for compound series 8, the anti\u2010coronavirus activity clearly depended on the bulkiness of the C\u20108 substituent of the azaspiro[4.5]decane (R).", [["C\u20108 substituent", "CHEMICAL", 213, 228], ["azaspiro[4.5]decane", "CHEMICAL", 236, 255], ["C\u20108", "CHEMICAL", 213, 216], ["azaspiro[4.5]decane", "CHEMICAL", 236, 255], ["influenza virus", "ORGANISM", 70, 85], ["anti\u2010coronavirus", "SIMPLE_CHEMICAL", 146, 162], ["C\u20108 substituent", "SIMPLE_CHEMICAL", 213, 228], ["azaspiro[4.5]decane", "SIMPLE_CHEMICAL", 236, 255], ["the structurally related influenza virus fusion inhibitors", "TREATMENT", 45, 103], ["compound series", "TEST", 123, 138], ["the anti\u2010coronavirus activity", "PROBLEM", 142, 171], ["influenza virus", "OBSERVATION", 70, 85]]], ["No activity was seen for the unsubstituted compound 8j (R = H).", [["R = H", "SIMPLE_CHEMICAL", 56, 61], ["the unsubstituted compound", "PROBLEM", 25, 51], ["activity", "OBSERVATION", 3, 11]]], ["Intermediate activity was observed for 8k and 8l (EC50 = 28 and 18 \u00b5M), which carry a 4\u2010methyl and 4\u2010ethyl\u2010group, respectively.", [["methyl", "CHEMICAL", 88, 94], ["methyl", "SIMPLE_CHEMICAL", 88, 94], ["4\u2010ethyl\u2010group", "SIMPLE_CHEMICAL", 99, 112], ["EC50", "TEST", 50, 54], ["activity", "OBSERVATION_MODIFIER", 13, 21]]], ["A further increase in activity was seen for 8m, 8n, and 8p (EC50 values 5.5\u20138.1 \u00b5M), carrying, respectively, a 4\u2010propyl, 4\u2010tert\u2010butyl and 4\u2010phenyl group.", [["4\u2010propyl, 4\u2010tert\u2010butyl and 4\u2010phenyl", "CHEMICAL", 111, 146], ["propyl", "CHEMICAL", 113, 119], ["butyl", "CHEMICAL", 128, 133], ["4\u2010phenyl", "CHEMICAL", 138, 146], ["4\u2010propyl", "SIMPLE_CHEMICAL", 111, 119], ["4\u2010tert\u2010butyl", "SIMPLE_CHEMICAL", 121, 133], ["4\u2010phenyl", "SIMPLE_CHEMICAL", 138, 146], ["A further increase in activity", "PROBLEM", 0, 30], ["EC50 values", "TEST", 60, 71], ["a 4\u2010propyl", "TREATMENT", 109, 119], ["4\u2010tert\u2010butyl and 4\u2010phenyl group", "TREATMENT", 121, 152], ["increase", "OBSERVATION_MODIFIER", 10, 18], ["activity", "OBSERVATION_MODIFIER", 22, 30]]], ["An exception here is 8o (R = 4\u2010CF3), which did not show antiviral activity at concentrations up to 100 \u00b5M.", [["antiviral activity", "OBSERVATION", 56, 74]]], ["Its direct analog belonging to Group 7 (7m) however, was moderately active (EC50 = 31 \u00b5M), and so was 7n (EC50 = 12 \u00b5M), which carries the same substituent (4\u2010phenyl) as 8p.", [["\u2010phenyl", "CHEMICAL", 158, 165], ["\u2010phenyl", "CHEMICAL", 158, 165], ["4\u2010phenyl", "SIMPLE_CHEMICAL", 157, 165], ["EC50", "TEST", 76, 80], ["EC50", "TEST", 106, 110], ["moderately", "OBSERVATION_MODIFIER", 57, 67], ["active", "OBSERVATION_MODIFIER", 68, 74]]], ["Molecules 7k and 7l, which are the counterparts of 8k and 8n, were not active.CONCLUSIONWe report the chemical synthesis of a compound series with 4\u2010carboxamido\u20103\u2010oxo\u20101\u2010thia\u20104\u2010azaspiro[4.4]nonan/[4.5]decan/[4.6]undecan structure.", [["thia\u20104\u2010azaspiro[4.4]nonan", "CHEMICAL", 169, 194], ["4\u2010carboxamido\u20103\u2010oxo\u20101\u2010thia\u20104\u2010azaspiro[4.4]nonan", "CHEMICAL", 147, 194], ["[4.5]decan", "CHEMICAL", 195, 205], ["[4.6]undecan", "CHEMICAL", 206, 218], ["7l", "GENE_OR_GENE_PRODUCT", 17, 19], ["4\u2010carboxamido\u20103\u2010oxo\u20101\u2010thia\u20104\u2010azaspiro[4.4]nonan/[4.5]decan/[4.6]undecan", "SIMPLE_CHEMICAL", 147, 218], ["carboxamido\u20103\u2010oxo\u20101", "TREATMENT", 149, 168], ["azaspiro", "TEST", 176, 184], ["not", "UNCERTAINTY", 67, 70], ["active", "OBSERVATION_MODIFIER", 71, 77]]], ["Upon evaluation in virus\u2010infected cell culture assays, seven compounds proved to be able to inhibit human coronavirus 229E virus replication, with the most potent analog having an EC50 value of 5.5 \u00b5M.", [["cell culture", "ANATOMY", 34, 46], ["cell", "CELL", 34, 38], ["human", "ORGANISM", 100, 105], ["coronavirus 229E virus", "ORGANISM", 106, 128], ["virus\u2010infected cell culture", "CELL_LINE", 19, 46], ["human", "SPECIES", 100, 105], ["coronavirus 229E virus", "SPECIES", 106, 128], ["human coronavirus 229E virus", "SPECIES", 100, 128], ["evaluation", "TEST", 5, 15], ["virus\u2010infected cell culture assays", "TEST", 19, 53], ["human coronavirus 229E virus replication", "TREATMENT", 100, 140], ["an EC50 value", "TEST", 177, 190]]], ["The anti\u2010coronavirus activity was found to be strongly dependent on the substituents at the C\u20102 and C\u20108 positions of the azaspiro[4.5]decane scaffold.", [["azaspiro[4.5]decane", "CHEMICAL", 121, 140], ["C\u20102", "CHEMICAL", 92, 95], ["C\u2010", "CHEMICAL", 100, 102], ["azaspiro[4.5]decane", "CHEMICAL", 121, 140], ["C\u20102", "SIMPLE_CHEMICAL", 92, 95], ["azaspiro[4.5]decane", "SIMPLE_CHEMICAL", 121, 140], ["strongly dependent", "PROBLEM", 46, 64], ["the azaspiro[4.5]decane scaffold", "TREATMENT", 117, 149]]], ["While a series of closely related analogs was previously demonstrated to target influenza virus fusion by interfering with hemagglutinin refolding at low pH, the present molecules have no activity against human influenza A/H1N1, A/H3N2, and B viruses.", [["influenza virus", "ORGANISM", 80, 95], ["hemagglutinin", "GENE_OR_GENE_PRODUCT", 123, 136], ["human", "ORGANISM", 205, 210], ["influenza A/H1N1", "ORGANISM", 211, 227], ["A/H3N2", "ORGANISM", 229, 235], ["B viruses", "ORGANISM", 241, 250], ["hemagglutinin", "PROTEIN", 123, 136], ["influenza virus", "SPECIES", 80, 95], ["human", "SPECIES", 205, 210], ["influenza virus", "SPECIES", 80, 95], ["human influenza A/H1N1", "SPECIES", 205, 227], ["A/H3N2", "SPECIES", 229, 235], ["B viruses", "SPECIES", 241, 250], ["target influenza virus fusion", "TREATMENT", 73, 102], ["hemagglutinin refolding", "TREATMENT", 123, 146], ["low pH", "PROBLEM", 150, 156], ["human influenza", "PROBLEM", 205, 220], ["H1N1", "PROBLEM", 223, 227], ["H3N2", "PROBLEM", 231, 235], ["B viruses", "PROBLEM", 241, 250], ["no", "UNCERTAINTY", 185, 187]]], ["Ongoing mechanistic investigations will reveal the biochemical basis for their inhibitory effect on coronavirus.General ::: Chemistry ::: EXPERIMENTALMelting points were determined in open capillary tubes with a B\u00fcchi B\u2010540 melting point apparatus and are uncorrected.", [["capillary tubes", "ANATOMY", 189, 204], ["coronavirus", "ORGANISM", 100, 111], ["capillary tubes", "TISSUE", 189, 204], ["Ongoing mechanistic investigations", "TEST", 0, 34], ["coronavirus", "PROBLEM", 100, 111], ["EXPERIMENTALMelting points", "PROBLEM", 138, 164], ["open capillary tubes", "TREATMENT", 184, 204], ["capillary tubes", "OBSERVATION", 189, 204]]], ["IR spectra were recorded in KBr disks on a Shimadzu IR Affinity\u20101 FTIR spectrophotometer.", [["IR spectra", "TEST", 0, 10], ["a Shimadzu IR Affinity", "TREATMENT", 41, 63]]], ["1H and 13C\u2010NMR spectra were recorded on Varian Unity Inova (500 MHz) and Varian Mercury (400 MHz) spectrophotometers.", [["1H", "CHEMICAL", 0, 2], ["13C", "CHEMICAL", 7, 10], ["1H", "SIMPLE_CHEMICAL", 0, 2], ["13C", "SIMPLE_CHEMICAL", 7, 10], ["NMR spectra", "TEST", 11, 22], ["Varian Unity Inova", "TREATMENT", 40, 58], ["Varian Mercury (400 MHz) spectrophotometers", "TREATMENT", 73, 116]]], ["All chemical shifts were reported as \u03b4 (ppm) values and spin\u2010spin couplings (J) were expressed in Hz.", [["chemical shifts", "OBSERVATION", 4, 19]]], ["Microanalyses were performed on a Thermo Finnigan Flash EA 1112 elemental analyzer.", [["Microanalyses", "TEST", 0, 13], ["a Thermo Finnigan Flash EA", "TREATMENT", 32, 58]]], ["Electrospray ionization (ESI)/MS were determined on Agilent 6460 TripQuad LC\u2010MS/MS and Waters 2695 Alliance Micromass ZQ LC/MS spectrometers.General ::: Chemistry ::: EXPERIMENTALThe original spectra of the investigated compounds are provided as Supporting Information.", [["Electrospray ionization", "TREATMENT", 0, 23], ["Agilent", "TEST", 52, 59], ["MS", "PROBLEM", 80, 82], ["Waters", "TREATMENT", 87, 93]]], ["The InChI codes of the investigated compounds together with some biological activity data are also provided as Supporting Information.Synthesis of methyl phenoxyacetate (1) or methyl 3\u2010phenylpropanoate (2) ::: Chemistry ::: EXPERIMENTALA solution of phenoxyacetic acid (0.01 mol) or 3\u2010phenylpropionic acid (0.01 mol) and sulfuric acid (98%) (0.1 ml) in 50 ml of methanol was heated for 24 hr.", [["methyl phenoxyacetate", "CHEMICAL", 147, 168], ["methyl 3\u2010phenylpropanoate", "CHEMICAL", 176, 201], ["phenoxyacetic acid", "CHEMICAL", 250, 268], ["3\u2010phenylpropionic acid", "CHEMICAL", 283, 305], ["sulfuric acid", "CHEMICAL", 321, 334], ["methyl phenoxyacetate", "CHEMICAL", 147, 168], ["methyl 3\u2010phenylpropanoate", "CHEMICAL", 176, 201], ["phenoxyacetic acid", "CHEMICAL", 250, 268], ["3\u2010phenylpropionic acid", "CHEMICAL", 283, 305], ["sulfuric acid", "CHEMICAL", 321, 334], ["methanol", "CHEMICAL", 362, 370], ["methyl phenoxyacetate (1)", "SIMPLE_CHEMICAL", 147, 172], ["methyl 3\u2010phenylpropanoate (2) ::", "SIMPLE_CHEMICAL", 176, 208], ["phenoxyacetic acid", "SIMPLE_CHEMICAL", 250, 268], ["3\u2010phenylpropionic acid", "SIMPLE_CHEMICAL", 283, 305], ["sulfuric acid", "SIMPLE_CHEMICAL", 321, 334], ["methanol", "SIMPLE_CHEMICAL", 362, 370], ["InChI", "PROTEIN", 4, 9], ["Synthesis of methyl phenoxyacetate", "TREATMENT", 134, 168], ["EXPERIMENTALA solution of phenoxyacetic acid", "TREATMENT", 224, 268], ["3\u2010phenylpropionic acid", "TREATMENT", 283, 305], ["sulfuric acid", "TEST", 321, 334], ["methanol", "TREATMENT", 362, 370]]], ["The solution was neutralized with 0.01 mol of sodium bicarbonate solution, the mixture was extracted with diethyl ether and, after distillation of solvent, the ester was used without further purification.10, 13", [["sodium bicarbonate", "CHEMICAL", 46, 64], ["diethyl ether", "CHEMICAL", 106, 119], ["ester", "CHEMICAL", 160, 165], ["sodium bicarbonate", "CHEMICAL", 46, 64], ["diethyl ether", "CHEMICAL", 106, 119], ["ester", "CHEMICAL", 160, 165], ["sodium bicarbonate", "SIMPLE_CHEMICAL", 46, 64], ["diethyl ether", "SIMPLE_CHEMICAL", 106, 119], ["ester", "SIMPLE_CHEMICAL", 160, 165], ["The solution", "TREATMENT", 0, 12], ["sodium bicarbonate solution", "TREATMENT", 46, 73], ["diethyl ether", "TREATMENT", 106, 119], ["distillation of solvent", "TREATMENT", 131, 154], ["further purification", "TREATMENT", 183, 203]]]], "92dfdf67dbb4ddd13762656356f6a39271f8e847": [["All rights reserved COVID-19 was confirmed on SARS-CoV-2 real time reverse transcriptase polymerase chain reaction (RT-PCR) from the throat swab.", [["throat swab", "ANATOMY", 133, 144], ["COVID-19", "CHEMICAL", 20, 28], ["COVID-19", "DNA", 20, 28], ["reverse transcriptase", "PROTEIN", 67, 88], ["COVID", "TEST", 20, 25], ["SARS", "TEST", 46, 50], ["CoV", "TEST", 51, 54], ["transcriptase polymerase chain reaction", "PROBLEM", 75, 114], ["RT-PCR", "TEST", 116, 122], ["the throat swab", "TEST", 129, 144], ["throat", "ANATOMY", 133, 139]]], ["The patient was immediately transferred to intensive care, where he was intubated and ventilated and remained for 49 days.", [["patient", "ORGANISM", 4, 11], ["patient", "SPECIES", 4, 11], ["intubated", "TREATMENT", 72, 81], ["ventilated", "TREATMENT", 86, 96]]], ["Ventilation proved difficult with rising oxygen requirements and decreased lung compliance.", [["lung", "ANATOMY", 75, 79], ["oxygen", "CHEMICAL", 41, 47], ["oxygen", "CHEMICAL", 41, 47], ["oxygen", "SIMPLE_CHEMICAL", 41, 47], ["lung", "ORGAN", 75, 79], ["Ventilation", "TREATMENT", 0, 11], ["rising oxygen requirements", "PROBLEM", 34, 60], ["decreased lung compliance", "PROBLEM", 65, 90], ["oxygen requirements", "OBSERVATION", 41, 60], ["decreased", "OBSERVATION_MODIFIER", 65, 74], ["lung", "ANATOMY", 75, 79], ["compliance", "OBSERVATION", 80, 90]]], ["During the first week, his fraction of inspired oxygen (FiO 2 ) was consistently 0.6 -0.75 and intermittently as high as 0.95 (i.e. 95% oxygen), with low and deteriorating PaO 2 /FiO 2 ratios ( Figure 2 ).", [["oxygen", "CHEMICAL", 48, 54], ["oxygen", "CHEMICAL", 136, 142], ["oxygen", "CHEMICAL", 48, 54], ["FiO 2 )", "CHEMICAL", 56, 63], ["oxygen", "CHEMICAL", 136, 142], ["PaO 2", "CHEMICAL", 172, 177], ["FiO 2", "CHEMICAL", 179, 184], ["oxygen", "SIMPLE_CHEMICAL", 48, 54], ["oxygen", "SIMPLE_CHEMICAL", 136, 142], ["his fraction", "TEST", 23, 35], ["inspired oxygen", "TREATMENT", 39, 54], ["FiO", "TEST", 56, 59], ["low and deteriorating PaO", "PROBLEM", 150, 175], ["FiO", "TEST", 179, 182]]], ["This was consistent with severe acute respiratory distress syndrome (ARDS).", [["respiratory", "ANATOMY", 38, 49], ["acute respiratory distress syndrome", "DISEASE", 32, 67], ["ARDS", "DISEASE", 69, 73], ["severe acute respiratory distress syndrome", "PROBLEM", 25, 67], ["ARDS", "PROBLEM", 69, 73], ["consistent with", "UNCERTAINTY", 9, 24], ["severe", "OBSERVATION_MODIFIER", 25, 31], ["acute", "OBSERVATION_MODIFIER", 32, 37], ["respiratory distress syndrome", "OBSERVATION", 38, 67], ["ARDS", "OBSERVATION", 69, 73]]], ["He underwent multiple cycles of prone positioning and treatment with nitric oxide (a pulmonary vasodilator) in attempts to improve his oxygenation and empirical treatment with antimicrobial agents despite no definite evidence of bacterial co-infection.", [["pulmonary", "ANATOMY", 85, 94], ["nitric oxide", "CHEMICAL", 69, 81], ["bacterial co-infection", "DISEASE", 229, 251], ["nitric oxide", "CHEMICAL", 69, 81], ["nitric oxide", "SIMPLE_CHEMICAL", 69, 81], ["pulmonary", "ORGAN", 85, 94], ["prone positioning", "TREATMENT", 32, 49], ["treatment", "TREATMENT", 54, 63], ["nitric oxide", "TREATMENT", 69, 81], ["a pulmonary vasodilator", "TREATMENT", 83, 106], ["his oxygenation", "TREATMENT", 131, 146], ["empirical treatment", "TREATMENT", 151, 170], ["antimicrobial agents", "TREATMENT", 176, 196], ["bacterial co-infection", "PROBLEM", 229, 251], ["pulmonary", "ANATOMY", 85, 94], ["no definite evidence of", "UNCERTAINTY", 205, 228], ["bacterial", "OBSERVATION_MODIFIER", 229, 238], ["co-infection", "OBSERVATION", 239, 251]]], ["After a repeat chest X-ray demonstrated bilateral early fibrotic changes ( Figure 1B) , and with no improvement in gas exchange, methylprednisolone was commenced at 1 mg/kg BD for 10 days.", [["methylprednisolone", "CHEMICAL", 129, 147], ["methylprednisolone", "CHEMICAL", 129, 147], ["methylprednisolone", "SIMPLE_CHEMICAL", 129, 147], ["a repeat chest X-ray", "TEST", 6, 26], ["bilateral early fibrotic changes", "PROBLEM", 40, 72], ["methylprednisolone", "TREATMENT", 129, 147], ["chest", "ANATOMY", 15, 20], ["bilateral", "ANATOMY_MODIFIER", 40, 49], ["early", "OBSERVATION_MODIFIER", 50, 55], ["fibrotic", "OBSERVATION", 56, 64], ["no", "UNCERTAINTY", 97, 99], ["improvement", "OBSERVATION_MODIFIER", 100, 111], ["gas exchange", "OBSERVATION", 115, 127]]]], "c7a390faa039a6e9260caff9fff1c5c28b261467": [["It plays an integral component of quality of life, health and well-being both in the general population and those affected by illnesses.", [["integral", "OBSERVATION_MODIFIER", 12, 20], ["component", "OBSERVATION_MODIFIER", 21, 30]]], ["1 The relationship with the transcendent or sacred has a strong influence on a people's beliefs, attitudes, emotions and behaviour.", [["people", "ORGANISM", 79, 85], ["people", "SPECIES", 79, 85]]], ["2 Spirituality practices have been recognised as a powerful coping mechanism for dealing with life-changing and traumatic events.", [["traumatic events", "PROBLEM", 112, 128]]], ["1 During this global pandemic of Coronavirus disease 2019 (COVID- 19) , does spiritual care contribute as a coping strategy for practitioners and families?The effects of Coronavirus disease 2019 on spiritual careCoronavirus disease is a serious public health problem that has been confirmed by the World Health Organization (WHO) as a pandemic because of its worldwide spread.", [["Coronavirus disease", "DISEASE", 33, 52], ["Coronavirus disease", "DISEASE", 170, 189], ["careCoronavirus disease", "DISEASE", 208, 231], ["Coronavirus disease", "PROBLEM", 33, 52], ["COVID", "TEST", 59, 64], ["Coronavirus disease", "PROBLEM", 170, 189], ["spiritual careCoronavirus disease", "PROBLEM", 198, 231], ["Coronavirus disease", "OBSERVATION", 33, 52], ["Coronavirus disease", "OBSERVATION", 170, 189], ["serious", "OBSERVATION_MODIFIER", 237, 244]]], ["3 The World Health Organization reports that 4 307 287 people have been tested positive for COVID-19 worldwide in 216 countries.", [["people", "ORGANISM", 55, 61], ["people", "SPECIES", 55, 61], ["COVID", "TEST", 92, 97]]], ["3 Out of the confirmed cases, globally there have been 295 101 deaths related to COVID-19.", [["deaths", "DISEASE", 63, 69], ["COVID-19", "CHEMICAL", 81, 89], ["COVID-19", "DNA", 81, 89], ["COVID", "TEST", 81, 86]]], ["3 In the South African context, the Department of Health reports that 403 018 tests were conducted, of which 12 739 people were found to be infected by COVID-19 and 5676 people managed to recover from the disease.", [["people", "ORGANISM", 116, 122], ["people", "ORGANISM", 170, 176], ["people", "SPECIES", 116, 122], ["people", "SPECIES", 170, 176], ["018 tests", "TEST", 74, 83], ["COVID", "TEST", 152, 157], ["the disease", "PROBLEM", 201, 212], ["infected", "OBSERVATION", 140, 148], ["disease", "OBSERVATION", 205, 212]]], ["The recent COVID-19 crisis has resulted in 238 deaths in South Africa.", [["deaths", "DISEASE", 47, 53], ["The recent COVID", "TEST", 0, 16]]], ["4 The effects of COVID-19 have had a major impact on people's and front-line health workers' activities, routines, livelihoods, mental health and well-being.", [["COVID-19", "CHEMICAL", 17, 25], ["COVID-19", "CHEMICAL", 17, 25], ["people", "ORGANISM", 53, 59], ["people", "SPECIES", 53, 59]]], ["3, 5 Healthcare workers risk their lives to save people who have COVID-19 while promoting compassionate care.", [["people", "ORGANISM", 49, 55], ["people", "SPECIES", 49, 55]]], ["People who have COVID-19 tend to present with severe distress associated with the disease that affects different aspects of their wholeness, including physical, emotional, mental, social and spiritual components.", [["distress", "DISEASE", 53, 61], ["physical, emotional, mental, social and spiritual components", "DISEASE", 151, 211], ["People", "ORGANISM", 0, 6], ["People", "SPECIES", 0, 6], ["COVID", "TEST", 16, 21], ["severe distress", "PROBLEM", 46, 61], ["the disease", "PROBLEM", 78, 89], ["physical, emotional, mental, social and spiritual components", "PROBLEM", 151, 211], ["severe", "OBSERVATION_MODIFIER", 46, 52], ["distress", "OBSERVATION", 53, 61], ["disease", "OBSERVATION", 82, 89]]], ["6 This means that the healthcare workers need to create a supportive environment that could promote interdependence through a transformative approach of spiritual care.", [["spiritual care", "TREATMENT", 153, 167]]], ["7 It further means that all patients and their families should be treated with dignity and be given the voice to express their concerns irrespective of gender, religion, culture, race, sexual orientation and disability.", [["disability", "DISEASE", 208, 218], ["patients", "ORGANISM", 28, 36], ["patients", "SPECIES", 28, 36], ["dignity", "TREATMENT", 79, 86], ["culture", "TEST", 170, 177]]], ["6, 7 Note: Special Collection: COVID-19.The effects of Coronavirus disease 2019 on spiritual careCoronavirus disease 2019 (COVID-19) has presented unprecedented health challenges across all strata in society throughout the world.", [["Coronavirus disease", "DISEASE", 55, 74], ["careCoronavirus disease", "DISEASE", 93, 116], ["COVID-19", "CHEMICAL", 123, 131], ["COVID", "TEST", 31, 36], ["Coronavirus disease", "PROBLEM", 55, 74], ["spiritual careCoronavirus disease", "PROBLEM", 83, 116], ["Coronavirus disease", "OBSERVATION", 55, 74]]], ["During this time, spiritual care forms a vital component of holistic health management, especially in terms of coping, coming to terms with illness, suffering and ultimately death.", [["illness", "DISEASE", 140, 147], ["death", "DISEASE", 174, 179], ["spiritual care", "TREATMENT", 18, 32], ["holistic health management", "TREATMENT", 60, 86]]], ["The relationship with the transcendent or sacred has a strong influence on a people's beliefs, attitudes, emotions and behaviour.", [["people", "ORGANISM", 77, 83], ["people", "SPECIES", 77, 83]]], ["Populations, communities, families and individuals have always found solace through their religious or philosophical beliefs during times of personal adversity and widespread anxiety or disaster.", [["anxiety", "DISEASE", 175, 182]]], ["Although spiritual care has always been a part of the domain of religious beliefs, a more contemporary perspective is that spiritual care forms part of the human psyche and thus forms part of human care, health and well-being for families, patients and healthcare workers.", [["human", "ORGANISM", 156, 161], ["human", "ORGANISM", 192, 197], ["patients", "ORGANISM", 240, 248], ["human", "SPECIES", 156, 161], ["human", "SPECIES", 192, 197], ["patients", "SPECIES", 240, 248], ["human", "SPECIES", 156, 161], ["human", "SPECIES", 192, 197]]], ["Spiritual care deals with the provision of compassion and empathy during periods of heightened stress, distress and anxiety within care.", [["anxiety", "DISEASE", 116, 123], ["Spiritual care", "TREATMENT", 0, 14], ["heightened stress", "PROBLEM", 84, 101], ["distress", "PROBLEM", 103, 111], ["anxiety", "PROBLEM", 116, 123]]], ["This article provides insights into the necessity of providing spiritual care as a means of coping and well-being for families, patients and healthcare workers during the COVID-19 pandemic.The effects of Coronavirus disease 2019 on spiritual careKeywords: spiritual care; Covid-19; pandemic; well-being; coping.Spiritual care -'A deeper immunity' -A response to Covid-19 pandemicRead online:Spiritual care -'A deeper immunity' -A response to Covid-19 pandemicScan this QR code with your smart phone or mobile device to read online.Spiritual care -'A deeper immunity' -A response to Covid-19 pandemicSpiritual care comprises activities that healthcare workers engage in to promote the quality of life and well-being of the clients.", [["Coronavirus disease", "DISEASE", 204, 223], ["patients", "ORGANISM", 128, 136], ["Covid-19 pandemicScan this QR code", "DNA", 442, 476], ["patients", "SPECIES", 128, 136], ["spiritual care", "TREATMENT", 63, 77], ["Coronavirus disease", "PROBLEM", 204, 223], ["spiritual care", "TREATMENT", 256, 270], ["Spiritual care", "TREATMENT", 311, 325], ["Covid", "TEST", 362, 367], ["Spiritual care", "TREATMENT", 391, 405], ["mobile device", "TREATMENT", 502, 515], ["Covid-19 pandemicSpiritual care", "TREATMENT", 582, 613], ["Coronavirus disease", "OBSERVATION", 204, 223]]], ["6, 8 The activities that the healthcare workers and people who have COVID-19 engage in include compassionate presence, listening to patients' fears, hopes and dreams, obtaining a spiritual history, being attentive to all spheres of patients' lives and their families.", [["people", "ORGANISM", 52, 58], ["patients", "ORGANISM", 132, 140], ["patients", "ORGANISM", 232, 240], ["people", "SPECIES", 52, 58], ["patients", "SPECIES", 132, 140], ["patients", "SPECIES", 232, 240]]], ["8 However, in terms of COVID-19, some of the activities, such as the involvement of chaplains and spiritual practices, can be limited because of precautionary measures for infection control.", [["infection", "DISEASE", 172, 181], ["COVID", "TEST", 23, 28], ["spiritual practices", "TREATMENT", 98, 117], ["precautionary measures", "TREATMENT", 145, 167], ["infection control", "TREATMENT", 172, 189]]], ["9 Spirituality is significant in healthcare because it promotes coping strategies for stress, promotes recovery and resilience and prevents burnout.Spirituality for clinical settingsStudies have reported that healthcare practitioners who provide spiritual care to their patients contribute significantly to improve their patients' overall well-being.", [["burnout", "DISEASE", 140, 147], ["patients", "ORGANISM", 270, 278], ["patients", "ORGANISM", 321, 329], ["patients", "SPECIES", 270, 278], ["patients", "SPECIES", 321, 329], ["stress", "PROBLEM", 86, 92], ["burnout", "PROBLEM", 140, 147], ["spiritual care", "TREATMENT", 246, 260], ["significant", "OBSERVATION_MODIFIER", 18, 29]]], ["10, 11 Spiritual care is regarded as a life-enhancing factor and a coping resource, which allows patients to deal with adversity in a better way.", [["patients", "ORGANISM", 97, 105], ["patients", "SPECIES", 97, 105]]], ["12 Research reports significantly increased immune functions in response to spiritual care practices.", [["significantly increased immune functions", "PROBLEM", 20, 60], ["spiritual care practices", "TREATMENT", 76, 100], ["increased", "OBSERVATION_MODIFIER", 34, 43], ["immune functions", "OBSERVATION", 44, 60]]], ["1 The current restrictions imposed in South Africa amidst the lockdown prevent free movement and access to normal daily services.", [["free movement", "OBSERVATION", 79, 92]]], ["South Africans are restricted to the confines of their homes, which may increase levels of anxiety in the general population and even more so in those affected by illnesses.", [["anxiety", "DISEASE", 91, 98], ["anxiety", "PROBLEM", 91, 98], ["increase", "OBSERVATION_MODIFIER", 72, 80], ["levels", "OBSERVATION_MODIFIER", 81, 87]]], ["This may negatively affect the health and well-being of many South Africans.", [["Africans", "ORGANISM", 67, 75]]], ["These restrictions impede the facilitation of spiritual care in clinical settings.", [["spiritual care", "TREATMENT", 46, 60]]], ["13 Spiritual care is based on a bio-psycho-socio-spiritual integrative model that requires a specific set of skills such as active listening, spiritual assessment skills and the ability to refer patients to pastoral care, or other types of intervention services focused on spirituality.", [["patients", "ORGANISM", 195, 203], ["patients", "SPECIES", 195, 203], ["Spiritual care", "TREATMENT", 3, 17], ["spiritual assessment", "TEST", 142, 162], ["intervention services", "TREATMENT", 240, 261]]], ["For this reason, under the current circumstances, healthcare professionals should be extra-sensitive to the spiritual needs of their patients and their own, as studies have reported that patients' reliance on spirituality increases during life-changing events.", [["patients", "ORGANISM", 133, 141], ["patients", "ORGANISM", 187, 195], ["patients", "SPECIES", 133, 141], ["patients", "SPECIES", 187, 195]]], ["6, 8 However, this may be problematic as research indicates that whilst many health professionals agree that spiritual care is important for their patients, many are ill-equipped to deal with this aspect.", [["patients", "ORGANISM", 147, 155], ["patients", "SPECIES", 147, 155], ["spiritual care", "TREATMENT", 109, 123]]], ["14 Collaborative effort may be required to draw on the expertise of those practitioners of spiritual care to support the spiritual care needs of families.", [["spiritual care", "TREATMENT", 91, 105]]], ["15 For example, when families engage in healthrisking behaviour, such as smoking, substance abuse, not exercising or not eating correctly, their behaviours could result in in non-communicable diseases such as diabetes, hypertension, etc. Not only do they place themselves at risk but they also create a negative social atmosphere for their growing children.", [["smoking", "CHEMICAL", 73, 80], ["substance abuse", "DISEASE", 82, 97], ["diabetes", "DISEASE", 209, 217], ["hypertension", "DISEASE", 219, 231], ["children", "ORGANISM", 348, 356], ["children", "SPECIES", 348, 356], ["non-communicable diseases", "PROBLEM", 175, 200], ["diabetes", "PROBLEM", 209, 217], ["hypertension", "PROBLEM", 219, 231], ["diabetes", "OBSERVATION", 209, 217], ["hypertension", "OBSERVATION", 219, 231]]], ["However, families also provide care and support -care of children, the sick and the elderly and support in times of challenges.", [["children", "ORGANISM", 57, 65], ["children", "SPECIES", 57, 65]]], ["The most challenging time requiring family support and support to families is during a chronic illness, when one is critically ill and during end of life.", [["chronic illness", "DISEASE", 87, 102], ["family support", "TREATMENT", 36, 50], ["a chronic illness", "PROBLEM", 85, 102], ["most challenging", "OBSERVATION_MODIFIER", 4, 20]]], ["16 Research has shown that the spiritual care provider plays an important role when families are faced with challenging health risks and the prospect of palliative care.", [["palliative care", "TREATMENT", 153, 168]]], ["17 For example, when families are able to get in touch with a spiritual care provider, they offer a supportive role in the decision-making of a family member who is a patient; they have a sense of peace; they have the opportunity for bereavement and grief counselling and just being able to cope in a very difficult time.", [["patient", "ORGANISM", 167, 174], ["patient", "SPECIES", 167, 174]]], ["18Spiritual care in the South African pandemicThe rise in COVID-19 cases in South Africa has necessitated the need for more technologically driven healthcare solutions such as telemedicine.", [["COVID", "TEST", 58, 63], ["rise", "OBSERVATION_MODIFIER", 50, 54]]], ["Globally, many governments and healthcare systems have utilised telemedicine as a primary means of healthcare support during the COVID-19 outbreak.", [["healthcare support", "TREATMENT", 99, 117], ["the COVID", "TEST", 125, 134]]], ["A rise in the number of remotely monitored patients has been reported for most countries.", [["patients", "ORGANISM", 43, 51], ["patients", "SPECIES", 43, 51], ["rise", "OBSERVATION_MODIFIER", 2, 6]]], ["21 During this transition from the physical clinical setting to the virtual one, the importance of spiritual care should not be lost or forgotten because it forms part of the holistic approach to deal with the body-mind-spirit aspect of the population.", [["body", "ANATOMY", 210, 214], ["body", "ORGANISM_SUBDIVISION", 210, 214], ["spiritual care", "TREATMENT", 99, 113]]]], "PMC7235300": [["For example, there is substantial evidence that divided political elites polarized American attitudes toward climate science (Carmichael and Brulle, 2017; Merkley and Stecula, forthcoming; Tesler, 2018).", [["substantial", "OBSERVATION_MODIFIER", 22, 33], ["political", "OBSERVATION_MODIFIER", 56, 65]]], ["Most research on cue-taking has been situated in the United States, but some work has illustrated the importance of elite cues comparatively (Bischof and Wagner, 2019) and in Canada specifically (Merolla et al., 2016).Elite Cues and Public OpinionThe implications of elite disagreement on an issue like the COVID-19 pandemic are considerable.", [["elite disagreement", "PROBLEM", 267, 285], ["the COVID", "TEST", 303, 312]]], ["Divided parties send polarizing signals to the mass public that could undermine efforts to fight the virus.", [["the virus", "PROBLEM", 97, 106]]], ["In the United States, Republican officials voiced skepticism about the severity of the pandemic early in the crisis, and attitudes toward COVID-19 are heavily polarized, perhaps as a result (Gadarian et al., 2020).", [["COVID", "TEST", 138, 143]]], ["The past few decades have seen polarization increase in Canada (Cochrane, 2015).", [["polarization", "OBSERVATION_MODIFIER", 31, 43], ["increase", "OBSERVATION_MODIFIER", 44, 52]]], ["Here, we evaluate the degree to which the politics in Canada regarding COVID-19 can be characterized by partisan polarization.Data and MethodsWe employ data from the social media accounts of federal Members of Parliament (MPs), Google search trends, and public opinion surveys to evaluate the response to COVID-19 by Canadian political elites and the mass public.", [["COVID-19", "CHEMICAL", 71, 79], ["COVID-19", "CHEMICAL", 71, 79], ["COVID", "TEST", 71, 76], ["public opinion surveys", "TEST", 254, 276], ["COVID", "TEST", 305, 310], ["the mass public", "PROBLEM", 347, 362], ["mass", "OBSERVATION", 351, 355]]], ["To assess elite cues, we collected all tweets from MPs who use Twitter (292 accounts, with a total of 33,142 tweets since January 1, 2020).", [["MPs", "GENE_OR_GENE_PRODUCT", 51, 54], ["MPs", "CELL_TYPE", 51, 54]]], ["We calculate the share of MP tweets mentioning COVID-19 by party and then benchmark these series against other issues (environment and immigration).", [["MP", "DISEASE", 26, 28]]], ["Hand-coding was done on all tweets related to COVID-19 in order to identify signals downplaying the severity of the crisis and messages promoting social distancing.Data and MethodsFollowing the elite cue analysis, we gauge the relationship between partisanship and concern about COVID-19 at both the aggregate and individual levels.", [["partisanship", "DISEASE", 248, 260], ["COVID-19", "DNA", 46, 54], ["COVID", "TEST", 46, 51], ["the crisis", "PROBLEM", 112, 122], ["the elite cue analysis", "TEST", 190, 212], ["COVID", "TEST", 279, 284], ["crisis", "OBSERVATION", 116, 122]]], ["We collected Google search trends for the search term \u201ccoronavirus\u201d in the first half (1\u201314) and second half (15\u201331) of March.", [["coronavirus\u201d", "DISEASE", 55, 67], ["coronavirus", "ORGANISM", 55, 66], ["coronavirus", "PROBLEM", 55, 66]]], ["These data show the relative difference in search interest in the coronavirus between municipalities.", [["coronavirus", "DISEASE", 66, 77], ["coronavirus", "ORGANISM", 66, 77], ["These data", "TEST", 0, 10]]], ["We obtained municipal-level estimates of the Conservative party's (CPC) vote share in 2015, as well as population size (logged), population density (logged), average median income, and share of population with a postsecondary education.1 We construct an urban index, with population size and density, and a socio-economic status (SES) index, from education and income levels (both scaled 0\u20131).", [["an urban index", "TEST", 251, 265], ["income levels", "TEST", 361, 374], ["size", "OBSERVATION_MODIFIER", 114, 118], ["population", "OBSERVATION_MODIFIER", 272, 282], ["size", "OBSERVATION_MODIFIER", 283, 287], ["density", "OBSERVATION", 292, 299]]], ["We estimate a model predicting relative search interest in the coronavirus with Conservative party vote share, the urban and SES indices, and provincial fixed effects with robust standard errors.Data and MethodsWe conducted a survey of 2,499 Canadian citizens 18 years and older from the online sample provider Dynata fielded from April 2 to April 6.", [["coronavirus", "DISEASE", 63, 74], ["coronavirus", "ORGANISM", 63, 74], ["SES indices", "TEST", 125, 136], ["provincial fixed effects", "PROBLEM", 142, 166], ["fixed effects", "OBSERVATION", 153, 166]]], ["National level quotas were set on region (that is, Atlantic, Quebec, Ontario, West), age, gender and language.", [["National level quotas", "TEST", 0, 21]]], ["We create a COVID-19 severity index from these responses, scaled from 0 to 1.Data and MethodsWe also asked our respondents whether or not they have engaged in a series of social distancing behaviours.", [["a COVID", "TEST", 10, 17]]], ["We use principal components analysis to identify two dimensions that run through these responses, roughly corresponding to their offline (for example, avoiding large crowds) and online (for example, working from home) social distancing.", [["principal components analysis", "TEST", 7, 36]]], ["Factor loadings can be found in Table A1 of the appendix.", [["appendix", "ANATOMY", 48, 56], ["appendix", "ORGAN", 48, 56], ["Factor loadings", "PROBLEM", 0, 15], ["appendix", "ANATOMY", 48, 56]]], ["We estimate models regressing our severity and social distancing indices on partisanship and left\u2013right ideology,2 with controls for income, education, age, religiosity, urban residence, gender, French language and region.Aggregate-Level Analyses ::: ResultsThis elite consensus on the seriousness of COVID-19 is reflected in aggregate-level partisan differences in search traffic on the coronavirus.", [["COVID-19", "CHEMICAL", 301, 309], ["coronavirus", "ORGANISM", 388, 399], ["COVID-19", "DNA", 301, 309], ["COVID", "TEST", 301, 306], ["the coronavirus", "PROBLEM", 384, 399]]], ["The estimates from our model are provided in Table A2 in the appendix.", [["appendix", "ORGAN", 61, 69], ["appendix", "ANATOMY", 61, 69]]], ["We plot our model predictions for Canadian municipalities in Figure 2 across Conservative party vote share (left panel) and our socio-economic (centre panel) and urban status indices (right panel).", [["centre panel", "TEST", 144, 156], ["urban status indices", "TEST", 162, 182], ["right panel", "TEST", 184, 195], ["right", "ANATOMY_MODIFIER", 184, 189]]], ["There is no significant association between Conservative party vote share and search interest in the coronavirus.", [["coronavirus", "DISEASE", 101, 112], ["coronavirus", "ORGANISM", 101, 112], ["the coronavirus", "PROBLEM", 97, 112], ["no", "UNCERTAINTY", 9, 11], ["significant", "OBSERVATION_MODIFIER", 12, 23]]], ["Interest in the coronavirus among municipalities is much more strongly determined by socio-economic (p < 0.001) and urban characteristics (p < 0.001).", [["coronavirus", "DISEASE", 16, 27], ["coronavirus", "ORGANISM", 16, 27]]]], "20ccbb4d31435fdfb33fe7cb31f4f0c9cf0b9ba2": [["GALLERY DAYIt's one of those \"end of semester\" days in December-I am looking forward to wrapping up the term, the familiar mix of exhaustion and anticipation in my bones.", [["bones", "ANATOMY", 164, 169], ["bones", "ORGAN", 164, 169], ["bones", "ANATOMY", 164, 169]]], ["A pile of \"plushies\"-giant stuffed fabric white blood cells decorated with their known surface markers invites tactile exploration, and an impromptu game of toss.", [["white blood cells", "ANATOMY", 42, 59], ["surface", "ANATOMY", 87, 94], ["blood cells", "CELL", 48, 59], ["giant stuffed fabric white blood cells", "CELL_TYPE", 21, 59], ["surface markers", "PROTEIN", 87, 102], ["A pile of \"plushies\"", "PROBLEM", 0, 20], ["giant stuffed fabric white blood cells", "PROBLEM", 21, 59], ["tactile exploration", "TEST", 111, 130], ["pile", "OBSERVATION_MODIFIER", 2, 6], ["giant", "OBSERVATION_MODIFIER", 21, 26], ["surface", "OBSERVATION_MODIFIER", 87, 94]]], ["An immune cell synapse wired with LEDs lights up in series as \"activation\" switches are flicked on.", [["immune cell synapse", "ANATOMY", 3, 22], ["immune cell", "CELL", 3, 14], ["An immune cell synapse", "TREATMENT", 0, 22], ["LEDs lights", "TREATMENT", 34, 45], ["immune cell synapse", "OBSERVATION", 3, 22]]], ["A towering croquembouche \"lymph node\" of choux pastries invites them to pull out individual ones to taste-flavored with different fillings, the pastries represent the different cells in a lymph node.", [["lymph node", "ANATOMY", 26, 36], ["cells", "ANATOMY", 177, 182], ["lymph node", "ANATOMY", 188, 198], ["lymph node", "MULTI-TISSUE_STRUCTURE", 26, 36], ["cells", "CELL", 177, 182], ["lymph node", "MULTI-TISSUE_STRUCTURE", 188, 198], ["A towering croquembouche \"lymph node", "PROBLEM", 0, 36], ["a lymph node", "PROBLEM", 186, 198], ["lymph node", "OBSERVATION", 26, 36], ["different cells", "OBSERVATION", 167, 182], ["lymph node", "OBSERVATION", 188, 198]]], ["As the puffs get eaten, the spun sugar matrix of the tower loses shape, much as a lymph node matrix would without resident cells.", [["lymph node matrix", "ANATOMY", 82, 99], ["cells", "ANATOMY", 123, 128], ["sugar", "CHEMICAL", 33, 38], ["lymph node", "MULTI-TISSUE_STRUCTURE", 82, 92], ["cells", "CELL", 123, 128], ["resident cells", "CELL_TYPE", 114, 128], ["the spun sugar matrix", "TEST", 24, 45], ["a lymph node matrix", "TREATMENT", 80, 99], ["lymph node matrix", "OBSERVATION", 82, 99]]], ["The hematopoiesis cookie table is a hit.", [["hematopoiesis", "OBSERVATION", 4, 17]]], ["The student who set it up explains how a basic set of ingredients is flexibly transformed into different kinds of cookies-at which points commitments to certain final products occur and when and how steps become irreversible; class-mates sample some of the finished products and take turns building cookies of different \"lineages\" with nuts, fruit, chocolate chips, bits of candy sparking a spontaneous discussion about food allergies, routes of exposure and safe handling practices.", [["nuts", "ANATOMY", 336, 340], ["fruit", "ANATOMY", 342, 347], ["food allergies", "DISEASE", 420, 434], ["nuts", "ORGANISM_SUBDIVISION", 336, 340], ["fruit", "ORGANISM_SUBDIVISION", 342, 347], ["chocolate chips", "TREATMENT", 349, 364], ["food allergies", "PROBLEM", 420, 434], ["safe handling practices", "TREATMENT", 459, 482]]], ["A student clears their throat and the hum of chatter subsides.", [["throat", "ANATOMY", 23, 29], ["throat", "ORGANISM_SUBDIVISION", 23, 29], ["throat", "ANATOMY", 23, 29]]], ["There are tough but respectful questions on animal research ethics, a plausible timeline for a universal flu vaccine and the structural inequities of access to cutting edge cancer therapies such as CAR-T cells.", [["cancer", "ANATOMY", 173, 179], ["CAR-T cells", "ANATOMY", 198, 209], ["cancer", "DISEASE", 173, 179], ["cancer", "CANCER", 173, 179], ["CAR-T cells", "CELL", 198, 209], ["CAR", "PROTEIN", 198, 201], ["T cells", "CELL_TYPE", 202, 209], ["a universal flu vaccine", "TREATMENT", 93, 116], ["cutting edge cancer therapies", "TREATMENT", 160, 189], ["CAR-T cells", "PROBLEM", 198, 209], ["tough", "OBSERVATION_MODIFIER", 10, 15]]], ["After the Q&A, students read each other's artist's statements, take turns trying to sit on the fold-out monocyte chair without falling, and play with the stick and string co-stimulation maze which can only be solved with 3 manipulations in the correct sequence!THE PERFECT LIBERAL ARTOver 20 years ago, I was an undergraduate in an immunology class, irresistibly drawn to the discipline despite the confounding maze of nomenclatures, the alphabet soup of transgenic TCR names and the flood of cell types and molecules that went over my head.", [["monocyte", "ANATOMY", 104, 112], ["cell", "ANATOMY", 493, 497], ["head", "ANATOMY", 536, 540], ["TCR", "CHEMICAL", 466, 469], ["monocyte", "CELL", 104, 112], ["TCR", "GENE_OR_GENE_PRODUCT", 466, 469], ["cell", "CELL", 493, 497], ["head", "ORGANISM_SUBDIVISION", 536, 540], ["transgenic TCR names", "PROTEIN", 455, 475], ["string co-stimulation maze", "TREATMENT", 164, 190], ["cell types and molecules", "PROBLEM", 493, 517], ["LIBERAL", "OBSERVATION_MODIFIER", 273, 280], ["transgenic TCR", "OBSERVATION", 455, 469], ["cell types", "OBSERVATION", 493, 503], ["head", "ANATOMY", 536, 540]]], ["I don't think that, at the time, I could have foreseen a class period quite like the one I just described: students making the material their own in inventive and surprising ways, going confidently into the heart of foundational and cutting-edge concepts and using their intellectual and practical engagement with the material to connect their study of immunology with their lives.", [["heart", "ANATOMY", 207, 212], ["heart", "ORGAN", 207, 212], ["heart", "ANATOMY", 207, 212]]], ["Teaching and learning immunology as a liberal art together with my students has been transformative for all of us.THE PERFECT LIBERAL ARTMacalester College is an urban small undergraduate liberal arts college with \u223c2,000 students\u221230% students of color, 14% international, and 16% first-generation.", [["color", "TEST", 246, 251], ["LIBERAL", "OBSERVATION_MODIFIER", 126, 133]]], ["I teach an immunology survey course with laboratory for undergraduates who have taken cell biology and genetics.", [["cell", "ANATOMY", 86, 90], ["cell", "CELL", 86, 90]]], ["Though the human immune system is the primary focus of the course, we study amoeba, social insects, bacteria, plants, and jawless fish to better understand the evolution of protective responses.", [["immune system", "ANATOMY", 17, 30], ["human", "ORGANISM", 11, 16], ["immune system", "ANATOMICAL_SYSTEM", 17, 30], ["human", "SPECIES", 11, 16], ["human", "SPECIES", 11, 16], ["bacteria", "PROBLEM", 100, 108]]], ["Students write multipledraft review papers with graphical abstracts, volunteer with the Immune Deficiency Foundation, present art/performance works and write weekly reflective essays connecting their immunology learning to other parts of their academic or personal lives.", [["the Immune Deficiency", "PROBLEM", 84, 105]]], ["My immunological methods course is embedded in my research program investigating the connections between environmental toxins, allergic responses, and chronic pain; students participate in scientific conversations and critique scaffolded by preparatory writing assignments, map metaarguments from sub-fields of published literature, cooperatively design, and execute experiments, and write a collaborative scientific paper.", [["allergic responses", "DISEASE", 127, 145], ["chronic pain", "DISEASE", 151, 163], ["allergic responses", "PROBLEM", 127, 145], ["chronic pain", "PROBLEM", 151, 163], ["map metaarguments", "TEST", 274, 291], ["chronic", "OBSERVATION_MODIFIER", 151, 158], ["pain", "OBSERVATION", 159, 163]]], ["I use my upper-level seminar courses-Neuroimmunology and Cancer Immunology to teach more advanced students about public communication of science.", [["Cancer", "DISEASE", 57, 63]]], ["In our college's First Year Course program I offer semester-long immunology-themed courses: AIDS/Influenza/Malaria -ancient pathogens in a brave new world explores the persistence and reemergence of infections and inflammatory diseases in vulnerable populations around the world and Bodies on Fire centers on the global pandemic of inflammatory diseases.", [["AIDS", "DISEASE", 92, 96], ["Influenza/Malaria -ancient pathogens", "DISEASE", 97, 133], ["infections", "DISEASE", 199, 209], ["inflammatory diseases", "DISEASE", 214, 235], ["inflammatory diseases", "DISEASE", 332, 353], ["AIDS", "PROBLEM", 92, 96], ["Influenza", "PROBLEM", 97, 106], ["Malaria", "PROBLEM", 107, 114], ["ancient pathogens", "PROBLEM", 116, 133], ["infections", "PROBLEM", 199, 209], ["inflammatory diseases", "PROBLEM", 214, 235], ["vulnerable populations", "PROBLEM", 239, 261], ["inflammatory diseases", "PROBLEM", 332, 353], ["infections", "OBSERVATION", 199, 209], ["inflammatory", "OBSERVATION_MODIFIER", 214, 226], ["vulnerable", "OBSERVATION_MODIFIER", 239, 249], ["global", "OBSERVATION_MODIFIER", 313, 319], ["pandemic", "OBSERVATION_MODIFIER", 320, 328], ["inflammatory diseases", "OBSERVATION", 332, 353]]], ["These courses do not have pre-requisites and are structured around connecting patient/physician memoirs, popular science books, and science journalism with the scientists and scientific discoveries they describe and typically ask students to explore these connections through writing, movement, and art.THE PERFECT LIBERAL ARTHistorian William Cronon describes the essence of liberal education as \"gaining the power and the wisdom, the generosity, and the freedom to connect\"-through the acts of listening, reading, writing, talking, solving puzzles, seeking complex truths, seeing other perspectives, working in a community and being willing to both lead and follow in honest and imaginative ways (2) .", [["patient", "ORGANISM", 78, 85], ["patient", "SPECIES", 78, 85], ["liberal education", "TREATMENT", 376, 393], ["LIBERAL", "OBSERVATION_MODIFIER", 315, 322]]], ["Structurally, a liberal arts education connects the natural and physical sciences, humanities, social sciences, quantitative thinking, and artistic inquiry.", [["a liberal arts education", "TREATMENT", 14, 38]]], ["Even as they engage deeply with methods and analyses in particular areas of study, students learn to appreciate different ways of making meaning of our world with tools from different disciplines.", [["methods and analyses", "TEST", 32, 52]]], ["They learn to recognize and interrogate the societal structures and deep assumptions that drive the ways in which such bodies of knowledge are constructed within and across academic disciplines.THE PERFECT LIBERAL ARTImmunology is a perfect fit for a liberal arts education.", [["a liberal arts education", "TREATMENT", 249, 273], ["deep", "ANATOMY_MODIFIER", 68, 72], ["LIBERAL", "OBSERVATION_MODIFIER", 206, 213]]], ["While traditional practices such as variolation and uses of immunomodulatory foods and botanical medicines have existed for thousands of years in societies around the globe, the constructs of cellular and circulating immune mechanisms have been articulated in the context of academic biomedicine only as recently as the late 1800s.", [["cellular", "ANATOMY", 192, 200], ["cellular", "CELL", 192, 200], ["variolation", "TREATMENT", 36, 47], ["immunomodulatory foods", "TREATMENT", 60, 82], ["botanical medicines", "TREATMENT", 87, 106], ["cellular and circulating immune mechanisms", "PROBLEM", 192, 234], ["globe", "ANATOMY", 167, 172]]], ["Concepts of preservation of self over \"non-self \" have morphed into understandings of danger, disruption, repair, and memory embedded deep within cell lineages, epigenetic imprints and tissue architectures.", [["cell", "ANATOMY", 146, 150], ["tissue", "ANATOMY", 185, 191], ["cell", "CELL", 146, 150], ["tissue", "TISSUE", 185, 191], ["repair", "TREATMENT", 106, 112], ["repair", "OBSERVATION", 106, 112], ["cell lineages", "OBSERVATION", 146, 159]]], ["Mechanisms once described more bluntly as \"killing pathogens\" are now understood as highly regulated, selective, tunable responses to commensal and non-commensal microbes that constitute the multi-species ecosystems of multicellular hosts.", [["multicellular hosts", "CELL", 219, 238], ["multicellular hosts", "OBSERVATION", 219, 238]]], ["While the immune system gives us critical protection for survival, virtually every global health concern from emerging infections, allergies and asthma, autoimmunity, chronic pain, and other psychiatric, cardiovascular, and metabolic imbalances are all fueled by these same mechanisms of inflammation, shifted by context to become harmful and pathological.", [["immune system", "ANATOMY", 10, 23], ["cardiovascular", "ANATOMY", 204, 218], ["infections", "DISEASE", 119, 129], ["allergies", "DISEASE", 131, 140], ["asthma", "DISEASE", 145, 151], ["autoimmunity", "DISEASE", 153, 165], ["chronic pain", "DISEASE", 167, 179], ["psychiatric", "DISEASE", 191, 202], ["inflammation", "DISEASE", 288, 300], ["emerging infections", "PROBLEM", 110, 129], ["allergies", "PROBLEM", 131, 140], ["asthma", "PROBLEM", 145, 151], ["autoimmunity", "PROBLEM", 153, 165], ["chronic pain", "PROBLEM", 167, 179], ["other psychiatric, cardiovascular, and metabolic imbalances", "PROBLEM", 185, 244], ["inflammation", "PROBLEM", 288, 300], ["infections", "OBSERVATION", 119, 129], ["chronic", "OBSERVATION_MODIFIER", 167, 174], ["pain", "OBSERVATION", 175, 179], ["metabolic imbalances", "OBSERVATION", 224, 244], ["inflammation", "OBSERVATION", 288, 300]]], ["Author Chimamanda Ngozi Adichie, in her TED Talk \"The Danger of a Single Story, \" warns that assuming a single story about a people leads to dangerous misconceptions, and learning to listen for the many different stories is essential for cross-cultural understanding (4) .", [["people", "ORGANISM", 125, 131], ["people", "SPECIES", 125, 131]]], ["Immune responses demand careful contextual analyses, and to study them closely is to learn to grapple with complexity and uncertainty-an essential skill in today's rapidly changing, connected yet divergent world.TOOLKITS FOR LIFE, WORK, AND STORYTELLINGAnother advantage of studying immunology is its immediate personal and social relevance.", [["contextual analyses", "TEST", 32, 51]]], ["Students only have to look at their own bodies, experiences of well-being and illnesses, and their environments for applications of what they learn.", [["illnesses", "PROBLEM", 78, 87]]], ["As a powerful example of this, I have observed my Neuroimmunology students particularly resonate with learning about the role inflammation plays in mental health.", [["inflammation", "DISEASE", 126, 138]]], ["Students on college campuses are experiencing anxiety and depression at unprecedented levels, and managing neurological diagnoses while removed from their families and support systems (5) .", [["neurological", "ANATOMY", 107, 119], ["anxiety", "DISEASE", 46, 53], ["depression", "DISEASE", 58, 68], ["anxiety", "PROBLEM", 46, 53], ["depression", "PROBLEM", 58, 68]]], ["Understanding the roles of pathological inflammation intertwined with these mental health conditions, exploring the connections of stress, diet, and rest to these neuro-inflammatory pathways are empowering for students; appreciating the \"bodily\" basis of psychological challenges appears to make them seem more tractable.", [["inflammation", "DISEASE", 40, 52], ["pathological inflammation", "PROBLEM", 27, 52], ["psychological challenges", "TREATMENT", 255, 279], ["inflammation", "OBSERVATION", 40, 52]]], ["While these lessons do not take the place of the counseling and/or psychiatric support they or their peers need and receive, I have observed that students do find this scientific parsing of the mind-body connection to be of practical use.TOOLKITS FOR LIFE, WORK, AND STORYTELLINGMany immunology students are drawn to careers in biomedical research and its applications in the practices of medicine and/or public health.", [["body", "ANATOMY", 199, 203], ["psychiatric", "DISEASE", 67, 78], ["body", "ORGANISM_SUBDIVISION", 199, 203], ["psychiatric support", "TREATMENT", 67, 86]]], ["Immunological researchdiscovery, translational, academic, clinical, industrial-and its applications in drug development, medical technologies, and public health interventions are at once scientific and social endeavors.", [["medical technologies", "TREATMENT", 121, 141], ["public health interventions", "TREATMENT", 147, 174]]], ["Countering anti-vaccine movements, crafting community, and government public health responses to disease outbreaks, regulating environmental toxicants in food, water, and air all contain important immunological arguments at their core.", [["disease outbreaks", "PROBLEM", 97, 114]]], ["Iteratively learning to read the often dense and technical immunological literature and synthesizing and communicating these findings in their own written and spoken words is both preparation for future work in biomedical fields and a core tenet of a liberal arts education-the importance of listening, reading, speaking, arguing, and writing.", [["a liberal arts education", "TREATMENT", 249, 273], ["dense", "OBSERVATION_MODIFIER", 39, 44]]], ["These skills are not unique to the study of immunology, but immunology offers undergraduates and their professors in a liberal arts context a rich and pragmatic field within the biomedical sciences in which to practice them.", [["the study", "TEST", 31, 40]]], ["However, they also write white papers and reflective essays connecting their learning in immunology to other disciplines, prepare educational materials for community organizations, teach secondary school students and mentor younger peers and, in doing so, practice translating the technical jargon of scientific communication into information that their audiences need and can use.TOOLKITS FOR LIFE, WORK, AND STORYTELLINGA spacious liberal arts education makes room for multidisciplinary training, provides opportunities for immersive learning and community engagement and asks students to connect their learning to the world in different ways, giving them opportunities to make this complicated and compelling field their own.", [["multidisciplinary training", "TREATMENT", 471, 497]]], ["The perceived \"difficulty\" of immunology can be deconstructed in this more permissive, integrative environment to allow creative strategies for making meaning and finding purposeful engagement with the subject.MAPS AND METAPHORS FOR A WORLD IN CRISISImmune systems are synergistic wholes of interconnected parts continuously stirred up by new discoveries that complicate existing knowledge and demand new ideas and interpretations; this has been so since Paul Ehrlich sketched his intricate visions of cells shedding neutralizing anti-toxins and butted heads with Ilya Metchnikoff 's cheeky but utterly prescient observation that immunity might just look like hungry amoeba out to forage (6).", [["cells", "ANATOMY", 502, 507], ["cells", "CELL", 502, 507], ["anti-toxins", "GENE_OR_GENE_PRODUCT", 530, 541], ["creative strategies", "TREATMENT", 120, 139], ["cells shedding neutralizing anti-toxins", "TREATMENT", 502, 541]]], ["In the last two decades, our view of the immune system has been transformed by newly discovered innate cell subsets, the regulation of immunity by microbial and viral symbionts, the control of immune responses by metabolic switches, and the realization that all cells, not just the ones that we recognize as immune cells, participate in and regulate immune responses of multicellular organisms.", [["immune system", "ANATOMY", 41, 54], ["cell", "ANATOMY", 103, 107], ["cells", "ANATOMY", 262, 267], ["immune cells", "ANATOMY", 308, 320], ["innate cell", "CELL", 96, 107], ["cells", "CELL", 262, 267], ["immune cells", "CELL", 308, 320], ["innate cell subsets", "CELL_TYPE", 96, 115], ["immune cells", "CELL_TYPE", 308, 320], ["viral symbionts", "PROBLEM", 161, 176], ["metabolic switches", "TREATMENT", 213, 231], ["all cells", "PROBLEM", 258, 267], ["immune cells", "PROBLEM", 308, 320], ["multicellular organisms", "PROBLEM", 370, 393], ["innate cell subsets", "OBSERVATION", 96, 115], ["viral symbionts", "OBSERVATION", 161, 176], ["metabolic switches", "OBSERVATION", 213, 231], ["multicellular organisms", "OBSERVATION", 370, 393]]], ["This framework of synergistic interactions and multi-factorial outcomes can provide our students with maps and metaphors useful beyond immunology, for broader understandings of complex social and planetary processes.MAPS AND METAPHORS FOR A WORLD IN CRISISThe precarious balance of protective vs. harmful immune responses is a mirror of the collateral costs of inequities, statesanctioned violence, and xenophobia in our societies.", [["collateral", "ANATOMY", 341, 351], ["statesanctioned violence", "DISEASE", 373, 397], ["xenophobia", "DISEASE", 403, 413], ["collateral", "MULTI-TISSUE_STRUCTURE", 341, 351], ["xenophobia", "PROBLEM", 403, 413], ["planetary processes", "OBSERVATION", 196, 215]]], ["Chronic inflammation and accompanying adverse health outcomes are materially correlated with lower socio-economic status, lack of access to nutritious foods, stressful living conditions and unstable access to healthcare (7) .", [["inflammation", "DISEASE", 8, 20], ["Chronic inflammation", "PROBLEM", 0, 20], ["accompanying adverse health outcomes", "PROBLEM", 25, 61], ["inflammation", "OBSERVATION", 8, 20], ["adverse", "OBSERVATION_MODIFIER", 38, 45]]], ["That any immune response takes a toll on the living tissue it is trying to protect from real or imagined threats parallels the effect that xenophobic, reactive intolerance, and unregulated violence can have on a community or society at large.", [["tissue", "ANATOMY", 52, 58], ["tissue", "TISSUE", 52, 58], ["xenophobic", "PROBLEM", 139, 149], ["reactive intolerance", "PROBLEM", 151, 171], ["reactive intolerance", "OBSERVATION", 151, 171], ["large", "OBSERVATION_MODIFIER", 236, 241]]], ["Just as our own cells and those of our commensal symbionts maintain a collaborative understanding that we disrupt at our peril, our local and global communities are sensitive to the behavior of individuals and cooperation between the diverse populations who live in them.", [["cells", "ANATOMY", 16, 21], ["cells", "CELL", 16, 21]]], ["Tolerance, balance, homeostasis, repair are technical terms with specific immunological meanings that are just as relevant to our social fabric as they are to our understanding of healthy and disease states of our bodies.", [["repair", "TREATMENT", 33, 39], ["repair", "OBSERVATION", 33, 39]]], ["And likewise, jingoistic militarized language about the immune system vanquishing pathogens can echo intolerant social rhetoric.", [["immune system", "ANATOMY", 56, 69]]], ["The nuance and care required to understand and modulate immune responses and their outcomes serve as object lessons in how we speak and act as individual and collectives in social and political arenas.MAPS AND METAPHORS FOR A WORLD IN CRISISAn immunological framework can also be applied to the relationship of humans with our planet as a whole.", [["humans", "ORGANISM", 311, 317], ["humans", "SPECIES", 311, 317], ["humans", "SPECIES", 311, 317], ["A WORLD IN CRISISAn immunological framework", "TREATMENT", 224, 267]]], ["Humaninduced climate change has driven our planet and its inhabitants to a perilous state of imbalance, with rapid rise in temperature and sea levels, catastrophic weather events, heat stress, food shortages, displacement of peoples, biodiversity loss, emerging pathogens (such as SARS-Cov2), and exacerbation of poverty and conflict, all of which create negative health outcomes for those who are most vulnerable and have the least access to resources.", [["biodiversity loss", "DISEASE", 234, 251], ["SARS-Cov2", "DISEASE", 281, 290], ["poverty", "DISEASE", 313, 320], ["Humaninduced climate change", "TREATMENT", 0, 27], ["rapid rise in temperature and sea levels", "PROBLEM", 109, 149], ["catastrophic weather events", "PROBLEM", 151, 178], ["heat stress", "PROBLEM", 180, 191], ["biodiversity loss", "PROBLEM", 234, 251], ["emerging pathogens", "PROBLEM", 253, 271], ["biodiversity loss", "OBSERVATION", 234, 251]]], ["The United Nations Intergovernmental Panel on Climate Change (8) advocates for immediate, massive, and collective action to mitigate this crisis if we are to survive.", [["this crisis", "PROBLEM", 133, 144], ["massive", "OBSERVATION_MODIFIER", 90, 97]]], ["The literal health effects of climate change are, and will be marked by inflammatory processes in our individual bodies, and sharp increases in global disease burdens; it is as if the entire planet is in a state of chronic inflammatory distress.", [["inflammatory distress", "DISEASE", 223, 244], ["inflammatory processes", "PROBLEM", 72, 94], ["sharp increases in global disease burdens", "PROBLEM", 125, 166], ["chronic inflammatory distress", "PROBLEM", 215, 244], ["literal", "OBSERVATION_MODIFIER", 4, 11], ["health", "OBSERVATION_MODIFIER", 12, 18], ["marked", "OBSERVATION_MODIFIER", 62, 68], ["inflammatory", "OBSERVATION", 72, 84], ["sharp", "OBSERVATION_MODIFIER", 125, 130], ["increases", "OBSERVATION_MODIFIER", 131, 140], ["global", "OBSERVATION_MODIFIER", 144, 150], ["disease", "OBSERVATION", 151, 158], ["chronic", "OBSERVATION_MODIFIER", 215, 222], ["inflammatory", "OBSERVATION", 223, 235]]], ["That learning process comes easiest to those of us who teach who also believe that there is an aspect of our vocation . . . is not merely to share information but to share in the intellectual and spiritual growth of our students.BEYOND INFORMATIONIn information-dense, rapidly evolving fields of study, it is natural to feel overwhelmed by the responsibility to share information as accurately and comprehensively as possible before our limited time with any one group of students comes to a close.", [["dense", "OBSERVATION_MODIFIER", 262, 267]]], ["It resolutely refuses to be told as a \"single story\" and any arcane details memorized for exams are known to have modest shelf lives in any case.", [["exams", "TEST", 90, 95]]], ["So with each passing year, I am challenged to re-imagine how I can best help my students be as prepared as possible to hear and understand all of the immunological stories that have not been written yet-to be able to know the workings of their future bodies and minds a little better, to understand and appreciate why a pandemic coronavirus can ravage one body it infects and leave another unscathed, to be able to use these stories to build healthy lives and communities, and make new discoveries.BEYOND INFORMATIONIn her more recent book, Teaching Community: A Pedagogy of Hope (10), bell hooks says: \"It is imperative that we (teachers) maintain hope even when the harshness of reality suggests otherwise.\"", [["body", "ANATOMY", 356, 360], ["coronavirus", "DISEASE", 329, 340], ["coronavirus", "ORGANISM", 329, 340], ["body", "ORGANISM_SUBDIVISION", 356, 360], ["pandemic coronavirus", "SPECIES", 320, 340], ["a pandemic coronavirus", "PROBLEM", 318, 340]]], ["I take these words to heart.", [["heart", "ANATOMY", 22, 27], ["heart", "ORGAN", 22, 27], ["heart", "ANATOMY", 22, 27]]], ["Much of western biomedical science has been built around concepts of illness rather than wellness and I wonder whether it is simply too overwhelming to keep coming back to narratives and mechanisms of morbidity, dysfunction, and imbalance.", [["illness", "DISEASE", 69, 76], ["morbidity", "PROBLEM", 201, 210], ["dysfunction", "PROBLEM", 212, 223]]], ["Psychologist Alison Gopnik has demonstrated that children who \"pretend play, \" in elaborate, unreal scenarios with the aid of language, props and gestures, are able to respond correctly to counterfactual questions about a novel real-world causal relationship (11) .", [["children", "ORGANISM", 49, 57], ["children", "SPECIES", 49, 57]]], ["While the evolutionary imperative for play may well be to develop robust cognitive functions, children play because it is a lot of fun.", [["children", "ORGANISM", 94, 102], ["children", "SPECIES", 94, 102]]], ["Eating a cardamom and orange cream-filled choux bun pulled out of a patisserie \"lymph node\" might not immediately seem central to learning about immune systems but it is delicious and it distills the joy of learning and sharing in a way that sticks in our brains and hearts-both my students' and mine.", [["lymph node", "ANATOMY", 80, 90], ["brains", "ANATOMY", 256, 262], ["hearts", "ANATOMY", 267, 273], ["lymph node", "MULTI-TISSUE_STRUCTURE", 80, 90], ["brains", "ORGAN", 256, 262], ["hearts", "ORGAN", 267, 273], ["a cardamom and orange cream", "TREATMENT", 7, 34], ["a patisserie \"lymph node", "PROBLEM", 66, 90], ["lymph node", "OBSERVATION", 80, 90], ["hearts", "ANATOMY", 267, 273]]], ["A liberal arts education with its emphasis on connective and integrative inquiry aims to be transformative, to crack the world open a little bit wider for every student with every course of study, every class, every discipline.", [["connective", "TISSUE", 46, 56], ["A liberal arts education", "TREATMENT", 0, 24]]], ["Teaching immunology as a liberal art has made me a more curious, capable and happier immunologist than I had known I could be.DATA AVAILABILITY STATEMENTThe original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author.", [["the study", "TEST", 193, 202]]]], "PMC7404936": [["INTRODUCTIONThe current novel coronavirus disease 2019 (COVID\u201019) is caused by the severe acute respiratory syndrome coronavirus\u20102 (SARS\u2010CoV\u20102),1first identified in Wuhan, China, in December 2019.2It was then declared a pandemic by the World Health Organization on March 11, 2020.", [["coronavirus disease", "DISEASE", 30, 49], ["acute respiratory syndrome coronavirus\u20102", "DISEASE", 90, 130], ["SARS", "DISEASE", 132, 136], ["coronavirus", "ORGANISM", 30, 41], ["severe acute respiratory syndrome coronavirus\u20102 (SARS\u2010CoV", "SPECIES", 83, 140], ["novel coronavirus disease", "PROBLEM", 24, 49], ["the severe acute respiratory syndrome coronavirus\u20102", "PROBLEM", 79, 130], ["coronavirus disease", "OBSERVATION", 30, 49], ["severe", "OBSERVATION_MODIFIER", 83, 89], ["acute", "OBSERVATION_MODIFIER", 90, 95], ["respiratory syndrome", "OBSERVATION", 96, 116]]], ["As of July 10, 2020, COVID\u201019 has spread to more than 200 countries and territories, caused over 580,000 fatalities, and infected more than 12 million individuals globally.", [["COVID", "TEST", 21, 26]]], ["The COVID\u201019 fatality rate seems to be higher among frail older adults compared with younger individuals in Canada; frail older adults also remain at a higher risk for severe complications from COVID\u201019.3Frailty is a common clinical syndrome that carries an increased risk for poor health outcomes due to a decline in function and the ability to cope with everyday life and stressors.4Frailty also has a significant association with poor oral health,5,6,7while numerous oral diseases have an important systemic impact on frail older adults.8Although most dental diseases are largely preventable, many older adults, particularly those who are frail, experience poor oral health and reduced quality of life.9,10The relevance of frailty to dental care is well understood and is usually the core content of most dental geriatric curricula worldwide11and in Canada.12Undergraduate dental geriatric education should \u201cfacilitate the acquisition of specialized knowledge and skills and influence the formation of professional attitudes towards the elderly13\u201d while blending didactic content, clinical care, and reflection.14This is the case for the dental geriatric curricula at the University of British Columbia (UBC) in Vancouver, Canada, where the content is distributed over multiple 50\u2010minute sessions, 26 for third\u2010year and 10 for fourth\u2010year undergraduate students.12,14Along with didactic content, pairs of third\u2010year students shadow a dentist providing care to frail adults at the university dental clinic for half a day, while pairs of fourth\u2010year students provide a full day of hands\u2010on care to frail adults residing in long\u2010term care (LTC) facilities.14Although UBC's third\u2010year geriatric dental care program activities began on January 7, 2020, and fourth\u2010year activities began on September 4, 2019, the COVID\u201019 pandemic directly impacted all patient care, which was canceled on March 11, 2020.", [["oral", "ANATOMY", 438, 442], ["oral", "ANATOMY", 470, 474], ["oral", "ANATOMY", 665, 669], ["COVID", "DISEASE", 194, 199], ["Frailty", "DISEASE", 204, 211], ["Frailty", "DISEASE", 385, 392], ["oral diseases", "DISEASE", 470, 483], ["dental diseases", "DISEASE", 555, 570], ["frailty", "DISEASE", 726, 733], ["adults", "ORGANISM", 128, 134], ["oral", "ORGANISM_SUBDIVISION", 438, 442], ["oral", "ORGANISM_SUBDIVISION", 470, 474], ["oral", "ORGANISM_SUBDIVISION", 665, 669], ["patient", "ORGANISM", 1850, 1857], ["patient", "SPECIES", 1850, 1857], ["The COVID\u2010", "TREATMENT", 0, 10], ["fatality rate", "TEST", 13, 26], ["severe complications", "PROBLEM", 168, 188], ["COVID\u2010", "TEST", 194, 200], ["a common clinical syndrome", "PROBLEM", 215, 241], ["poor health outcomes", "PROBLEM", 277, 297], ["a decline in function", "PROBLEM", 305, 326], ["poor oral health", "PROBLEM", 433, 449], ["numerous oral diseases", "PROBLEM", 461, 483], ["most dental diseases", "PROBLEM", 550, 570], ["dental geriatric education", "TREATMENT", 876, 902], ["UBC", "TEST", 1667, 1670], ["increased", "OBSERVATION_MODIFIER", 258, 267], ["significant", "OBSERVATION_MODIFIER", 404, 415], ["diseases", "OBSERVATION", 562, 570], ["distributed", "OBSERVATION_MODIFIER", 1255, 1266]]], ["This study aimed at exploring the extent to which third\u2010 and fourth\u2010year undergraduate dental students critically considered the impact of COVID\u201019 on education and the practice of dental geriatrics.METHODSThis study was approved by UBC's Behavioural Research Ethics Board (# H20\u201000013 and # H19\u201001005).", [["This study", "TEST", 0, 10], ["COVID\u2010", "TREATMENT", 139, 145], ["METHODSThis study", "TEST", 199, 216]]], ["We received written reflections from all 56 third\u2010year and 59 fourth\u2010year undergraduate students as part of a mandatory assignment for the required dental geriatric modules.", [["the required dental geriatric modules", "PROBLEM", 135, 172]]], ["Reflections were submitted to the first author (M.A.B.) by means of email between March 12 and May 8, 2020, as part of the modules\u2019 required assignments and were de\u2010identified for the thematic analysis.", [["the thematic analysis", "TEST", 180, 201]]], ["For a male fourth\u2010year student who was involved in the geriatric program activities, there was definite uncertainty about graduating in the midst of a pandemic and the amount of clinical care experience received: \u201cI haven't been able to perform the number of clinical procedures I would like to \u2026 with graduation around the corner, will I feel competent to provide all the care patients will need?\u201dExperiencing uncertainties ::: RESULTSOne female fourth\u2010year student who participated in the geriatric program activities, reflected on the uncertainty around safety:\u201cIf dentistry were to increase access to care to older adults in long\u2010term care facilities, the creation of aerosols must be addressed and corrected.", [["patients", "ORGANISM", 378, 386], ["patients", "SPECIES", 378, 386], ["clinical procedures", "TREATMENT", 259, 278], ["the creation of aerosols", "TREATMENT", 656, 680]]], ["Negative pressure rooms may be used to keep air from spreading away from the treatment facility, but that is not feasible in the context of nursing homes I don't think.\u201d", [["pressure rooms", "TREATMENT", 9, 23], ["pressure rooms", "OBSERVATION", 9, 23]]]], "f266600e61a8c0fbceb48929b7250a9f16771c9f": [["Over two-third of the staffers have experience with the treatment of severe acute respiratory syndrome (SARS) in a military-led infectious disease hospital established in 2003.", [["acute respiratory syndrome", "DISEASE", 76, 102], ["SARS", "DISEASE", 104, 108], ["infectious disease", "DISEASE", 128, 146], ["severe acute respiratory syndrome", "PROBLEM", 69, 102], ["severe", "OBSERVATION_MODIFIER", 69, 75], ["acute", "OBSERVATION_MODIFIER", 76, 81], ["respiratory syndrome", "OBSERVATION", 82, 102]]], ["Before they were deployed, the staffers received 6 weeks of extensive training on disease diagnosis and treatment, as well as prevention and surveillance.", [["extensive training", "TREATMENT", 60, 78], ["disease diagnosis", "TEST", 82, 99], ["treatment", "TREATMENT", 104, 113], ["surveillance", "TEST", 141, 153]]], ["The training program included measures of self-protection as the medical teams sought \"zero infections\" of their own staff.", [["infections", "DISEASE", 92, 102], ["The training program", "TREATMENT", 0, 20], ["self-protection", "TREATMENT", 42, 57], ["zero infections", "PROBLEM", 87, 102]]], ["The staffers also received English language training and were provided with information on local geographical conditions.", [["English language training", "TREATMENT", 27, 52]]], ["The PLA medical team set up a 100-bed Ebola Treatment Unit (ETU), treated 110 patients, and trained local health workers and 1500 local people about the basics of fighting the Ebola virus during 2 months.", [["Ebola", "DISEASE", 38, 43], ["Ebola", "DISEASE", 176, 181], ["PLA", "CHEMICAL", 4, 7], ["patients", "ORGANISM", 78, 86], ["people", "ORGANISM", 136, 142], ["Ebola virus", "ORGANISM", 176, 187], ["patients", "SPECIES", 78, 86], ["people", "SPECIES", 136, 142], ["Ebola virus", "SPECIES", 176, 187], ["Ebola virus", "SPECIES", 176, 187], ["the Ebola virus", "PROBLEM", 172, 187]]]], "PMC6939302": [["Common variable immunodeficiencyCommon variable immunodeficiency (or CVID) is the most common symptomatic primary immunodeficiency and is characterized by profound antibody dysfunction.3 This diagnosis represents a heterogeneous group of genetic etiologies all characterized by the shared phenotype of reduced serum levels of IgG, low IgA and/or IgM, and impaired antibody response to vaccination.", [["serum", "ANATOMY", 310, 315], ["immunodeficiency", "DISEASE", 16, 32], ["Common variable immunodeficiency", "DISEASE", 32, 64], ["CVID", "DISEASE", 69, 73], ["primary immunodeficiency", "DISEASE", 106, 130], ["immunodeficiency", "ORGANISM", 16, 32], ["serum", "ORGANISM_SUBSTANCE", 310, 315], ["IgG", "GENE_OR_GENE_PRODUCT", 326, 329], ["IgA", "GENE_OR_GENE_PRODUCT", 335, 338], ["IgM", "GENE_OR_GENE_PRODUCT", 346, 349], ["IgG", "PROTEIN", 326, 329], ["IgA", "PROTEIN", 335, 338], ["IgM", "PROTEIN", 346, 349], ["Common variable immunodeficiency", "PROBLEM", 0, 32], ["Common variable immunodeficiency", "PROBLEM", 32, 64], ["CVID", "PROBLEM", 69, 73], ["symptomatic primary immunodeficiency", "PROBLEM", 94, 130], ["profound antibody dysfunction", "PROBLEM", 155, 184], ["a heterogeneous group of genetic etiologies", "PROBLEM", 213, 256], ["reduced serum levels", "PROBLEM", 302, 322], ["IgG", "TEST", 326, 329], ["low IgA", "PROBLEM", 331, 338], ["IgM", "PROBLEM", 346, 349], ["impaired antibody response", "PROBLEM", 355, 381], ["variable", "OBSERVATION_MODIFIER", 7, 15], ["immunodeficiency", "OBSERVATION", 16, 32], ["variable", "OBSERVATION_MODIFIER", 39, 47], ["immunodeficiency", "OBSERVATION", 48, 64], ["primary immunodeficiency", "OBSERVATION", 106, 130], ["profound", "OBSERVATION_MODIFIER", 155, 163], ["antibody dysfunction", "OBSERVATION", 164, 184], ["heterogeneous", "OBSERVATION_MODIFIER", 215, 228], ["antibody response", "OBSERVATION", 364, 381]]], ["B\u2010cell numbers are typically present at low or normal levels, whereas CD4 T\u2010cell numbers may be decreased in some patients.4 CVID is believed to result from the absence of B\u2010cell maturation into long\u2010lived isotype\u2010switched memory B cells and plasma cells due to a variety of potential mechanisms that are poorly understood.", [["B\u2010cell", "ANATOMY", 0, 6], ["T\u2010cell", "ANATOMY", 74, 80], ["B\u2010cell", "ANATOMY", 172, 178], ["memory B cells", "ANATOMY", 223, 237], ["plasma cells", "ANATOMY", 242, 254], ["CVID", "DISEASE", 125, 129], ["CD4", "GENE_OR_GENE_PRODUCT", 70, 73], ["patients", "ORGANISM", 114, 122], ["B\u2010cell", "GENE_OR_GENE_PRODUCT", 172, 178], ["memory B cells", "CELL", 223, 237], ["plasma cells", "CELL", 242, 254], ["CD4", "PROTEIN", 70, 73], ["long\u2010lived isotype\u2010switched memory B cells", "CELL_TYPE", 195, 237], ["plasma cells", "CELL_TYPE", 242, 254], ["patients", "SPECIES", 114, 122], ["B\u2010cell numbers", "TEST", 0, 14], ["B\u2010cell maturation", "PROBLEM", 172, 189], ["plasma cells", "PROBLEM", 242, 254], ["normal", "OBSERVATION", 47, 53], ["may be", "UNCERTAINTY", 89, 95], ["decreased", "OBSERVATION_MODIFIER", 96, 105]]], ["Many patients with CVID experience heightened susceptibility to both infections and autoimmune and inflammatory complications (e.g., autoimmune cytopenia, enteropathy, and lung disease).5 Notably, patients with CVID with the lowest levels of isotype\u2010switched memory B cells (CD27+ IgD\u2212 IgM\u2212) have been reported to have the greatest risk of these complications.6 Because antibody deficiency is the prominent feature of CVID, Ig replacement therapy is the standard of care, although this treatment does not seem to alter the course of autoimmune and inflammatory complications in many patients.5", [["lung", "ANATOMY", 172, 176], ["isotype\u2010switched memory B cells", "ANATOMY", 242, 273], ["CVID", "DISEASE", 19, 23], ["infections", "DISEASE", 69, 79], ["autoimmune cytopenia", "DISEASE", 133, 153], ["enteropathy", "DISEASE", 155, 166], ["lung disease", "DISEASE", 172, 184], ["CVID", "DISEASE", 211, 215], ["antibody deficiency", "DISEASE", 370, 389], ["CVID", "DISEASE", 418, 422], ["patients", "ORGANISM", 5, 13], ["lung", "ORGAN", 172, 176], ["patients", "ORGANISM", 197, 205], ["memory B cells", "CELL", 259, 273], ["CD27", "GENE_OR_GENE_PRODUCT", 275, 279], ["IgD", "GENE_OR_GENE_PRODUCT", 281, 284], ["Ig", "GENE_OR_GENE_PRODUCT", 424, 426], ["patients", "ORGANISM", 583, 591], ["isotype\u2010switched memory B cells", "CELL_TYPE", 242, 273], ["CD27", "PROTEIN", 275, 279], ["IgD", "PROTEIN", 281, 284], ["IgM\u2212", "PROTEIN", 286, 290], ["patients", "SPECIES", 5, 13], ["patients", "SPECIES", 197, 205], ["patients", "SPECIES", 583, 591], ["CVID", "PROBLEM", 19, 23], ["heightened susceptibility", "PROBLEM", 35, 60], ["both infections", "PROBLEM", 64, 79], ["autoimmune and inflammatory complications", "PROBLEM", 84, 125], ["autoimmune cytopenia", "PROBLEM", 133, 153], ["enteropathy", "PROBLEM", 155, 166], ["lung disease)", "PROBLEM", 172, 185], ["CVID", "PROBLEM", 211, 215], ["isotype\u2010switched memory B cells", "PROBLEM", 242, 273], ["CD27", "TEST", 275, 279], ["these complications", "PROBLEM", 340, 359], ["antibody deficiency", "PROBLEM", 370, 389], ["CVID", "PROBLEM", 418, 422], ["Ig replacement therapy", "TREATMENT", 424, 446], ["autoimmune and inflammatory complications", "PROBLEM", 533, 574], ["infections", "OBSERVATION", 69, 79], ["autoimmune", "OBSERVATION", 84, 94], ["inflammatory", "OBSERVATION_MODIFIER", 99, 111], ["autoimmune cytopenia", "OBSERVATION", 133, 153], ["enteropathy", "OBSERVATION", 155, 166], ["lung", "ANATOMY", 172, 176], ["disease", "OBSERVATION", 177, 184], ["complications", "OBSERVATION", 346, 359], ["antibody deficiency", "OBSERVATION", 370, 389], ["prominent", "OBSERVATION_MODIFIER", 397, 406], ["CVID", "OBSERVATION", 418, 422], ["inflammatory", "OBSERVATION_MODIFIER", 548, 560]]]], "ae2408371f918db7960cbe632472f35017565e81": [["IntroductionThe effects of the COVID-19 pandemic do not impact people or communities equally.", [["people", "ORGANISM", 63, 69], ["people", "SPECIES", 63, 69], ["the COVID", "TREATMENT", 27, 36]]], ["For instance, there is strong evidence internationally that the severity of symptoms and the infection fatality rates (IFR) vary by orders of magnitude across age groups, with estimates of the IFR in children (aged 0-9) as low as 0.0016% compared to 7.8% in adults over 80 years of age (Verity et al., 2020) .", [["infection", "DISEASE", 93, 102], ["children", "ORGANISM", 200, 208], ["children", "SPECIES", 200, 208], ["the severity of symptoms", "PROBLEM", 60, 84], ["the infection fatality rates", "PROBLEM", 89, 117]]], ["Furthermore, overcrowded living conditions (House, 2009 ) and employment in high-contact service occupations (Koh, 2020) are also likely to be risk factors for infection, potentially increasing the burden of COVID-19 for socio-economically disadvantaged communities.IntroductionIndeed, in Singapore, structural socio-economic and healthcare inequities have fuelled a secondary COVID-19 outbreak.", [["infection", "DISEASE", 160, 169], ["infection", "PROBLEM", 160, 169], ["COVID", "TEST", 208, 213], ["a secondary COVID", "TEST", 365, 382], ["infection", "OBSERVATION", 160, 169]]], ["Despite its government's early claims to have contained the spread of COVID-19, a large secondary outbreak emerged in Singapore's migrant worker community in April (Singapore Ministry of Health, 2020) .", [["large", "OBSERVATION_MODIFIER", 82, 87], ["secondary", "OBSERVATION_MODIFIER", 88, 97], ["outbreak", "OBSERVATION", 98, 106]]], ["These communities are housed in crowded dormitory precincts where self-isolation is difficult (TWC2, 2020) and report high levels of job insecurity, which creates structural disincentives to reporting illness and to enact self-isolation (HOME 2020).", [["illness", "DISEASE", 201, 208]]], ["The experiences of migrant workers in Singapore, which include overcrowded housing, and lack of access to primary healthcare or sick leave, are an indicator of the importance of equitable epidemic control measures that account for the lived experiences of all.IntroductionIn Aotearoa New Zealand, inequities in health and healthcare (Waitangi Tribunal 2019) have been shown to substantially increase relative fatality rates for M\u0101ori and Pacific .", [["equitable epidemic control measures", "TREATMENT", 178, 213]]], ["Furthermore, M\u0101ori and Pacific people are more likely to live in crowded conditions than European New Zealanders (Stats NZ, 2018) .", [["people", "ORGANISM", 31, 37], ["people", "SPECIES", 31, 37], ["more likely", "UNCERTAINTY", 42, 53]]], ["Population count data also suggests that socio-economic status in Aotearoa New Zealand is a key indicator for a community's ability to reduce contacts during working hours, with wealthier communities able to work more easily from home (Data Ventures 2020).", [["Population count data", "TEST", 0, 21]]], ["This combination of structural inequities has the potential to lead to both higher transmissibility and higher infection fatality rates for COVID-19, resulting in higher risks for M\u0101ori and Pacific populations in New Zealand.IntroductionIn this paper, we extend the stochastic model of Plank et al. (2020) to allow for heterogeneous contact networks among different age groups and between communities in the presence of healthcare inequities.", [["infection", "DISEASE", 111, 120], ["structural inequities", "PROBLEM", 20, 41], ["both higher transmissibility", "PROBLEM", 71, 99], ["higher infection fatality rates", "PROBLEM", 104, 135], ["COVID", "TEST", 140, 145], ["M\u0101ori and Pacific populations", "PROBLEM", 180, 209], ["higher", "OBSERVATION_MODIFIER", 104, 110], ["infection", "OBSERVATION", 111, 120], ["Pacific populations", "OBSERVATION", 190, 209]]], ["Each group has its own parameter set to describe the average reproduction number, the probability of being asymptomatic, and the level of access to testing for individuals within the group.", [["testing", "TEST", 148, 155]]], ["The connections between such groups are described by a contact matrix, which determines the relative likelihood of an infected individual from group infecting someone from group .IntroductionThe main purpose of this study is not to produce detailed forecasts of COVID-19 cases in different age or other demographic groups.", [["matrix", "CELLULAR_COMPONENT", 63, 69], ["this study", "TEST", 211, 221], ["COVID", "TEST", 262, 267], ["infected", "OBSERVATION", 118, 126], ["main", "OBSERVATION_MODIFIER", 195, 199]]], ["Although estimates of contact rates between groups corresponding to 5-year age bands exist for New Zealand , these do not account for the effects of behavioural changes, social distancing and other interventions in response to .", [["behavioural changes", "PROBLEM", 149, 168]]], ["In addition, New Zealand is fortunate to have had a low number of COVID-19 cases, which mean it is difficult to contact rates across finely stratified age groups.", [["New", "OBSERVATION_MODIFIER", 13, 16], ["Zealand", "OBSERVATION", 17, 24]]], ["Stratifying the model at this level would therefore introduce too many undetermined parameters.IntroductionInstead, we aim to develop a coarse-grained model that can compare control interventions that differentially affect different broad age groups (e.g. school closures) and can help identify potential risks to particular communities.", [["a coarse-grained model", "PROBLEM", 134, 156], ["control interventions", "TREATMENT", 174, 195]]], ["This will be useful when combined with robust NZspecific data on contact rates between fine-grained groups at varying Alert Levels and epidemiological properties of COVID-19 within these groups.", [["COVID", "TEST", 165, 170]]], ["In this work, we use this model to explore two scenarios: the first is an agestructured model that splits the population into three groups based on age, which we use to investigate the effects of school closures, while the second splits the population into two communities in the presence of healthcare inequities.MethodsWe use a continuous-time branching process to model the number of infections in each group, with initial seed cases representing overseas arrivals .", [["infections", "DISEASE", 387, 397], ["this model", "TREATMENT", 21, 31], ["school closures", "TREATMENT", 196, 211], ["a continuous-time branching process", "TREATMENT", 328, 363], ["infections", "OBSERVATION", 387, 397]]], ["Within each group, individuals are assumed be homogeneous, with the exception of their individual reproduction number, which is heterogeneous and randomly distributed with a group-specific mean (see below). \uf0b7 Infected individuals fall into two categories: (i) those who show clinical symptoms at some point during their infection; and (ii) those who are asymptomatic or subclincal for the duration of their infection.", [["infection", "DISEASE", 320, 329], ["infection", "DISEASE", 407, 416], ["individuals", "ORGANISM", 218, 229], ["clinical symptoms", "PROBLEM", 275, 292], ["their infection", "PROBLEM", 314, 329], ["asymptomatic", "PROBLEM", 354, 366], ["their infection", "PROBLEM", 401, 416], ["homogeneous", "OBSERVATION_MODIFIER", 46, 57], ["individual", "OBSERVATION_MODIFIER", 87, 97], ["reproduction", "OBSERVATION_MODIFIER", 98, 110], ["number", "OBSERVATION_MODIFIER", 111, 117], ["heterogeneous", "OBSERVATION_MODIFIER", 128, 141], ["infection", "OBSERVATION", 320, 329], ["infection", "OBSERVATION", 407, 416]]], ["Each new infection is randomly assigned as subclinical with probability and clinical with probability 1 \u2212 , independent of who infected them.", [["infection", "DISEASE", 9, 18], ["Each new infection", "PROBLEM", 0, 18], ["new", "OBSERVATION_MODIFIER", 5, 8], ["infection", "OBSERVATION", 9, 18]]], ["This categorisation applies for the full duration of the infectious period, i.e. the clinical category includes pre-symptomatic individuals who later go on to develop clinical symptoms.", [["clinical symptoms", "PROBLEM", 167, 184], ["infectious", "OBSERVATION", 57, 67]]], ["The probability of being subclinical may vary between groups. \uf0b7 The average reproduction number of subclinical individuals in any group was assumed to be 50% of the average reproduction number of clinical individuals that group.", [["subclinical individuals", "PROBLEM", 99, 122], ["subclinical", "OBSERVATION", 25, 36], ["average", "OBSERVATION_MODIFIER", 68, 75], ["reproduction", "OBSERVATION_MODIFIER", 76, 88], ["number", "OBSERVATION_MODIFIER", 89, 95], ["subclinical", "OBSERVATION_MODIFIER", 99, 110]]], ["This reflects lower infectiousness of subclincal cases (Davies et al., 2020a) . \uf0b7 In the absence of case isolation measures (see below), each infected individual causes a randomly generated number ~( ) of new infections. \uf0b7 As well as population heterogeneity across the different groups, individual heterogeneity in transmission rates was included by setting = for clinical individuals in group and = for subclinical individuals in group , where is a gamma distributed random variable with mean 1 and variance 2 (Lloyd-Smith et al., 2005) . \uf0b7 The time between an individual becoming infected and infecting another individual, the generation time , is Weibull distributed with mean 5.0 days and standard deviation of 1.9 days (Ferretti 2020) .", [["infections", "DISEASE", 209, 219], ["case isolation measures", "TREATMENT", 100, 123], ["new infections", "PROBLEM", 205, 219], ["population heterogeneity", "PROBLEM", 234, 258], ["individual heterogeneity in transmission rates", "PROBLEM", 288, 334], ["infected", "PROBLEM", 583, 591], ["lower", "OBSERVATION_MODIFIER", 14, 19], ["infectiousness", "OBSERVATION", 20, 34], ["new", "OBSERVATION_MODIFIER", 205, 208], ["infections", "OBSERVATION", 209, 219], ["population", "OBSERVATION_MODIFIER", 234, 244], ["heterogeneity", "OBSERVATION", 245, 258], ["different", "OBSERVATION_MODIFIER", 270, 279], ["heterogeneity", "OBSERVATION_MODIFIER", 299, 312], ["infected", "OBSERVATION", 583, 591]]], ["The infection times of all secondary infections from individual are independent, identically distributed random variables from this distribution (see Figure 1 ).", [["infection", "DISEASE", 4, 13], ["infections", "DISEASE", 37, 47], ["The infection", "PROBLEM", 0, 13], ["all secondary infections", "PROBLEM", 23, 47], ["infection", "OBSERVATION", 4, 13], ["secondary", "OBSERVATION_MODIFIER", 27, 36], ["infections", "OBSERVATION", 37, 47]]], ["An alternative log normal distribution and a Gamma distribution were investigated (Nishiura et al., 2020) .", [["log normal", "OBSERVATION", 15, 25], ["distribution", "OBSERVATION_MODIFIER", 26, 38], ["Gamma distribution", "OBSERVATION_MODIFIER", 45, 63]]], ["Whilst they each required small changes in control levels to achieve a good fit with case data, they did not change the results significantly.Methods.", [["small changes in control levels", "TREATMENT", 26, 57], ["small", "OBSERVATION_MODIFIER", 26, 31]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted May 21, 2020 . . https://doi.org/10.1101 \uf0b7 Clinical individuals have an initial period during which they are either asymptomatic or have sufficiently mild symptoms that they have not isolated.", [["CC", "CHEMICAL", 0, 2], ["ND", "PROBLEM", 9, 11], ["The copyright holder", "TREATMENT", 201, 221], ["sufficiently mild symptoms", "PROBLEM", 397, 423], ["med", "ANATOMY", 105, 108], ["mild", "OBSERVATION_MODIFIER", 410, 414]]], ["During this period, their infectiousness is as shown by the blue curve in Figure 1 .", [["the blue curve", "TEST", 56, 70]]], ["Once they develop more serious symptoms, they are isolated and their infectiousness reduces to = 65% (Davies et al., 2020a) of the value it would have without isolation (green curve in Figure 1 ).", [["more serious symptoms", "PROBLEM", 18, 39]]], ["This represents a control policy of requiring symptomatic individuals to self-isolate. \uf0b7 In the model, individuals with subclinical infections are not isolated. \uf0b7 Clinical individuals have a probability of detection .", [["infections", "DISEASE", 132, 142], ["symptomatic individuals", "PROBLEM", 46, 69], ["subclinical infections", "PROBLEM", 120, 142], ["subclinical", "OBSERVATION_MODIFIER", 120, 131], ["infections", "OBSERVATION", 132, 142]]], ["Cases that are not detected do not get isolated and are not included in the data but, unlike subclinical individuals, are fully infectious. \uf0b7 All individuals are assumed to be no longer infectious 30 days after being infected.", [["fully infectious", "PROBLEM", 122, 138], ["infectious", "OBSERVATION", 128, 138], ["no longer", "UNCERTAINTY", 176, 185], ["infected", "OBSERVATION", 217, 225]]], ["This is an upper limit for computational convenience; in practice, individuals have very low infectiousness after about 12 days because of the shape of the generation time distribution (Fig. 1 ). \uf0b7 The time between infection and isolation the sum of two random variables 1 and 2 .", [["infection", "DISEASE", 215, 224], ["very low infectiousness", "PROBLEM", 84, 107], ["infection", "PROBLEM", 215, 224], ["upper limit", "OBSERVATION_MODIFIER", 11, 22], ["infection", "OBSERVATION", 215, 224]]], ["1 represents the time from infection to onset of symptoms and has a gamma distribution with mean 5.5 days and shape parameter 5.8 (Lauer et al., 2020) .", [["infection", "DISEASE", 27, 36], ["infection", "PROBLEM", 27, 36], ["symptoms", "PROBLEM", 49, 57], ["shape parameter", "TEST", 110, 125], ["infection", "OBSERVATION", 27, 36]]], ["2 is taken from New Zealand case data (see below). \uf0b7 The model does not explicitly include a latent period.", [["latent", "OBSERVATION_MODIFIER", 93, 99]]], ["However, the shape of the Weibull generation time distribution ( Figure 1 ) captures this effect, giving a low probability of a short generation time between infections. \uf0b7 The model is simulated using a time step of = 1 day.", [["infections", "DISEASE", 158, 168], ["a short generation time between infections", "PROBLEM", 126, 168], ["shape", "OBSERVATION_MODIFIER", 13, 18], ["Weibull generation", "OBSERVATION", 26, 44], ["infections", "OBSERVATION", 158, 168]]], ["At each step, infectious individual produces a Poisson distributed number of secondary infections with mean(which was not certified by peer review)where is the individual's mean number of secondary infections, is the probability density function of the Weibull distributed generation time (see Table 1 ), , is time individual became infected, , is the delay from becoming infected to being isolated, ( ) is the control effectivity at time (see below) in group , and ( ) is a function describing the reduction in infectiousness due to isolation:(which was not certified by peer review)\uf0b7 The contact matrix \u039b gives the probability \u039b that a secondary infection originating from group will be in group , with \u2211 \u039b = 1.", [["infections", "DISEASE", 87, 97], ["infections", "DISEASE", 198, 208], ["infection", "DISEASE", 648, 657], ["secondary infections", "PROBLEM", 77, 97], ["secondary infections", "PROBLEM", 188, 208], ["infected", "PROBLEM", 333, 341], ["the delay", "PROBLEM", 348, 357], ["infected", "PROBLEM", 372, 380], ["infectiousness", "PROBLEM", 512, 526], ["a secondary infection", "PROBLEM", 636, 657], ["infectious", "OBSERVATION", 14, 24], ["secondary", "OBSERVATION_MODIFIER", 77, 86], ["infections", "OBSERVATION", 87, 97], ["secondary", "OBSERVATION_MODIFIER", 188, 197], ["infections", "OBSERVATION", 198, 208], ["probability density", "OBSERVATION_MODIFIER", 217, 236], ["infected", "OBSERVATION", 333, 341], ["infected", "OBSERVATION", 372, 380], ["secondary", "OBSERVATION_MODIFIER", 638, 647], ["infection", "OBSERVATION", 648, 657]]], ["New infections from group are distributed across groups according to these probabilities. \uf0b7 The model was initialised with seed cases representing arrival of infected individuals from overseas.", [["infections", "DISEASE", 4, 14], ["New infections", "PROBLEM", 0, 14], ["infected individuals", "PROBLEM", 158, 178], ["infections", "OBSERVATION", 4, 14], ["infected", "OBSERVATION", 158, 166]]], ["For these cases, the infection date was estimated backwards from the date of onset of symptoms (distribution shown in Table 1 ).", [["infection", "DISEASE", 21, 30], ["the infection", "PROBLEM", 17, 30], ["symptoms", "PROBLEM", 86, 94], ["infection", "OBSERVATION", 21, 30]]], ["For cases that did not include an onset date, the infection date was backdated from the arrival date.", [["infection", "DISEASE", 50, 59], ["the infection", "PROBLEM", 46, 59], ["infection", "OBSERVATION", 50, 59]]], ["Cases missing an isolation date were assumed to remain fully infectious for the whole infectious period.", [["fully infectious", "PROBLEM", 55, 71], ["infectious", "OBSERVATION", 61, 71]]], ["Secondary infections that occurred before arrival in New Zealand were ignored (i.e. the right-hand side of Eq.", [["right-hand", "ANATOMY", 88, 98], ["Secondary infections", "DISEASE", 0, 20], ["Secondary infections", "PROBLEM", 0, 20], ["infections", "OBSERVATION", 10, 20], ["right", "ANATOMY_MODIFIER", 88, 93], ["hand", "ANATOMY", 94, 98]]], ["Cases that were flagged as having an international travel history but missing an arrival date were assumed to have assumed to have arrived on the same date at becoming infected, so all their secondary infections were included.", [["infections", "DISEASE", 201, 211], ["infected", "PROBLEM", 168, 176], ["all their secondary infections", "PROBLEM", 181, 211], ["infected", "OBSERVATION", 168, 176], ["secondary", "OBSERVATION_MODIFIER", 191, 200], ["infections", "OBSERVATION", 201, 211]]], ["To allow for the fact that the case data only includes clinical cases, an additional number ,~( /(1 \u2212 )) of subclinical seed cases were added.", [["subclinical seed cases", "PROBLEM", 108, 130]]], ["The arrival, onset and isolation dates for these subclinical seed cases were approximated by random sampling with replacement from the clinical seed cases.Case data.", [["these subclinical seed cases", "PROBLEM", 43, 71], ["replacement", "TREATMENT", 114, 125]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted May 21, 2020. . https://doi.org/10.1101/2020.05.17.20104976 doi: medRxiv preprint After isolation the infection intensity is reduced to a lower level (green curve).", [["CC", "CHEMICAL", 0, 2], ["infection", "DISEASE", 362, 371], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["The copyright holder", "TREATMENT", 201, 221], ["medRxiv", "TREATMENT", 325, 332], ["the infection intensity", "PROBLEM", 358, 381], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108], ["infection", "OBSERVATION", 362, 371], ["reduced", "OBSERVATION_MODIFIER", 385, 392]]], ["Subclinical infectives are not isolated and follow the shape of the blue curve throughout, but with a lower overall infectiousness.", [["Subclinical infectives", "PROBLEM", 0, 22], ["the blue curve", "TEST", 64, 78], ["a lower overall infectiousness", "PROBLEM", 100, 130], ["infectiousness", "OBSERVATION", 116, 130]]], ["Time from infection to isolation is the sum of two random variables = 1 + 2 drawn from shown in Table 1 .", [["infection", "DISEASE", 10, 19], ["infection", "PROBLEM", 10, 19], ["two random variables", "TEST", 47, 67], ["infection", "OBSERVATION", 10, 19]]], ["Clinical infections have probability \u210e of hospitalisation; length of hospital stay is a random variable drawn from the distribution shown in Table 1 .(which was not certified by peer review)To allow for the time lag from isolation to reporting, each isolated case was assigned a time for the delay to reporting drawn from a gamma distribution, with parameters approximated from the domestic cases (see Table 1 ).", [["infections", "DISEASE", 9, 19], ["Clinical infections", "PROBLEM", 0, 19], ["infections", "OBSERVATION", 9, 19]]], ["The international cases were assigned the actual reporting date as recorded in the data.Control sub-modelPopulation-wide control interventions were modelled via the function ( ), which represents the transmission rate relative to no population-wide control.", [["Control sub-modelPopulation", "TREATMENT", 88, 115], ["wide control interventions", "TREATMENT", 116, 142], ["wide", "OBSERVATION_MODIFIER", 116, 120], ["wide", "OBSERVATION_MODIFIER", 244, 248]]], ["Population-wide control interventions include closure of schools, universities or non-essential businesses, restrictions on large gatherings and domestic travel, social distancing measures and stay-at-home orders.", [["wide control interventions", "TREATMENT", 11, 37], ["closure of schools", "TREATMENT", 46, 64], ["wide", "OBSERVATION_MODIFIER", 11, 15]]], ["New Zealand's control measures are based on a scale of Alert Levels ranging from 1 to 4.", [["New Zealand's control measures", "TREATMENT", 0, 30], ["Alert Levels", "TEST", 55, 67]]], ["Level 1 controls are largely restricted to surveillance measures, while Level 4 is strong lockdown of most activities bar essential services.", [["surveillance measures", "TEST", 43, 64]]], ["We do not attempt to model the short periods of time at Alert Levels 2 and 3; instead we assume that Level 2 was in place up to 25 March, with an effective reproduction number consistent with the data up to this point.", [["Alert Levels", "TEST", 56, 68]]], ["After 25 March, transmission rates are reduced to represent Alert Level 4, which continues until the end of 27 April.Control sub-modelReductions in the transmission rates at Alert Levels are based on modelling literature (Moss et al., 2020; Kissler et al., 2020; Jarvis et al., 2020) and empirical estimates of the effective reproduction number in international data (Flaxman et al., 2020; Hsiang et al., 2020; Binny et al., 2020) and provide a reasonable fit with the New Zealand data.", [["transmission rates", "TEST", 16, 34], ["Alert Levels", "TEST", 174, 186]]], ["Estimates for Level 3 transmission reduction should be treated with caution at this stage and estimates used here may not be representative.", [["Level 3 transmission reduction", "TREATMENT", 14, 44], ["caution", "TREATMENT", 68, 75]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted May 21, 2020. . https://doi.org/10.1101/2020.05.17.20104976 doi: medRxiv preprint distancing in a school or early childhood setting, the difficulties in isolating older people in multi-generational households or maintaining an isolated household bubble in overcrowded housing.Contact sub-model and effective reproductive numberFor individuals in group , the average reproduction number, with a relative transmission , and without case isolation, is = (Contact sub-model and effective reproductive number).", [["CC", "CHEMICAL", 0, 2], ["people", "ORGANISM", 429, 435], ["people", "SPECIES", 429, 435], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["The copyright holder", "TREATMENT", 201, 221], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108], ["household bubble", "OBSERVATION", 496, 512]]], ["The average number of secondary infections in group caused by a randomly chosen index case in group is \u039b .", [["infections", "DISEASE", 32, 42], ["secondary infections", "PROBLEM", 22, 42], ["average", "OBSERVATION_MODIFIER", 4, 11], ["number", "OBSERVATION_MODIFIER", 12, 18], ["secondary", "OBSERVATION_MODIFIER", 22, 31], ["infections", "OBSERVATION", 32, 42]]], ["The overall population effective reproduction number is the dominant eigenvalue of the 2 \u00d7 2 block matrixContact sub-model and effective reproductive numberThe contact probability matrix \u039b is chosen to model particular scenarios to compare the relative efficacy of different control interventions or to help identify potential high-risk groups.", [["the 2 \u00d7 2 block matrixContact sub-model", "TREATMENT", 83, 122], ["different control interventions", "TREATMENT", 265, 296], ["overall", "OBSERVATION_MODIFIER", 4, 11], ["population", "OBSERVATION_MODIFIER", 12, 22], ["effective", "OBSERVATION_MODIFIER", 23, 32], ["dominant", "OBSERVATION_MODIFIER", 60, 68], ["eigenvalue", "OBSERVATION_MODIFIER", 69, 79]]], ["These include the proportion and relative infectiousness of subclinical cases, the heterogeneity in individual reproduction numbers, the mean generation time, and the values in the contact matrix.", [["matrix", "CELLULAR_COMPONENT", 189, 195], ["relative infectiousness of subclinical cases", "PROBLEM", 33, 77], ["infectiousness", "OBSERVATION_MODIFIER", 42, 56], ["subclinical cases", "OBSERVATION", 60, 77], ["heterogeneity", "OBSERVATION_MODIFIER", 83, 96], ["individual", "OBSERVATION_MODIFIER", 100, 110], ["reproduction", "OBSERVATION_MODIFIER", 111, 123], ["numbers", "OBSERVATION_MODIFIER", 124, 131]]], ["Any change in parameters that results in a change in the overall population reproduction number causes a corresponding change in the trajectory of case numbers.", [["Any change in parameters", "PROBLEM", 0, 24], ["a change", "PROBLEM", 41, 49], ["change", "OBSERVATION", 4, 10], ["change", "OBSERVATION_MODIFIER", 43, 49], ["change", "OBSERVATION_MODIFIER", 119, 125]]], ["However, if the value of is fixed, the model is robust to these parameters and the qualitative results described in the scenarios above are not affected.", [["the value", "TEST", 12, 21], ["these parameters", "TEST", 58, 74]]], ["Increasing heterogeneity in individual reproduction numbers increases variation between independent stochastic realisations and increases the probability of ultimate extinction (Lloyd-Smith et al., 2005) .", [["Increasing heterogeneity", "PROBLEM", 0, 24], ["individual reproduction numbers", "PROBLEM", 28, 59], ["heterogeneity", "OBSERVATION_MODIFIER", 11, 24], ["individual", "OBSERVATION_MODIFIER", 28, 38], ["reproduction", "OBSERVATION_MODIFIER", 39, 51], ["numbers", "OBSERVATION_MODIFIER", 52, 59], ["increases", "OBSERVATION_MODIFIER", 60, 69], ["variation", "OBSERVATION_MODIFIER", 70, 79], ["stochastic realisations", "OBSERVATION", 100, 123]]], ["This is important in scenarios that consider elimination of the virus as a potential outcome, but this was not the primary focus of our work here.", [["the virus", "PROBLEM", 60, 69]]], ["Increasing mean generation times slows the spread of the virus and, if the model were then calibrated against empirical case data, this would require a larger value of 0 (and by implication greater relative reduction in 0 at each Alert Level).", [["Increasing mean generation times", "PROBLEM", 0, 32], ["the virus", "PROBLEM", 53, 62], ["mean generation", "OBSERVATION", 11, 26]]], ["However, the distinction between short generation time and low 0 versus longer generation time and higher 0 is not crucial in scenarios where there is no significant herd immunity.", [["herd", "ORGANISM_SUBDIVISION", 166, 170], ["no", "UNCERTAINTY", 151, 153], ["significant", "OBSERVATION_MODIFIER", 154, 165], ["herd immunity", "OBSERVATION", 166, 179]]], ["Model results are insensitive to moderate changes in the contact matrix but will change slightly if very extreme values are used.Age-structured scenarioIn these scenarios, we consider the effect of school closure on disease spread.", [["matrix", "CELLULAR_COMPONENT", 65, 71], ["moderate changes in the contact matrix", "PROBLEM", 33, 71], ["very extreme values", "PROBLEM", 100, 119], ["school closure", "TREATMENT", 198, 212], ["disease spread", "PROBLEM", 216, 230], ["moderate", "OBSERVATION_MODIFIER", 33, 41]]], ["Detailed data about the effects of lockdown and other COVID-19 response measures on age-structured contact rates are not yet reliably available.", [["lockdown", "TREATMENT", 35, 43], ["other COVID", "TREATMENT", 48, 59]]], ["Although this may partially emerge from a combination of data sources including employment data, telecommunications data, calibrating this with New Zealand household size data and case and contact tracing data is beyond the scope of this paper.", [["employment data", "TEST", 80, 95], ["telecommunications data", "TEST", 97, 120], ["contact tracing data", "TEST", 189, 209]]], ["Nonetheless, the opening and closing of schools is an important policy choice, so we want to explore the possibility of answering this question using an age-structured model.Age-structured scenario.", [["structured scenario", "OBSERVATION", 178, 197]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted May 21, 2020. .", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["The copyright holder", "TREATMENT", 201, 221], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted May 21, 2020. . https://doi.org/10.1101/2020.05.17.20104976 doi: medRxiv preprint As such, we consider a population split into three age groups: under 19 year olds, 19 -65 year olds and over 65s.", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["The copyright holder", "TREATMENT", 201, 221], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["Data shows that these three age groups have very different rates of clinical severity to COVID-19 (Verity et al., 2020) and we assume that the probability of being subclinical is 80%, 33% and 20% respectively based on estimates by Davies et al. (2020b) .", [["COVID", "TEST", 89, 94]]], ["Seed cases are assigned to an age group according to the NZ data.(which was not certified by peer review)At Alert Levels 1 and 2, we assume that 50% of contacts between groups occur according to the relative size of each group in the population (here under 19s -20%, 19-65 year olds -65% and over 65s -15%).", [["Alert Levels", "TEST", 108, 120], ["size", "OBSERVATION_MODIFIER", 208, 212]]], ["It is also consistent with projections for age-stratified contact rates for New Zealand (Prem 2017) aggregated into coarser age groups.", [["consistent with", "UNCERTAINTY", 11, 26]]], ["We assume that older people have fewer contacts with other groups: only 5% of secondary cases originating from children are in older people, with remaining secondary cases from children split evenly between other children and adults.", [["people", "ORGANISM", 21, 27], ["children", "ORGANISM", 111, 119], ["people", "ORGANISM", 133, 139], ["children", "ORGANISM", 177, 185], ["children", "ORGANISM", 213, 221], ["people", "SPECIES", 21, 27], ["children", "SPECIES", 111, 119], ["people", "SPECIES", 133, 139], ["children", "SPECIES", 177, 185], ["children", "SPECIES", 213, 221]]], ["This models an average child's isolation bubble as containing a similar number of adults and other children.", [["children", "ORGANISM", 99, 107], ["children", "SPECIES", 99, 107]]], ["The majority (65%) of secondary infections originating from adults are still in other adults, with only 5% in older people and the remainder (30%) with children.", [["infections", "DISEASE", 32, 42], ["adults", "ORGANISM", 60, 66], ["people", "ORGANISM", 116, 122], ["children", "ORGANISM", 152, 160], ["people", "SPECIES", 116, 122], ["children", "SPECIES", 152, 160], ["secondary infections", "PROBLEM", 22, 42], ["majority", "OBSERVATION_MODIFIER", 4, 12], ["secondary", "OBSERVATION_MODIFIER", 22, 31], ["infections", "OBSERVATION", 32, 42]]], ["Finally, secondary cases originating from older people occur predominantly (65%) in other older people, only 5% in children and the remainder (30%) in adults. .", [["people", "ORGANISM", 48, 54], ["people", "ORGANISM", 96, 102], ["children", "ORGANISM", 115, 123], ["adults", "ORGANISM", 151, 157], ["people", "SPECIES", 48, 54], ["people", "SPECIES", 96, 102], ["children", "SPECIES", 115, 123], ["predominantly", "OBSERVATION_MODIFIER", 61, 74]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted May 21, 2020 . . https://doi.org/10.1101 The mean reproduction number, in the absence of control measures, for clinical cases, , is the same for adults (the largest population group) as in Plank et al. (2020) .", [["CC", "CHEMICAL", 0, 2], ["https://doi.org/10.1101", "CHEMICAL", 277, 300], ["ND", "PROBLEM", 9, 11], ["The copyright holder", "TREATMENT", 201, 221], ["med", "ANATOMY", 105, 108]]], ["For the children and older people groups, it is scaled according to the expected number of face-to-face contacts given in the 2017 International Social Survey Programme for New Zealand (Li 2018) .", [["children", "ORGANISM", 8, 16], ["people", "ORGANISM", 27, 33], ["children", "SPECIES", 8, 16], ["people", "SPECIES", 27, 33]]], ["This results in clinical cases among children having a much higher average reproduction number and among older people a much lower one.", [["children", "ORGANISM", 37, 45], ["people", "ORGANISM", 111, 117], ["children", "SPECIES", 37, 45], ["people", "SPECIES", 111, 117]]], ["We assume that control measures at Alert Levels 3 and 4 produce same relative in transmission from all three age groups.(which was not certified by peer review)This model fits well with data on the number of cases in NZ in each age group over time (see Figure 2 , red lines).", [["red lines", "CELL", 264, 273], ["Alert Levels", "TEST", 35, 47]]], ["The model results are most dependent on the proportion of subclinical and undetected cases in each group (as described above, these were sourced from literature not tuned to fit the model to data).", [["most dependent", "OBSERVATION_MODIFIER", 22, 36]]], ["This is in part due to the large number of international seed cases in the model but also suggests that age-specific epidemiological parameters play a more important role than the details of contact rates between age groups.", [["large", "OBSERVATION_MODIFIER", 27, 32], ["number", "OBSERVATION_MODIFIER", 33, 39]]], ["This suggests that the results seen here might remain robust once further data is available to inform actual contact and/or transmission rates.(which was not certified by peer review)We now consider hypothetical school closures as a test of the model.", [["hypothetical school closures", "TREATMENT", 199, 227]]], ["The blue line in Figure 2 shows the model output if the average reproduction number for the under 19s group during Levels 4 was at the much higher level associated with Level 3.", [["blue line", "CELL", 4, 13], ["The blue line", "TREATMENT", 0, 13], ["the model output", "TEST", 32, 48], ["Levels", "TEST", 115, 121], ["blue line", "OBSERVATION", 4, 13], ["model", "OBSERVATION_MODIFIER", 36, 41], ["output", "OBSERVATION_MODIFIER", 42, 48]]], ["We also keep the first row of the contact matrix the same as at Levels 1 and 2 (see Table 2 ).", [["matrix", "CELLULAR_COMPONENT", 42, 48]]], ["This means that a higher proportion of secondary infections originating from children are in other children.", [["infections", "DISEASE", 49, 59], ["children", "ORGANISM", 77, 85], ["children", "ORGANISM", 99, 107], ["children", "SPECIES", 77, 85], ["children", "SPECIES", 99, 107], ["secondary infections", "PROBLEM", 39, 59], ["higher", "OBSERVATION_MODIFIER", 18, 24], ["secondary", "OBSERVATION_MODIFIER", 39, 48], ["infections", "OBSERVATION", 49, 59]]], ["We see that relaxation of control for children has only a small effect on the total number of cases and the overall population effective reproduction number is still less than 1 (Table 1) .", [["children", "ORGANISM", 38, 46], ["children", "SPECIES", 38, 46], ["small effect", "OBSERVATION_MODIFIER", 58, 70]]], ["However, the light blue line shows the effect of opening schools with an associated increase in adult, i.e. parental, interaction.", [["the light blue line", "PROBLEM", 9, 28], ["blue line", "OBSERVATION", 19, 28], ["increase", "OBSERVATION_MODIFIER", 84, 92]]], ["Here, the average reproduction number for adults is also set to the higher level under Alert level 3 (Table 1 ) and the adult row of the contact matrix reverts back to the Level 1-2 values (Table 1 ).", [["matrix", "CELLULAR_COMPONENT", 145, 151]]], ["This has a much greater effect on the overall case numbers than the increased transmission rates of children alone.", [["children", "ORGANISM", 100, 108], ["children", "SPECIES", 100, 108], ["much greater effect", "OBSERVATION_MODIFIER", 11, 30]]], ["The overall population effective reproduction number is above 1 in this scenario (Table 2) .Scenario structured by inequity in access to healthcareSingapore has seen a second outbreak of infections after appearing to contain an initial outbreak (Singapore Ministry of Health, 2020) .", [["infections", "DISEASE", 187, 197], ["infections", "PROBLEM", 187, 197], ["overall", "OBSERVATION_MODIFIER", 4, 11], ["population", "OBSERVATION_MODIFIER", 12, 22], ["effective", "OBSERVATION_MODIFIER", 23, 32], ["second", "OBSERVATION_MODIFIER", 168, 174], ["outbreak", "OBSERVATION_MODIFIER", 175, 183], ["infections", "OBSERVATION", 187, 197]]], ["This second wave emerged in a migrant worker community with low socioeconomic indicators, overcrowded housing, and less access to healthcare and testing.", [["testing", "TEST", 145, 152]]], ["In this section we want to explore scenarios that capture aspects of this situation.Scenario structured by inequity in access to healthcareWe do not attempt to model the multitude of relevant socioeconomic and demographic variables in detail, but instead explore the effect of different transmission and case detection rates in a simplified scenario that captures certain aspects of these.", [["case detection rates", "TEST", 304, 324]]], ["We assume split the population into two groups, each with a different level of access to healthcare and COVID-19 testing and diagnosis.", [["COVID", "TEST", 104, 109], ["split", "OBSERVATION_MODIFIER", 10, 15]]], ["To simplify the model, we assume each group has the same proportion of subclinical cases, although we note that COVID-19 severity and access to healthcare are likely to have common covariates for example derivation index and ethnicity .", [["COVID", "TEST", 112, 117]]], ["For these reasons, we assume that transmission rates in this group drop significantly under Levels 3 and 4 control.Scenario structured by inequity in access to healthcareWe assume that the group with poorer access to healthcare is smaller in size and has a much lower clinical case detection rate of 5%.", [["transmission rates", "TEST", 34, 52], ["smaller", "OBSERVATION_MODIFIER", 231, 238], ["size", "OBSERVATION_MODIFIER", 242, 246]]], ["This should be interpreted as meaning that only the most clinically severe cases are detected .", [["the most clinically severe cases", "PROBLEM", 48, 80]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted May 21, 2020. . https://doi.org/10.1101/2020.05.17.20104976 doi: medRxiv preprint (although variation is severity of clinical cases in not explicitly modelled).", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["The copyright holder", "TREATMENT", 201, 221], ["medRxiv preprint", "TREATMENT", 325, 341], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["We also investigate the scenario where transmission rates in this group do not decrease as much as in the first group during Alert Levels 3-4 due to, for example, overcrowded housing and job security issues precluding self-isolation during illness.", [["illness", "DISEASE", 240, 247], ["transmission rates", "TEST", 39, 57], ["Alert Levels", "TEST", 125, 137], ["illness", "PROBLEM", 240, 247]]], ["These parameter choices represent a simple model of inequities in the healthcare system and socioeconomic correlates, rather than actual estimates of case detection and transmission rates for particular groups.", [["case detection", "TEST", 150, 164], ["transmission rates", "TEST", 169, 187], ["simple", "OBSERVATION_MODIFIER", 36, 42]]], ["The motivation for this is to identify potential factors and regions of parameter space where large outbreaks could go undetected for a long period, for example as occurred in Singapore.(which was not certified by peer review)For simplicity, all seed cases are in the larger group with high levels of healthcare access.", [["potential factors and regions of parameter space", "PROBLEM", 39, 87], ["large outbreaks", "PROBLEM", 94, 109], ["large", "OBSERVATION_MODIFIER", 94, 99], ["outbreaks", "OBSERVATION", 100, 109]]], ["In the first scenario, we assume that both groups have the same reduction in transmission rates at any given Alert Levels (Figure 3 , red lines).", [["red lines", "CELL", 134, 143], ["transmission rates", "TREATMENT", 77, 95], ["Alert Levels", "TEST", 109, 121], ["red lines", "TREATMENT", 134, 143], ["reduction", "OBSERVATION_MODIFIER", 64, 73]]], ["This models a desired outcome of a policy intervention, whereby an effective control strategy takes into account the differing contexts for different sectors of society in order to achieve equitable outcomes.", [["a policy intervention", "TREATMENT", 33, 54], ["an effective control strategy", "TREATMENT", 64, 93]]], ["In the second scenario (Figure 3 , blue lines), we assume that control measures are less effective in the group with poor healthcare access.", [["blue lines", "CELL", 35, 45], ["blue lines", "TREATMENT", 35, 45], ["control measures", "TREATMENT", 63, 79]]], ["Throughout the Level 4 period, reported case numbers are almost identical but, due to low access to testing, there is a rapidly growing number of undiagnosed infections in the group with poor healthcare access.", [["infections", "DISEASE", 158, 168], ["testing", "TEST", 100, 107], ["undiagnosed infections", "PROBLEM", 146, 168], ["rapidly", "OBSERVATION_MODIFIER", 120, 127], ["growing", "OBSERVATION_MODIFIER", 128, 135], ["number", "OBSERVATION_MODIFIER", 136, 142], ["undiagnosed", "OBSERVATION_MODIFIER", 146, 157], ["infections", "OBSERVATION", 158, 168]]], ["If this contact rate is large, a growth in the number of cases in one group will quickly lead to cases in the other group and outbreaks will be promptly detected through the higher testing rate of the group with better healthcare access.", [["large", "OBSERVATION_MODIFIER", 24, 29]]], ["This suggests that the highest-risk groups are those that have both low levels of access to healthcare and limited contact rates with other groups.", [["highest", "OBSERVATION_MODIFIER", 23, 30]]], ["Pacific peoples in Auckland also experience higher rates of overcrowding (Schluter 2007) and high rates of unmet healthcare needs (Ryan 2019) .", [["overcrowding", "DISEASE", 60, 72]]], ["This study suggests that Pacific communities in Auckland are at risk of large secondary outbreaks if structural inequities in healthcare are not addressed.Figure 3:The results of a model structured by access to healthcare, where cases are less likely to be detected in one group because of poor access to testing and diagnosis.", [["This study", "TEST", 0, 10], ["large secondary outbreaks", "PROBLEM", 72, 97], ["testing", "TEST", 305, 312], ["Pacific", "OBSERVATION_MODIFIER", 25, 32], ["large", "OBSERVATION_MODIFIER", 72, 77], ["secondary", "OBSERVATION_MODIFIER", 78, 87], ["outbreaks", "OBSERVATION", 88, 97], ["less likely", "UNCERTAINTY", 239, 250]]], ["The red line illustrates a scenario where control measures are equally effective for both groups.", [["red line", "ANATOMY", 4, 12], ["red line", "CELL_LINE", 4, 12], ["The red line", "TREATMENT", 0, 12], ["control measures", "TREATMENT", 42, 58], ["red line", "OBSERVATION", 4, 12]]], ["The blue line shows a scenario where control measures do not reduce transmission rates for the group with poor access to healthcare, eventually leading to an outbreak in both populations.", [["blue line", "CELL", 4, 13], ["blue line", "CELL_LINE", 4, 13], ["The blue line", "TREATMENT", 0, 13], ["control measures", "TREATMENT", 37, 53], ["an outbreak in both populations", "PROBLEM", 155, 186], ["blue line", "OBSERVATION", 4, 13], ["outbreak", "OBSERVATION", 158, 166]]], ["Pale lines show the corresponding daily number of new exposures.", [["Pale lines", "ANATOMY", 0, 10], ["Pale lines", "CELL", 0, 10], ["Pale lines", "CELL_LINE", 0, 10], ["Pale lines", "PROBLEM", 0, 10], ["lines", "OBSERVATION", 5, 10], ["daily", "OBSERVATION_MODIFIER", 34, 39], ["number", "OBSERVATION_MODIFIER", 40, 46], ["new", "OBSERVATION_MODIFIER", 50, 53], ["exposures", "OBSERVATION", 54, 63]]], ["Results are averaged over 500 independent, identically initialised realisations of the stochastic process.Figure 3:.", [["the stochastic process", "PROBLEM", 83, 105], ["stochastic process", "OBSERVATION", 87, 105]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted May 21, 2020 . . https://doi.org/10.1101DiscussionWe have extended the stochastic model of Plank et al. (2020) to include age structure and inequities in healthcare access.", [["CC", "CHEMICAL", 0, 2], ["ND", "PROBLEM", 9, 11], ["The copyright holder", "TREATMENT", 201, 221], ["med", "ANATOMY", 105, 108]]], ["Firstly, we considered school closures, where it is important to capture differences in infection and contact rates in adults and school pupils.", [["infection", "DISEASE", 88, 97], ["school closures", "TREATMENT", 23, 38], ["infection", "PROBLEM", 88, 97], ["infection", "OBSERVATION", 88, 97]]], ["Secondly, we looked at a scenario where socio-economic and healthcare inequities lead to a large secondary outbreak in a high-risk community, much like that which occurred in migrant worker communities Singapore.", [["a large secondary outbreak", "PROBLEM", 89, 115], ["large", "OBSERVATION_MODIFIER", 91, 96], ["secondary", "OBSERVATION_MODIFIER", 97, 106], ["outbreak", "OBSERVATION", 107, 115]]], ["The effective reproduction numbers for these scenarios are shown in There are some important caveats to this work.", [["effective", "OBSERVATION_MODIFIER", 4, 13]]], ["While we have endeavoured to consider scenarios that are consistent with existing evidence, for the most part the current evidence base is currently too thin to draw firm conclusions, particularly around school closures.", [["consistent with", "UNCERTAINTY", 57, 72]]], ["This study illustrates how such information will allow us to better understand the risk factors for specific communities in New Zealand and how specific control measures might reduce the impact on these communities.DiscussionThe age-structured model used very coarse age classes.", [["This study", "TEST", 0, 10], ["New Zealand", "TREATMENT", 124, 135], ["specific control measures", "TREATMENT", 144, 169]]], ["This allows investigate of school closures or other policy interventions that differentially affect transmission in different age groups.", [["school closures", "TREATMENT", 27, 42], ["other policy interventions", "TREATMENT", 46, 72]]], ["However, these coarse age classes are likely to contain significant heterogeneity in variables such as occupation, as well as masking finer-scale contact structures.", [["significant heterogeneity in variables", "PROBLEM", 56, 94], ["likely to contain", "UNCERTAINTY", 38, 55], ["significant", "OBSERVATION_MODIFIER", 56, 67], ["heterogeneity", "OBSERVATION", 68, 81]]], ["The model framework allows finer age classes once sufficient data is available to parameterise contact rates under different control interventions and epidemiological parameters (e.g. proportion of subclinical cases) for these groups.", [["different control interventions", "TREATMENT", 115, 146], ["epidemiological parameters", "TEST", 151, 177]]], ["Again this would require more detailed data to parameterise the contact structure for the increased number of groups this will require.DiscussionNonetheless, structuring the model by levels of inequity in healthcare, which itself may be a consequence of differing levels of socioeconomic deprivation and/or racial discrimination, is important in guiding New Zealand's .", [["socioeconomic deprivation", "TREATMENT", 274, 299], ["increased", "OBSERVATION_MODIFIER", 90, 99]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted May 21, 2020. . https://doi.org/10.1101/2020.05.17.20104976 doi: medRxiv preprint COVID-19 response.", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["The copyright holder", "TREATMENT", 201, 221], ["medRxiv preprint COVID", "TREATMENT", 325, 347], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["The New Zealand government has an obligation under Te Tiriti o Waitangi to deliver equitable health outcomes for M\u0101ori and other population groups (Waitangi Tribunal 2019).", [["New", "OBSERVATION_MODIFIER", 4, 7], ["Zealand", "OBSERVATION_MODIFIER", 8, 15]]], ["Our study highlights the potentially heightened risks of COVID-19 for M\u0101ori and Pacific peoples and communities, which experience inequities in health and healthcare access that not only increase the risks of infection but may also magnify the impacts of the disease.", [["infection", "DISEASE", 209, 218], ["Our study", "TEST", 0, 9], ["COVID", "TEST", 57, 62], ["infection", "PROBLEM", 209, 218], ["the disease", "PROBLEM", 255, 266], ["infection", "OBSERVATION", 209, 218], ["disease", "OBSERVATION", 259, 266]]], ["Furthermore, the scenarios we modelled show that the combination of unequitable access to health care combined with relatively low rates of contact with other more privileged sectors of the population are the biggest risk factors for undetected transmission.", [["health care", "TREATMENT", 90, 101]]], ["The government has a responsibility to work with these communities to ensure that their healthcare needs are being met by its COVID-19 response.(which was not certified by peer review)Internationally, there is a growing body of the international evidence that socioeconomic disparities do indeed magnify the impacts of the COVID-19.", [["socioeconomic disparities", "PROBLEM", 260, 285], ["the COVID", "TEST", 319, 328], ["growing", "OBSERVATION_MODIFIER", 212, 219]]], ["In the United States, for instance, predominantly African American communities have faced infection rates three times those of European American communities and death rates six times as high (Yancy 2020).", [["infection", "DISEASE", 90, 99], ["death", "DISEASE", 161, 166], ["faced infection rates", "PROBLEM", 84, 105], ["death rates", "TEST", 161, 172], ["infection", "OBSERVATION", 90, 99]]], ["A report from the United Kingdom suggests that ethnic minority groups are at significantly higher risk from COVID-19 (ICNARC 2020).", [["ethnic minority groups", "PROBLEM", 47, 69], ["COVID", "TEST", 108, 113]]], ["We have not modelled potential differences in clinical severity (e.g. hospitalisation rates) or transmission rates across groups with different levels of access to healthcare.", [["transmission rates across groups", "PROBLEM", 96, 128]]], ["This will be important to do, especially given these variables are likely to be correlated , amplifying the impact of COVID-19 in high-risk groups.", [["COVID", "TEST", 118, 123]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)(which was not certified by peer review)The copyright holder for this preprint this version posted May 21, 2020. .", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["The copyright holder", "TREATMENT", 242, 262], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)(which was not certified by peer review)The copyright holder for this preprint this version posted May 21, 2020. . https://doi.org/10.", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["The copyright holder", "TREATMENT", 242, 262], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]]], "PMC7159375": [["Bovine coronavirus (BCoV) is a member of the family Coronaviridae and causes severe diarrhea in neonatal calves and winter dysentery in adult cattle (Athanassious et al., 1994; Fukutomi et al., 1999; Cho et al., 2001a; Khalili et al., 2006; Stipp et al., 2009).", [["Bovine coronavirus", "DISEASE", 0, 18], ["diarrhea", "DISEASE", 84, 92], ["dysentery", "DISEASE", 123, 132], ["Bovine coronavirus", "ORGANISM", 0, 18], ["BCoV", "ORGANISM", 20, 24], ["Coronaviridae", "GENE_OR_GENE_PRODUCT", 52, 65], ["calves", "ORGANISM", 105, 111], ["cattle", "ORGANISM", 142, 148], ["Bovine", "SPECIES", 0, 6], ["coronavirus", "SPECIES", 7, 18], ["calves", "SPECIES", 105, 111], ["cattle", "SPECIES", 142, 148], ["Bovine coronavirus", "SPECIES", 0, 18], ["BCoV", "SPECIES", 20, 24], ["cattle", "SPECIES", 142, 148], ["Bovine coronavirus (BCoV)", "TREATMENT", 0, 25], ["the family Coronaviridae", "TREATMENT", 41, 65], ["severe diarrhea in neonatal calves", "PROBLEM", 77, 111], ["coronavirus", "OBSERVATION", 7, 18], ["severe", "OBSERVATION_MODIFIER", 77, 83], ["diarrhea", "OBSERVATION", 84, 92], ["neonatal calves", "ANATOMY", 96, 111]]], ["Bovine coronavirus infection of the upper respiratory tract has also been described in growing calves and adults (Lathrop et al., 2000a, 2000b; Cho et al., 2001b; Hasoksuz et al., 2002b).", [["upper respiratory tract", "ANATOMY", 36, 59], ["coronavirus infection", "DISEASE", 7, 28], ["Bovine coronavirus", "ORGANISM", 0, 18], ["upper respiratory", "ORGANISM_SUBDIVISION", 36, 53], ["tract", "ORGANISM_SUBDIVISION", 54, 59], ["calves", "ORGANISM", 95, 101], ["Bovine", "SPECIES", 0, 6], ["coronavirus", "SPECIES", 7, 18], ["calves", "SPECIES", 95, 101], ["Bovine coronavirus", "SPECIES", 0, 18], ["Bovine coronavirus infection of the upper respiratory tract", "PROBLEM", 0, 59], ["coronavirus", "OBSERVATION_MODIFIER", 7, 18], ["infection", "OBSERVATION", 19, 28], ["upper", "ANATOMY_MODIFIER", 36, 41], ["respiratory tract", "ANATOMY", 42, 59]]]], "PMC7365063": [["IntroductionThe global financial crisis and associated events and most recently the outbreak of COVID-19 have shaken developed and emerging economies.", [["COVID-19", "CHEMICAL", 96, 104], ["The global financial crisis", "PROBLEM", 12, 39], ["associated events", "PROBLEM", 44, 61], ["COVID", "TEST", 96, 101], ["global", "OBSERVATION_MODIFIER", 16, 22], ["financial crisis", "OBSERVATION", 23, 39], ["economies", "OBSERVATION", 140, 149]]], ["The upheavals in the international financial system are now more persistent and recurrent.", [["persistent", "OBSERVATION_MODIFIER", 65, 75]]], ["The international financial integration and synchronisation of business cycles are considered fundamentals for the market turbulence and spillover (Rejeb and Arfaoui, 2016; Nasir and Du, 2018; Huynh, 2019).", [["business cycles", "TREATMENT", 63, 78]]], ["There is also a great interest in the nature of asset dependencies for asset pricing, portfolio allocation and financial policy formulation.", [["asset pricing", "TREATMENT", 71, 84], ["portfolio allocation", "TREATMENT", 86, 106], ["financial policy formulation", "TREATMENT", 111, 139], ["great", "OBSERVATION_MODIFIER", 16, 21], ["interest", "OBSERVATION_MODIFIER", 22, 30]]], ["The portfolio return can be influenced by misallocation, especially during market turmoil.", [["misallocation", "OBSERVATION", 42, 55]]], ["Asset dependencies, therefore, are vital to verify how the assets can affect each other and how strongly they are interlinked.", [["Asset dependencies", "PROBLEM", 0, 18]]], ["According to the diversification principle, the probability of investment losses could be diminished by investing in assets with low correlations.IntroductionAs a result of globalisation, the emerging countries which are often very dependant on commodities, have become highly integrated with the rest of the world.", [["investment losses", "PROBLEM", 63, 80]]], ["Emerging stock markets are vulnerable to several global shocks with severe commodity price fluctuations (oil price shocks), increased financial instability and a potential slowdown in the global economy.", [["oil", "ORGANISM_SUBDIVISION", 105, 108], ["oil price shocks", "TREATMENT", 105, 121], ["increased financial instability", "PROBLEM", 124, 155], ["severe", "OBSERVATION_MODIFIER", 68, 74], ["increased", "OBSERVATION_MODIFIER", 124, 133], ["financial instability", "OBSERVATION", 134, 155], ["slowdown", "OBSERVATION_MODIFIER", 172, 180], ["global", "OBSERVATION_MODIFIER", 188, 194], ["economy", "OBSERVATION", 195, 202]]], ["Therefore, risk management has become crucial, particularly during extreme market conditions, as investors seek protection.", [["risk management", "TREATMENT", 11, 26]]], ["Traditionally, a good place of safety against macroeconomic risk is the gold market (Erb and Harvey, 2006; Reboredo, 2013).", [["good", "OBSERVATION_MODIFIER", 17, 21]]], ["In developed stock markets, gold is reported to be a good safe-haven asset during the peak of the recent financial crisis (Ciner et al., 2013; Flavin et al., 2014; Bredin et al., 2015; Junttila et al., 2018; Baek, 2019).", [["stock markets", "OBSERVATION", 13, 26]]], ["There is empirical evidence showing that gold is a poor safe-haven or is not a safe-haven for emerging stock markets (see, e.g. Baur and McDermott, 2010; Beckmann et al., 2015; Bekiros et al., 2017).", [["gold", "OBSERVATION_MODIFIER", 41, 45]]], ["The substantially eased investment in gold makes gold increasingly acts like stocks (Bekiros et al., 2017).IntroductionThe proposition that gold has played a comparatively minor safe-haven role in emerging stock markets reinforces the need for an alternative.", [["gold", "CHEMICAL", 140, 144], ["an alternative", "TREATMENT", 244, 258], ["substantially", "OBSERVATION_MODIFIER", 4, 17]]], ["In this context, a major development has occurred through the financial innovation in the age of the 4th Industrial revolution, specifically, the cryptocurrencies and bitcoins.", [["the cryptocurrencies and bitcoins", "PROBLEM", 142, 175]]], ["It has brought a new phenomenon amongst international investors who now sell precious metals and buy Bitcoin (Rehman and Apergis, 2018).", [["new", "OBSERVATION_MODIFIER", 17, 20]]], ["Nevertheless, there is very limited evidence showing meaningful effects of cryptocurrencies on stocks.", [["cryptocurrencies on stocks", "PROBLEM", 75, 101]]], ["Furthermore, the linearity assumption introduced in the existing literature may overlook asset connections.", [["the linearity assumption", "TREATMENT", 13, 37], ["linearity", "OBSERVATION_MODIFIER", 17, 26]]], ["Positive and negative shocks of gold/Bitcoin prices may affect stock market differently where there are asymmetric effects of gold/Bitcoin on the stock market.", [["Bitcoin", "SIMPLE_CHEMICAL", 131, 138], ["gold/Bitcoin prices", "TREATMENT", 32, 51], ["gold/Bitcoin on the stock market", "TREATMENT", 126, 158], ["negative shocks", "OBSERVATION", 13, 28], ["asymmetric", "OBSERVATION_MODIFIER", 104, 114]]], ["This provides the rationale for the subject study and to investigate the notion that whether cryptocurrency can be a better safe-haven asset for emerging stock market.", [["the subject study", "TEST", 32, 49]]], ["A comprehensive study that includes old and new assets and focuses on a developing market has not been conducted hitherto.", [["A comprehensive study", "TEST", 0, 21], ["new", "OBSERVATION_MODIFIER", 44, 47], ["assets", "OBSERVATION", 48, 54]]], ["This study will address the gap and investigate how emerging stock market, old and new alternative assets are associated.", [["This study", "TEST", 0, 10]]], ["This paper is applying both linear and nonlinear approaches to examine correlation and hedging effectiveness of gold and Bitcoin for emerging stocks.IntroductionContextualising on the debate on the role of gold which is a pre-industrial age asset in the era of 4th industrial revolution and cryptocurrencies which are new instruments of the modern age, using daily data on Thai stocks, gold prices, and cryptocurrency (Bitcoin), this study finds that correlations between stock/gold and stock/cryptocurrency pairs are positive in most of the cases.", [["gold", "SIMPLE_CHEMICAL", 112, 116], ["Bitcoin", "SIMPLE_CHEMICAL", 121, 128], ["cryptocurrencies", "PROBLEM", 291, 307], ["Thai stocks", "TREATMENT", 373, 384], ["this study", "TEST", 429, 439], ["stock/gold and stock/cryptocurrency pairs", "TEST", 472, 513], ["new", "OBSERVATION_MODIFIER", 318, 321]]], ["This study also reveals that the hedging ability of gold and cryptocurrency against an adverse movement in the stock market is more complicated than the linear relation explored in the previous studies.", [["gold", "CHEMICAL", 52, 56], ["gold", "SIMPLE_CHEMICAL", 52, 56], ["This study", "TEST", 0, 10], ["the hedging ability of gold and cryptocurrency", "PROBLEM", 29, 75], ["an adverse movement in the stock market", "PROBLEM", 84, 123], ["the previous studies", "TEST", 181, 201], ["adverse", "OBSERVATION_MODIFIER", 87, 94], ["movement", "OBSERVATION_MODIFIER", 95, 103], ["more complicated", "OBSERVATION_MODIFIER", 127, 143]]], ["After splitting the entire sample period into different market states, estimates of stock and gold returns reveal that the effects of gold on the stock market are indeed asymmetric in most cases, except for one period of the bull market from May 2004 to October 2007.", [["gold", "CHEMICAL", 134, 138], ["asymmetric", "OBSERVATION_MODIFIER", 170, 180]]], ["Negative asymmetry is more likely to occur regardless of stock market conditions.", [["asymmetry", "PROBLEM", 9, 18], ["asymmetry", "OBSERVATION", 9, 18], ["is more likely", "UNCERTAINTY", 19, 33]]], ["Diversification implies putting an asset with whom it has a weak positive correlation.", [["a weak positive correlation", "PROBLEM", 58, 85]]], ["A weak (strong) hedge is a non-correlated (negative-correlated) asset with another asset on average.", [["weak", "OBSERVATION_MODIFIER", 2, 6]]], ["An asset that is uncorrelated (negatively correlated) to another asset in times of stress is a weak (strong) safe-haven.", [["stress", "PROBLEM", 83, 89]]], ["From the risk perspective, gold and cryptocurrency are suitable for diversification purpose only.", [["gold and cryptocurrency", "PROBLEM", 27, 50], ["diversification purpose", "TEST", 68, 91]]], ["Neither gold nor cryptocurrency acts as a good instrument for hedging in the emerging stock market.", [["gold", "SIMPLE_CHEMICAL", 8, 12]]], ["Our key results further suggest that putting gold or cryptocurrency to a stock portfolio does not enhance its risk-adjusted return.", [["gold", "CHEMICAL", 45, 49]]], ["Furthermore, stock/gold and stock/Bitcoin dependencies are not uniform throughout the bearish and bullish markets.", [["stock/gold and stock", "TREATMENT", 13, 33], ["Bitcoin dependencies", "PROBLEM", 34, 54], ["gold", "OBSERVATION_MODIFIER", 19, 23], ["not", "UNCERTAINTY", 59, 62], ["uniform", "OBSERVATION_MODIFIER", 63, 70]]], ["This is also in line with traditional wisdom that the universe of investable assets is driven by rising macroeconomic factors, such as economic expectations or anticipated inflations.IntroductionThe remainder of this paper is organised as follows: Section 2 reviews relevant literature.", [["rising macroeconomic factors", "PROBLEM", 97, 125], ["anticipated inflations", "TREATMENT", 160, 182]]], ["Section 5 concludes and provide policy implications.Literature reviewSince the global financial crisis 2008\u20132009, there has been increasing interest in the safe-haven property of gold against stock markets.", [["gold", "SIMPLE_CHEMICAL", 179, 183], ["increasing", "OBSERVATION_MODIFIER", 129, 139]]], ["Many studies focusing on developed economies, for instance, Ciner et al. (2013) investigated asset dependencies.", [["Many studies", "TEST", 0, 12]]], ["They concluded that gold acts as a safe-haven for US stocks in the 90 s and the recent global financial crisis.", [["US stocks", "TEST", 50, 59], ["the recent global financial crisis", "PROBLEM", 76, 110], ["financial crisis", "OBSERVATION", 94, 110]]], ["Bredin et al. (2015) illustrated further evidence that gold is a safe-haven asset for stocks in the long-run up to one year.", [["gold", "CHEMICAL", 55, 59], ["gold", "SIMPLE_CHEMICAL", 55, 59]]], ["Nevertheless, there is no cointegration between the variables.", [["cointegration between the variables", "PROBLEM", 26, 61], ["no", "UNCERTAINTY", 23, 25], ["cointegration", "OBSERVATION", 26, 39]]], ["Remarkably, gold returns are more likely to deteriorate under extreme market with bond returns than with stock returns.", [["more likely", "UNCERTAINTY", 29, 40]]], ["The results imply that during temporary market downturns, gold will best act as a safe-haven asset for stocks.", [["temporary market downturns", "TREATMENT", 30, 56]]], ["Furthermore, there is an attempt to clarify the safe-haven property of gold at sectoral levels in developed stock markets.", [["gold", "CHEMICAL", 71, 75], ["gold", "SIMPLE_CHEMICAL", 71, 75], ["stock markets", "OBSERVATION", 108, 121]]], ["The results revealed that the correlations between gold and stock market returns have changed considerably, especially in energy sector stocks.", [["the correlations between gold and stock market", "PROBLEM", 26, 72]]], ["During the crisis, the correlations between gold futures and aggregate US stocks were found to be negative, supporting the safe-haven hypothesis of gold.", [["gold", "SIMPLE_CHEMICAL", 148, 152], ["the crisis", "PROBLEM", 7, 17], ["aggregate US stocks", "TEST", 61, 80]]], ["Lucey and Li (2015) revealed that gold is not the strongest or best safe haven for stocks when compared to other precious metals such as palladium, silver and platinum.Literature reviewContrary to the results on developed stock markets, research on the hedging of extreme price fluctuations in emerging markets indicates that gold is not a safe-haven or is only a weak safe-haven.", [["Li", "CHEMICAL", 10, 12], ["palladium", "CHEMICAL", 137, 146], ["silver", "CHEMICAL", 148, 154], ["platinum", "CHEMICAL", 159, 167], ["palladium", "CHEMICAL", 137, 146], ["silver", "CHEMICAL", 148, 154], ["platinum", "CHEMICAL", 159, 167], ["gold", "SIMPLE_CHEMICAL", 34, 38], ["palladium", "SIMPLE_CHEMICAL", 137, 146], ["silver", "SIMPLE_CHEMICAL", 148, 154], ["platinum", "SIMPLE_CHEMICAL", 159, 167], ["palladium, silver and platinum", "TREATMENT", 137, 167], ["Li", "ANATOMY", 10, 12]]], ["However, Wen and Cheng (2018), argued that the safe-haven property of gold prevails.", [["gold", "SIMPLE_CHEMICAL", 70, 74]]], ["They investigated the safe-haven properties of gold and US dollar against emerging economies1stocks by employing Copulas approach to measure low-high tail dependence between the markets and downside portfolio risk.", [["gold", "SIMPLE_CHEMICAL", 47, 51], ["high tail", "OBSERVATION_MODIFIER", 145, 154]]], ["Although safe-haven properties of gold and the US dollar were found, gold was not the strongest safe-haven asset against emerging stocks.", [["gold", "SIMPLE_CHEMICAL", 34, 38]]], ["The results revealed that the US dollar was superior to gold in most cases, particularly in China and Thailand.Literature reviewIn comparison to the above-discussed studies on gold, the literature on assessing the safe-haven role of cryptocurrencies for stock markets is relatively limited.", [["the US dollar", "TEST", 26, 39]]], ["Perhaps, due to the reason that the cryptocurrencies2have just started to exist since the inception of Bitcoin in 2009.", [["the cryptocurrencies2have", "PROBLEM", 32, 57]]], ["Yet, the apparent failure of central banks and governments during the global financial crisis 2008\u20132009 and European sovereign-debt crisis 2010\u201313 have made cryptocurrencies increasingly popular amongst investors (Balcilar et al., 2017).", [["failure", "OBSERVATION", 18, 25], ["central banks", "OBSERVATION", 29, 42]]], ["There is a significant increase in the number of businesses that agree to accept Bitcoin as a medium of exchange.", [["Bitcoin", "CHEMICAL", 81, 88], ["Bitcoin", "TREATMENT", 81, 88], ["significant", "OBSERVATION_MODIFIER", 11, 22], ["increase", "OBSERVATION_MODIFIER", 23, 31]]], ["The popularity of bitcoin has continued to increase, although it has suffered from numerous hacks, bad creditability, and government restrictions.", [["bitcoin", "CHEMICAL", 18, 25], ["numerous hacks", "PROBLEM", 83, 97], ["popularity", "OBSERVATION_MODIFIER", 4, 14], ["increase", "OBSERVATION_MODIFIER", 43, 51], ["numerous", "OBSERVATION_MODIFIER", 83, 91], ["hacks", "OBSERVATION_MODIFIER", 92, 97]]], ["Bitcoin has gained popularity as an investment asset, besides being a fairly recent invention.", [["Bitcoin", "CHEMICAL", 0, 7]]], ["Consequently, many academic papers have focused on Bitcoin.Literature reviewThere is no strong evidence to support hedging effectiveness and safe-haven property of Bitcoin for stock at the aggregate market level.", [["Bitcoin", "CHEMICAL", 164, 171], ["Bitcoin", "SIMPLE_CHEMICAL", 51, 58], ["Bitcoin", "SIMPLE_CHEMICAL", 164, 171], ["Bitcoin", "TREATMENT", 51, 58], ["Bitcoin", "TREATMENT", 164, 171], ["no strong evidence", "UNCERTAINTY", 85, 103]]], ["For instance, Bouri et al. (2017a) evaluated Bitcoin's potential for diversification, hedging, and being safe-haven asset against bonds, stocks, gold, the US dollar and oil.", [["oil", "ANATOMY", 169, 172], ["Bitcoin", "CHEMICAL", 45, 52], ["gold", "SIMPLE_CHEMICAL", 145, 149], ["oil", "ORGANISM_SUBSTANCE", 169, 172], ["diversification", "PROBLEM", 69, 84]]], ["Their analysis included European and Asia Pacific stocks (US, UK, Germany, Japan, and China) and employed a Bivariate DCC model and regression analysis.", [["Their analysis", "TEST", 0, 14], ["a Bivariate DCC model", "TREATMENT", 106, 127], ["regression analysis", "TEST", 132, 151]]], ["The results indicated that Bitcoin can be used as a diversifier only on some occasions and it is a poor hedger.", [["Bitcoin", "CHEMICAL", 27, 34], ["Bitcoin", "SIMPLE_CHEMICAL", 27, 34]]], ["Furthermore, that the Bitcoin occasionally acts as a potential safe-haven asset and this property is time-variant.", [["Bitcoin", "SIMPLE_CHEMICAL", 22, 29]]], ["However, Bitcoin can serve as a good hedge and safe-haven asset for stocks at the sectoral level.", [["Bitcoin", "CHEMICAL", 9, 16], ["Bitcoin", "SIMPLE_CHEMICAL", 9, 16]]], ["Bouri et al. (2017b), examined the potentials of Bitcoin for diversification, hedging, and being safe-haven asset against general commodity index and energy commodity index.", [["Bitcoin", "CHEMICAL", 49, 56], ["Bitcoin", "SIMPLE_CHEMICAL", 49, 56], ["Bitcoin", "TREATMENT", 49, 56]]], ["Their empirical results revealed that Bitcoin serves as a good hedge and safe-haven for energy commodities, but it is not good for non-energy commodities.", [["Bitcoin", "CHEMICAL", 38, 45], ["Bitcoin", "SIMPLE_CHEMICAL", 38, 45]]], ["In the pre-crash 2013, there was evidence showing the hedging and safe-haven properties of Bitcoin.", [["Bitcoin", "CHEMICAL", 91, 98], ["Bitcoin", "SIMPLE_CHEMICAL", 91, 98], ["Bitcoin", "TREATMENT", 91, 98]]], ["Moreover, there is empirical evidence showing hedging effectiveness of Bitcoin against the stock when the risk of stock return is measured by the implied volatility index.", [["Bitcoin", "CHEMICAL", 71, 78], ["Bitcoin", "SIMPLE_CHEMICAL", 71, 78], ["Bitcoin", "TREATMENT", 71, 78], ["volatility index", "OBSERVATION", 154, 170]]], ["They measured global uncertainty using implied volatility index that is created from fourteen emerging and developed stock markets.", [["implied volatility index", "PROBLEM", 39, 63], ["volatility index", "OBSERVATION", 47, 63], ["stock markets", "OBSERVATION", 117, 130]]], ["Their findings showed that Bitcoin does act as a hedge against global uncertainty.Literature reviewAll in all, gold has not found to play a major role in diversification in emerging stock markets.", [["Bitcoin", "CHEMICAL", 27, 34]]], ["To achieve the benefits from international portfolio diversification, alternative safe-haven assets for emerging stock markets are required to be examined.", [["international portfolio diversification", "TREATMENT", 29, 68], ["emerging stock markets", "TREATMENT", 104, 126]]], ["Furthermore, it is discernible from the literature mentioned above that many existing studies focused on either Bitcoin or gold as a single diversifier, hedge or safe-haven asset against the stock.", [["Bitcoin", "SIMPLE_CHEMICAL", 112, 119]]], ["Hence, a comparative study of old and new assets is needed.", [["a comparative study", "TEST", 7, 26]]], ["Furthermore, it is vital to focus on emerging markets which do have idiosyncratic characteristics and as the studies on the role of gold as safe-haven suggest, there is a contrast between emerging and developed markets.", [["idiosyncratic characteristics", "PROBLEM", 68, 97], ["the studies", "TEST", 105, 116]]], ["The nexus between cryptocurrencies and the stock market as well as precious metals such as gold is vital when it comes the question of diversification (Huynh et al. (2020a) and Huang and Kilic (2019).", [["Kilic", "ANATOMY", 187, 192]]], ["Especially, the movements in precious metals\u2019 prices could be considered as the sources of economic uncertainties, which stimulates the potential shocks in stock markets (Huynh, 2020).", [["precious metals\u2019 prices", "TREATMENT", 29, 52], ["economic uncertainties", "PROBLEM", 91, 113]]], ["Last but not least, the techniques often used by the studies acknowledged above considered that correlation changes as discrete events.", [["the studies", "TEST", 49, 60], ["discrete events", "PROBLEM", 119, 134]]], ["Modelling these techniques to determine the dependency of financial assets during extreme markets (bullish or bearish) is not appropriate.", [["Modelling these techniques", "TEST", 0, 26]]], ["From this perspective, the Autoregressive Distributed Lag (ARDL) and Nonlinear ARDL models are more suitable for analysis on the subject.3To comprehend asymmetries, the nonlinear ARDL model offers insight into the correlations in different market conditions.Data ::: Data & methodologyThis study examines asymmetric correlations and hedging effectiveness of gold and cryptocurrencies for the Thai stock market.", [["gold", "SIMPLE_CHEMICAL", 358, 362], ["the Autoregressive Distributed Lag (ARDL) and Nonlinear ARDL models", "PROBLEM", 23, 90], ["the nonlinear ARDL model", "TREATMENT", 165, 189], ["This study", "TEST", 285, 295], ["asymmetries", "OBSERVATION", 152, 163]]], ["Interest in the subject market stems from Thailand's development journey based on rapid industrialisation with significant economic growth over the last few decades, characterised by its more volatile records in the recent past (Wadud and Ahmed, 2016).", [["rapid industrialisation", "PROBLEM", 82, 105], ["significant economic growth", "PROBLEM", 111, 138], ["significant", "OBSERVATION_MODIFIER", 111, 122], ["economic", "OBSERVATION_MODIFIER", 123, 131], ["growth", "OBSERVATION_MODIFIER", 132, 138]]], ["In particular, we attempt to investigate the effects of global assets on the various stock market conditions, to further understand the benefits of international portfolio diversification.", [["international portfolio diversification", "TREATMENT", 148, 187]]], ["The Asian crisis brought a sudden cessation in Thailand's economic growth in the late 1990s.", [["The Asian crisis", "PROBLEM", 0, 16]]], ["The country suffered from large declines in output and then succumbed to a regime with increased uncertainties in the new millennium.", [["large declines in output", "PROBLEM", 26, 50], ["increased uncertainties", "PROBLEM", 87, 110], ["large", "OBSERVATION_MODIFIER", 26, 31], ["declines", "OBSERVATION", 32, 40], ["output", "OBSERVATION_MODIFIER", 44, 50]]], ["These uncertainties were stemming from global events and recessions as well as Thailand's own changing domestic scenarios.4Stock Exchange of Thailand (SET) has been widely recognised as the main emerging market in Southeast Asia.", [["global events", "PROBLEM", 39, 52], ["recessions", "PROBLEM", 57, 67], ["recessions", "OBSERVATION", 57, 67], ["domestic scenarios", "OBSERVATION", 103, 121], ["widely", "OBSERVATION_MODIFIER", 165, 171], ["main", "OBSERVATION_MODIFIER", 190, 194]]], ["The SET has shown remarkable development, despite domestic instability and global uncertainty.", [["SET", "GENE_OR_GENE_PRODUCT", 4, 7], ["SET", "PROTEIN", 4, 7], ["domestic instability", "PROBLEM", 50, 70], ["remarkable", "OBSERVATION_MODIFIER", 18, 28], ["development", "OBSERVATION_MODIFIER", 29, 40], ["domestic instability", "OBSERVATION", 50, 70]]], ["It also continues to be an attractive investment venue for local and foreign investors.", [["foreign investors", "OBSERVATION", 69, 86]]], ["Capital inflows to the stock market have been continuously increasing after financial liberalisation in 1992.", [["Capital inflows", "TREATMENT", 0, 15], ["inflows", "OBSERVATION", 8, 15], ["stock market", "OBSERVATION", 23, 35], ["continuously", "OBSERVATION_MODIFIER", 46, 58], ["increasing", "OBSERVATION_MODIFIER", 59, 69]]], ["In 2019, SET was considered the highest market capitalisation of newly listed companies in Southeast Asia (the stock exchange of Thailand, 2019).", [["SET", "GENE_OR_GENE_PRODUCT", 9, 12]]], ["The World Federation of Exchanges (2018) ranked SET amongst the world top 10 largest returns market, 21st biggest in terms of the number of listed companies, 23rd largest market by capitalisation and 23rd largest by value traded.", [["largest", "OBSERVATION_MODIFIER", 77, 84], ["largest", "OBSERVATION_MODIFIER", 163, 170], ["largest", "OBSERVATION_MODIFIER", 205, 212]]], ["As far as we know, the study on hedging and safe-haven assets has received very little attention in the context of the Thai stock market.", [["the study", "TEST", 19, 28]]], ["Therefore, the subject study will address this caveat in the existing body of knowledge by drawing on recent data, old, and new assets classes which will provide the basis for further research in other emerging stock markets.Data ::: Data & methodologyWe use the daily closing price of the Thai stock market index and gold price of the London Bullion Market Association (LBMA).", [["the subject study", "TEST", 11, 28]]], ["Daily data of Bitcoin covers the period of 2013 to 2019.", [["Bitcoin", "TREATMENT", 14, 21]]]], "a00af863fe2402a434f74c7acf31ad0b50693b99": [["IntroductionThe coronavirus pandemic represents the first global interruption to medical education since World War II.", [["coronavirus pandemic", "DISEASE", 16, 36], ["coronavirus", "ORGANISM", 16, 27], ["The coronavirus pandemic", "PROBLEM", 12, 36], ["medical education", "TREATMENT", 81, 98], ["coronavirus pandemic", "OBSERVATION", 16, 36]]], ["This public health emergency has required undergraduate and postgraduate medical training programs around the world to rapidly respond, including redeploying learners to other clinical spaces or removing them entirely, and moving education online to promote physical distancing (Association of American Medical Colleges 2020; Harvey 2020; Rose 2020).", [["postgraduate medical training programs", "TREATMENT", 60, 98]]], ["The current COVID-19 pandemic has changed the status quo of medical training as we know it -whether for better or for worse remains unclear and may have profound implications.IntroductionPrior localized disruptions to medical training have negatively affected trainees, such as pandemics and climate emergencies.", [["medical training", "TREATMENT", 60, 76], ["medical training", "TREATMENT", 218, 234]]], ["The severe acute respiratory syndrome (SARS) pandemic in 2003 revealed the tension between embracing learning opportunities that a public health emergency offers and protecting the needs and well-being of learners (Rieder et al. 2004; Sherbino & Atzema 2004; Rambaldini et al. 2005) .", [["acute respiratory syndrome", "DISEASE", 11, 37], ["SARS", "DISEASE", 39, 43], ["The severe acute respiratory syndrome", "PROBLEM", 0, 37], ["pandemic", "PROBLEM", 45, 53], ["severe", "OBSERVATION_MODIFIER", 4, 10], ["acute", "OBSERVATION_MODIFIER", 11, 16], ["respiratory syndrome", "OBSERVATION", 17, 37], ["tension", "OBSERVATION_MODIFIER", 75, 82]]], ["The SARS pandemic adversely affected the mental health of learners and healthcare professionals, and heightened anxiety amongst learners was associated with a perceived negative educational experience (Maunder et al. 2003; Bai et al. 2004; Landis & Bradley 2005; Rambaldini et al. 2005) .", [["SARS", "DISEASE", 4, 8], ["anxiety", "DISEASE", 112, 119]]], ["In 2005, the rapid restructuring of the medical school curriculum in response to Hurricane Katrina resulted in a decline in academic performance (Crawford et al. 2008) .", [["rapid", "OBSERVATION_MODIFIER", 13, 18], ["restructuring", "OBSERVATION_MODIFIER", 19, 32], ["decline", "OBSERVATION_MODIFIER", 113, 120]]], ["Lessons from both SARS and Hurricane Katrina highlighted the importance of support networks and attention to learner wellness, recognizing the additional stressors that these disruptions can place on medical trainees (Landis & Bradley 2005; Rambaldini et al. 2005; DiCarlo et al. 2007; Crawford et al. 2008) .", [["SARS", "DISEASE", 18, 22], ["support networks", "TREATMENT", 75, 91]]], ["These emergencies led to significant and rapid innovation in curriculum structure and content (DiCarlo et al. 2007) .", [["significant and rapid innovation in curriculum structure", "PROBLEM", 25, 81], ["significant", "OBSERVATION_MODIFIER", 25, 36], ["rapid", "OBSERVATION_MODIFIER", 41, 46], ["innovation", "OBSERVATION", 47, 57]]], ["Despite a heightened awareness fifteen years ago of the potential implications of interruptions to medical education, many organizations and systems entered the current pandemic relatively unprepared.IntroductionRunning Head: The global impact of COVID-19 on learners 4 Medical education's understanding of the impact of global emergencies and disruptions to medical training remains limited to SARS and localized emergencies, yet the current pandemic remains the single most substantial disruption to contemporary medical training with global impact.", [["SARS", "DISEASE", 395, 399], ["medical education", "TREATMENT", 99, 116], ["COVID", "TEST", 247, 252], ["medical training", "TREATMENT", 359, 375], ["SARS", "PROBLEM", 395, 399], ["contemporary medical training", "TREATMENT", 502, 531]]], ["The extent to which COVID-19 has impacted medical training remains speculative and anecdotal, and the consequences and implications may be profound.", [["COVID-19", "CHEMICAL", 20, 28], ["impacted medical training", "TREATMENT", 33, 58]]], ["The research question for this exploratory study was: How have medical learners been impacted by the COVID-19 pandemic around the world?Data CollectionWe administered a cross-sectional survey between March 25 and June 14, 2020, shortly after the World Health Organization declared COVID-19 a pandemic.", [["this exploratory study", "TEST", 26, 48], ["COVID", "TEST", 281, 286]]], ["Criterion and snowball sampling techniques were used to collect data from undergraduate (e.g., medical students) and postgraduate (e.g., interns, house staff, resident physicians) medical learners at any medical school around the world.", [["snowball sampling techniques", "TEST", 14, 42]]], ["This study explicitly focused on medical learners given that they provide a significant proportion of patient care yet are still considered learners.Data CollectionOur decision to use a survey was based on the ability of this method to efficiently collect empirical data from a large population (Kelley et al. 2003) The survey instrument was designed to include both quantitative and qualitative questions in order to later compare variables across groups, allow participants to provide insight into how they have been impacted using their own words, and use the qualitative data to potentially expand upon the results of the quantitative data (Appendix A).", [["patient", "ORGANISM", 102, 109], ["patient", "SPECIES", 102, 109], ["participants", "SPECIES", 463, 475], ["This study", "TEST", 0, 10], ["empirical data", "TEST", 256, 270], ["large", "OBSERVATION_MODIFIER", 278, 283]]], ["All participants completed demographic questions followed by questions specific to their level of training.", [["participants", "SPECIES", 4, 16]]], ["All questions were developed de novo, except the 6-item State-Trait Anxiety Inventory (STAI-6) (Marteau & Bekker 1992) .", [["Anxiety Inventory", "TEST", 68, 85], ["STAI", "TEST", 87, 91]]], ["CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)Data CollectionThe copyright holder for this preprint this version posted September 3, 2020. . https: //doi.org/10.1101 //doi.org/10. /2020 Running Head: The global impact of COVID-19 on learners 5 pandemic on five domains of wellness was informed by a holistic framework for learner wellness (Kassam & Ellaway 2020 ).Data CollectionAn initial survey underwent pilot testing to refine comprehension and functionality.", [["CC", "CHEMICAL", 0, 2], ["Data Collection", "TEST", 199, 214], ["COVID", "TEST", 374, 379], ["pilot testing", "TEST", 560, 573], ["med", "ANATOMY", 102, 105], ["Head", "ANATOMY", 347, 351], ["global", "OBSERVATION_MODIFIER", 357, 363], ["impact", "OBSERVATION_MODIFIER", 364, 370]]], ["The survey was administered online using Qualtrics software by distributing an anonymous, re-usable link over social media and through snowball sampling.Data AnalysisQuantitative data were imported into SPSS Version 26 (IBM Corp., New York) for analysis.Data AnalysisCountries were coded to the geographic regions defined by the World Bank to explore geographic differences (World Bank) Descriptive statistics were calculated for each item.", [["Data AnalysisQuantitative data", "TEST", 153, 183], ["analysis", "TEST", 245, 253], ["Data AnalysisCountries", "TEST", 254, 276]]], ["Total scores were computed for scaled questions, with positively worded items reverse coded in the calculation.", [["Total scores", "TEST", 0, 12]]], ["Independent t-tests were used to compare total scores between medical students and residents, and an Analysis of Variance test was used to compare data across geographic regions using a post-hoc correction to account for multiple comparisons.", [["Independent t-tests", "TEST", 0, 19], ["Variance test", "TEST", 113, 126], ["a post-hoc correction", "TREATMENT", 184, 205], ["multiple comparisons", "TEST", 221, 241]]], ["To examine the psychometric properties of the survey, Cronbach's alpha was computed for scaled items to assess reliability evidence and an exploratory factor analysis was used to examine construct validity.Data AnalysisQualitative data were back translated to English and analyzed in NVivo Version 12 (QSR International, Melbourne).", [["Cronbach's alpha", "TEST", 54, 70], ["an exploratory factor analysis", "TEST", 136, 166], ["Data AnalysisQualitative data", "TEST", 206, 235]]], ["Three investigators read through the data to identify emerging themes, which were then organized into a coding framework for deductive thematic and content analysis to similarly examine trends between levels and across geographic regions (Miles et al. 2014) .Data AnalysisTwo investigators (KB, MM) independently coded 100 responses to refine the initial coding framework and assess inter-rater agreement.", [["deductive thematic", "TEST", 125, 143], ["content analysis", "TEST", 148, 164]]], ["After an additional 400 responses were analyzed and the Kappa statistic continued to suggest acceptable inter-rater agreement, and a decision was made to divide to improve efficiency given the volume of data.", [["the Kappa statistic", "TEST", 52, 71]]], ["Theme summaries were compiled for interpretation by the study team, who then compared and contrasted the results of the qualitative data with the quantitative data to .", [["the quantitative data", "TEST", 142, 163]]], ["CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)Data AnalysisThe copyright holder for this preprint this version posted September 3, 2020. . https://doi.org/10.1101/2020.09.01.20186304 doi: medRxiv preprint 6 examine how these findings converge or diverge from, and ultimately expand upon, the quantitative results.Data AnalysisThe University of Calgary Conjoint Health Research Ethics Board reviewed and approved this study (File #20-0484).", [["CC", "CHEMICAL", 0, 2], ["Data Analysis", "TEST", 199, 212], ["medRxiv preprint", "TREATMENT", 341, 357], ["Data Analysis", "TEST", 466, 479], ["this study", "TEST", 565, 575], ["med", "ANATOMY", 102, 105]]], ["Participation in this study was voluntary.", [["this study", "TEST", 17, 27]]], ["Implied consent was obtained from all participants.", [["participants", "SPECIES", 38, 50]]], ["Participants had the option to either skip individual questions or select \"prefer not to answer.\"ResultsA total of 6492 learners from 140 countries completed the survey.", [["Participants", "SPECIES", 0, 12]]], ["The majority of participants were medical students (81.0%) and from Europe and Central Asia (43.4%) ( Table 1 ).", [["participants", "ORGANISM", 16, 28], ["participants", "SPECIES", 16, 28]]], ["[ Table 1 , Table 2, Figure 1 ]Undergraduate Medical LearnersThe majority (84.3%) of clinical-level medical students were excused from clinical duties; however, some worked clinically in some capacity (9.0%).", [["some capacity", "TEST", 187, 200]]], ["The qualitative data highlighted how reduced clinical exposure limited opportunities to explore specialties, decreased career interests, and created anxiety about .", [["anxiety", "DISEASE", 149, 156], ["created anxiety", "PROBLEM", 141, 156]]], ["CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted September 3, 2020. . https://doi.org/10.1101/2020.09.01.20186304 doi: medRxiv preprint 7 implications for future milestones (e.g., examinations, residency match).", [["CC", "CHEMICAL", 0, 2], ["medRxiv preprint", "TREATMENT", 327, 343], ["examinations", "TEST", 388, 400], ["med", "ANATOMY", 102, 105]]], ["While the majority of medical students did not report the pandemic influenced their career interests, 11.4% of medical students reported increased interests in both Public Health and Infectious Disease as a result of the pandemic, as well as other clinical specialties (e.g., Emergency Medicine, Critical Care, Internal Medicine) and new interests in incorporating epidemiology into their future careers.(which was not certified by peer review)Decreased interest in clinical careers and concerns about the impact of the pandemic on job prospects in their country were noted qualitatively.(which was not certified by peer review)Over half of medical students reported feeling under-utilized (53.8%); 52.4% wanted to assist clinically (52.4%) and felt comfortable doing so (54.8%).", [["Infectious Disease", "DISEASE", 183, 201], ["increased", "OBSERVATION_MODIFIER", 137, 146], ["Infectious", "OBSERVATION", 183, 193]]], ["While 57.9% worried about the risk of exposure to the virus during rotations, 73.0% worried about the risk of exposure in the community.", [["the virus", "PROBLEM", 50, 59]]], ["Over two thirds (70.6%) reported feeling worried about the disruption to their progression through medical training, with 45.0% worrying about their chances to match to residency.", [["medical training", "TREATMENT", 99, 115]]], ["Only 21.0% thought the pandemic would have a minimal impact on their learning or skill development, and only 31.0% felt that it would have a minimal impact on their ability to enter residency with sufficient knowledge and skill to provide safe, high-quality care.", [["minimal", "OBSERVATION_MODIFIER", 45, 52]]], ["Three-quarters of residents agreed their learning was negatively impacted by COVID-19 and 60% felt it disrupted their career progression and timeline.", [["COVID", "TEST", 77, 82]]], ["Only 16% reported working more than normal during the pandemic and 36.7% working less than normal.", [["pandemic", "DISEASE", 54, 62]]], ["Over one-third felt comfortable providing patient care at this time, and 60.8% felt prepared to use personal protective equipment (PPE).", [["patient", "ORGANISM", 42, 49], ["patient", "SPECIES", 42, 49], ["personal protective equipment", "TREATMENT", 100, 129]]], ["66.5% agreed that COVID-19 had negatively impacted their wellbeing.", [["COVID-19", "CHEMICAL", 18, 26], ["COVID", "TEST", 18, 23]]], ["CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted September 3, 2020. . https://doi.org/10.1101/2020.09.01.20186304 doi: medRxiv preprint 8Shared QuestionsAll scaled items had acceptable internal consistency (\u03b1>.7) and factor loadings, suggesting reliability and validity evidence.", [["CC", "CHEMICAL", 0, 2], ["All scaled items", "TEST", 361, 377], ["factor loadings", "TEST", 425, 440], ["med", "ANATOMY", 102, 105]]], ["Statistically significant differences were detected between levels of training (p<.05) and geographic regions ( [ Figure 2 ] Seventy-four percent of residents and 57% of medical students reported being more anxious than usual (Table 3 ; Figure B .4).", [["more anxious", "PROBLEM", 202, 214], ["significant", "OBSERVATION_MODIFIER", 14, 25]]], ["Onequarter of participants identifying as Asian reported an increase in racist comments or behaviors in the clinical setting during COVID-19.", [["participants", "SPECIES", 14, 26], ["an increase in racist comments", "PROBLEM", 57, 87], ["COVID", "TEST", 132, 137]]], ["Over half (54.7%) of learners living with a disability felt their school's response to the pandemic would further disadvantage them due to their disability.Shared Questions[ Table 3 ] Some learners reported having to be in quarantine or isolation at the time of the survey.", [["disability", "DISEASE", 44, 54], ["disability", "DISEASE", 145, 155]]], ["CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted September 3, 2020. .9The qualitative data highlighted how normal education and training processes were severely disrupted by the pandemic (Appendix D).", [["CC", "CHEMICAL", 0, 2], ["severely disrupted", "PROBLEM", 360, 378], ["med", "ANATOMY", 102, 105]]], ["Strategies such as town halls, surveys, and learner representation on decision-making committees helped ensure their circumstances were accurately understood and enabled them to raise concerns overlooked by decision-makers.9Clear and effective communication during the pandemic was essential for learners, while poor or absent communication left learners uncertain of what was happening and contributed to their anxiety.", [["anxiety", "DISEASE", 412, 419], ["their anxiety", "PROBLEM", 406, 419], ["effective", "OBSERVATION_MODIFIER", 234, 243]]], ["Effective communication provided clarity and reassurance about the pandemic's impacts and the institutional response.", [["reassurance", "TREATMENT", 45, 56]]], ["Irregular (sporadic) communication created an \"information vacuum\" that was filled by speculation, rumors, and misinformation.", [["Irregular (sporadic) communication", "PROBLEM", 0, 34]]], ["Overly frequent communication was overwhelming and led students to ignore institutional communications.9Numerous interventions were implemented in response to COVID-19, including virtual teaching strategies (e.g., Zoom, Microsoft Teams), office hours and town halls, and clinical strategies (e.g., patient handover via teleconference, alternating call schedules to minimize exposure).9When done effectively, online learning maintained educational momentum and provided learners with motivation, a routine, and a sense of purpose.", [["patient", "ORGANISM", 298, 305], ["patient", "SPECIES", 298, 305], ["Numerous interventions", "TREATMENT", 104, 126], ["COVID", "TEST", 159, 164], ["virtual teaching strategies", "TREATMENT", 179, 206]]], ["Some participants stated that their program or school had done nothing in response to the pandemic, and that either their education had continued as usual or, in some instances, students were told to stay at home and self-direct their learning without any guidance from their program.9.", [["participants", "SPECIES", 5, 17]]], ["CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted September 3, 2020. .DiscussionThis study provides empirical data about the impact of COVID-19 on medical education around the world, notably the effects on learning and wellbeing.", [["CC", "CHEMICAL", 0, 2], ["COVID", "TREATMENT", 342, 347], ["medical education", "TREATMENT", 354, 371], ["med", "ANATOMY", 102, 105]]], ["However, the extent that COVID-19 has impacted learners differs significantly between levels of training and geographic regions.", [["extent", "OBSERVATION_MODIFIER", 13, 19], ["geographic", "OBSERVATION_MODIFIER", 109, 119]]], ["However, not all learners may share these views.", [["these views", "TEST", 36, 47]]], ["In addition to concerns about physical safety, some participants in our study believed the role of trainees is to be educated and that any deviation from that role is inappropriate.", [["participants", "SPECIES", 52, 64], ["our study", "TEST", 68, 77]]], ["On one hand, it has been argued that medical students specifically, as an unpaid workforce, are not essential workers, and may increase disease transmission and .", [["increase disease transmission", "PROBLEM", 127, 156], ["increase", "OBSERVATION_MODIFIER", 127, 135], ["disease", "OBSERVATION", 136, 143]]], ["CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted September 3, 2020. .11waste scarce supplies of PPE (Menon et al. 2020) .", [["CC", "CHEMICAL", 0, 2], ["med", "ANATOMY", 102, 105]]], ["It has also been argued that medical education is equally important to patient care during a pandemic (Klasen et al. 2020 ).", [["patient", "ORGANISM", 71, 78], ["patient", "SPECIES", 71, 78]]], ["CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted September 3, 2020. .12This pandemic remains an ongoing challenge for medical education.", [["CC", "CHEMICAL", 0, 2], ["medical education", "TREATMENT", 326, 343], ["med", "ANATOMY", 102, 105]]], ["While the uncertainty of COVID-19 required organizations to adopt a \"worst-case scenario\" approach, medical schools not only continue to react to the needs of the health system, but proactively plan for the future.12While some participants in this study applauded their program's response, it is important to learn from this experience and improve planning and policies for current and future emergencies that Table 4 .", [["participants", "SPECIES", 227, 239], ["COVID", "TEST", 25, 30], ["this study", "TEST", 243, 253]]], ["We must continue to share innovations and key lessons amongst the global medical education community.12Future research is warranted to understand the long-term impact and potential consequences of the COVID-19 on education, patient care, and health system outcomes.12[ Table 4 ]LimitationsWe acknowledge that this study has several limitations, including the response and selection bias.", [["patient", "ORGANISM", 224, 231], ["patient", "SPECIES", 224, 231], ["the COVID", "TREATMENT", 197, 206], ["this study", "TEST", 309, 319]]], ["Further, this study excluded participants who did not speak any of the 20 languages of the survey and there may be inconsistencies across the survey translations despite our best attempts to ensure questions and constructs translated accurately.", [["participants", "SPECIES", 29, 41], ["this study", "TEST", 9, 19]]], ["Due to the public circulation of the survey, participants could not be validated as medical learners.", [["participants", "SPECIES", 45, 57]]], ["A small fraction (3.5%) of participants did not specify their level of training and were excluded from the comparisons across levels of training.", [["participants", "ORGANISM", 27, 39], ["participants", "SPECIES", 27, 39], ["A small fraction", "TEST", 0, 16], ["small", "OBSERVATION_MODIFIER", 2, 7], ["fraction", "OBSERVATION_MODIFIER", 8, 16]]], ["The geographic comparisons remain limited, as other classification systems (e.g., the World Health Organization regions) may have generated different results and there may be more pronounced differences between countries within similar regions (e.g., the United States vs. Canada).", [["may be", "UNCERTAINTY", 168, 174], ["more pronounced", "OBSERVATION_MODIFIER", 175, 190]]], ["Finally, the variable responses to COVID-19 across countries and time is worth noting.", [["COVID", "TEST", 35, 40]]], ["CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted September 3, 2020. . https://doi.org/10.1101/2020.09.01.20186304 doi: medRxiv preprint 13 organizations and training programs.", [["CC", "CHEMICAL", 0, 2], ["training programs", "TREATMENT", 365, 382], ["med", "ANATOMY", 102, 105]]], ["Future research could examine potential associations between temporality and the political and health system responses to examine how these factors may extend to influence medical learners (Pablos-M\u00e9ndez et al. 2020 ).ConclusionsThis global study provides empirical data surrounding the profound impact that COVID-19 has had on medical learners, which can inform responses to the current pandemic, future disruptions to training, and future research.", [["This global study", "TEST", 229, 246], ["empirical data", "TEST", 256, 270], ["profound", "OBSERVATION_MODIFIER", 287, 295]]], ["The results highlight the differences and similarities between levels of training and geographic regions.", [["geographic", "OBSERVATION_MODIFIER", 86, 96]]], ["Despite the global shift toward online education, all education may not be created or perceived equally, as the results of this study suggest medical students fear their education will be of lower quality at this time.", [["online education", "TREATMENT", 32, 48], ["this study", "TEST", 123, 133]]], ["A delicate balance remains between medical training and the acute needs of the health system to ensure that both education and patient care remain safe.", [["patient", "ORGANISM", 127, 134], ["patient", "SPECIES", 127, 134], ["medical training", "TREATMENT", 35, 51]]], ["Finally, this study highlights how the COVID-19 pandemic has negatively impacted the wellbeing of medical learners globally, particularly those at the postgraduate level of training, which may be associated with their anxiety relating to the anticipatory losses of their educational experience.ConclusionsWhile the goal of this study was to broadly examine the impacts of COVID-19 on medical education, it highlights several areas for further exploration.", [["anxiety", "DISEASE", 218, 225], ["this study", "TEST", 9, 19], ["their anxiety", "PROBLEM", 212, 225], ["this study", "TEST", 323, 333], ["COVID", "TREATMENT", 372, 377], ["medical education", "TREATMENT", 384, 401], ["further exploration", "TEST", 435, 454]]], ["CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted September 3, 2020.Practice Points\u2022 The rapid reorganization of medical training in response to COVID-19 has been substantial across all levels of training and geographic regions \u2022 Medical learners are concerned that the disruption will negatively influence their learning, training trajectory, and career outcomes. \u2022 The majority of medical learners feel under-utilized and are motivated to help out during times of need \u2022 The mental health and wellbeing of learners may be further diminished at this time \u2022 Medical schools should ideally learn from this experience and improve planning and policies for current and future disruptions or emergencies .", [["CC", "CHEMICAL", 0, 2], ["medical training", "TREATMENT", 320, 336], ["COVID", "TEST", 352, 357], ["the disruption", "PROBLEM", 473, 487], ["further diminished", "PROBLEM", 731, 749], ["med", "ANATOMY", 102, 105], ["rapid", "OBSERVATION_MODIFIER", 296, 301], ["substantial", "OBSERVATION_MODIFIER", 370, 381]]], ["CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted September 3, 2020.", [["CC", "CHEMICAL", 0, 2], ["med", "ANATOMY", 102, 105]]], ["CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted September 3, 2020. .", [["CC", "CHEMICAL", 0, 2], ["med", "ANATOMY", 102, 105]]], ["CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted September 3, 2020. . https://doi.org/10.1101/2020.09.01.20186304 doi: medRxiv preprint .", [["CC", "CHEMICAL", 0, 2], ["medRxiv preprint", "TREATMENT", 327, 343], ["med", "ANATOMY", 102, 105]]], ["CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted September 3, 2020. https://datahelpdesk.worldbank.org/knowledgebase/articles/378834-how-does-the-world-bankclassify-countries .", [["CC", "CHEMICAL", 0, 2], ["med", "ANATOMY", 102, 105]]], ["CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted September 3, 2020. . .", [["CC", "CHEMICAL", 0, 2], ["med", "ANATOMY", 102, 105]]], ["CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted September 3, 2020. . https://doi.org/10.1101/2020.09.01.20186304 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted September 3, 2020. \u2022 Engage learners in the decision-making process as much as possible, and as early as possible.\u2022Include learners on planning committees and in the development of policies.\u2022Create avenues for learners to be engaged in decision-making and to provide feedback to administrators and decision-makers, such as town halls, open office hours, or surveys. \u2022 Acknowledge the diverse experiences and needs of learners and allow for flexibility in solutions.", [["CC", "CHEMICAL", 0, 2], ["flexibility in solutions", "TREATMENT", 977, 1001], ["med", "ANATOMY", 102, 105], ["med", "ANATOMY", 382, 385]]], ["For instance, recognize that some -but not all -junior learners may wish to help and that the health system may benefit from utilizing this skilled workforce.", [["this skilled workforce", "TREATMENT", 135, 157]]], ["Provide multiple options to learners when possible to promote autonomy and flexibility. \u2022 Develop a robust policies and procedures from this experience.", [["robust", "OBSERVATION_MODIFIER", 100, 106], ["policies", "OBSERVATION", 107, 115]]], ["Plan for how the program or institution will respond to disruptions to medical training, including any subsequent waves of COVID-19, future pandemics, climate change emergencies, etc.\u2022.CC-BY-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted September 3, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted September 3, 2020. .", [["CC", "CHEMICAL", 185, 187], ["medical training", "TREATMENT", 71, 87], ["COVID", "TEST", 123, 128], ["climate change emergencies", "TREATMENT", 151, 177], ["med", "ANATOMY", 286, 289], ["med", "ANATOMY", 498, 501]]], ["CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)(which was not certified by peer review)The copyright holder for this preprint this version posted September 3, 2020. .", [["CC", "CHEMICAL", 0, 2], ["med", "ANATOMY", 102, 105]]]], "PMC7385435": [["Ethics ::: Materials and MethodsThe study was approved by the institutional ethics committee.", [["The study", "TEST", 32, 41]]], ["An online written informed consent was obtained from all potential participants.Study Design and Eligibility Criteria ::: Materials and MethodsThis was an online-questionnaire-based cross-sectional study conducted in India during the month of April 2020.The online questionnaire was designed on Google Forms and circulated in multiple WhatsApp groups, targeting doctors and nurses involved in triage, screening, diagnosing, and treatment of COVID-19 patients and suspects.", [["patients", "ORGANISM", 450, 458], ["participants", "SPECIES", 67, 79], ["patients", "SPECIES", 450, 458], ["Methods", "TREATMENT", 136, 143], ["cross-sectional study", "TEST", 182, 203], ["screening", "TEST", 401, 410], ["diagnosing", "TEST", 412, 422], ["COVID", "TEST", 441, 446]]], ["Those who were currently doing their internship were excluded.Study Procedures ::: Materials and MethodsThe link to the online questionnaire was circulated on April 10, 2020, and the target sample size was achieved on April 25, 2020.", [["Methods", "TREATMENT", 97, 104], ["size", "OBSERVATION_MODIFIER", 197, 201]]], ["A maximum of three reminders were sent in all WhatsApp groups.", [["maximum", "OBSERVATION_MODIFIER", 2, 9]]], ["The questionnaire had five sections, namely, baseline sociodemographic characteristics, Generalized Anxiety Disorder 7-item (GAD-7), Patient Health Questionnaire-9 (PHQ-9), Perceived Stress Scale-10 (PSS-10), and miscellaneous psychosocial questions.", [["sections", "ANATOMY", 27, 35], ["Anxiety Disorder", "DISEASE", 100, 116], ["Patient", "SPECIES", 133, 140], ["Generalized Anxiety Disorder", "PROBLEM", 88, 116], ["GAD", "TEST", 125, 128], ["PHQ", "TEST", 165, 168], ["Perceived Stress Scale", "TEST", 173, 195]]], ["Data were collected anonymously, with only one response was permitted per person.Study Procedures ::: Materials and MethodsPHQ-9 is a 9-item self-report questionnaire used in clinical practice for screening, diagnosing, monitoring, and measuring the severity of depression.", [["depression", "DISEASE", 262, 272], ["person", "SPECIES", 74, 80], ["MethodsPHQ", "TEST", 116, 126], ["screening", "TEST", 197, 206], ["diagnosing", "TEST", 208, 218], ["monitoring", "TEST", 220, 230], ["depression", "PROBLEM", 262, 272], ["depression", "OBSERVATION", 262, 272]]], ["PHQ scores \u226510 have a sensitivity of 88% and a specificity of 88% for major depression and require treatment.8 PSS-10 is an instrument designed to measure the degree to which situations in one\u2019s life are appraised as stressful.", [["depression", "DISEASE", 76, 86], ["PHQ scores", "TEST", 0, 10], ["a sensitivity", "TEST", 20, 33], ["a specificity", "TEST", 45, 58], ["major depression", "PROBLEM", 70, 86], ["treatment", "TREATMENT", 99, 108]]], ["PSS items have been found to have good correlations with other stress measures, self-reported health and health service measures, health behavior measures, smoking status, and help-seeking behavior.9 GAD-7 is a 7-item self-report questionnaire used in clinical practice for screening and assessing severity of generalized anxiety disorder.", [["help-seeking behavior", "DISEASE", 176, 197], ["anxiety disorder", "DISEASE", 322, 338], ["PSS items", "TEST", 0, 9], ["other stress measures", "TREATMENT", 57, 78], ["screening", "TEST", 274, 283], ["generalized anxiety disorder", "PROBLEM", 310, 338]]], ["Cut-off points of 5, 10, and 15 may be interpreted as representing mild, moderate, and severe levels of anxiety on the GAD-7.", [["anxiety", "DISEASE", 104, 111], ["Cut", "TEST", 0, 3], ["mild, moderate, and severe levels of anxiety", "PROBLEM", 67, 111], ["the GAD", "TEST", 115, 122], ["off points", "OBSERVATION_MODIFIER", 4, 14], ["mild", "OBSERVATION_MODIFIER", 67, 71], ["moderate", "OBSERVATION_MODIFIER", 73, 81], ["severe", "OBSERVATION_MODIFIER", 87, 93]]], ["A score of >10 would require further evaluation.10Sample Size Estimation ::: Materials and MethodsConsidering an estimated prevalence of depression (p) among HCPs to be 13.5% based on the study by Zhu et al.,11 the sample size estimated using the formula (Z\u03b1)2pq/d2 using an alpha error of 5% and an absolute precision (d) of 5% was 179.", [["depression", "DISEASE", 137, 147], ["A score", "TEST", 0, 7], ["further evaluation", "TEST", 29, 47], ["depression", "PROBLEM", 137, 147], ["the study", "TEST", 184, 193], ["the sample size", "TEST", 211, 226], ["the formula (Z\u03b1)", "TREATMENT", 243, 259], ["an alpha error", "TEST", 272, 286], ["an absolute precision", "TEST", 297, 318], ["Size", "OBSERVATION_MODIFIER", 57, 61]]], ["If estimated considering the prevalence of stress (p = 29.8%), although a different tool being used, and anxiety (p = 24.1%), the sample size, with the other assumptions remaining constant, would be 322 and 281, respectively.", [["anxiety", "DISEASE", 105, 112], ["stress", "PROBLEM", 43, 49], ["p", "TEST", 51, 52], ["anxiety", "PROBLEM", 105, 112], ["the sample size", "TEST", 126, 141], ["size", "OBSERVATION_MODIFIER", 137, 141]]], ["Considering the largest value among the three and assuming an approximate 10% of questionnaires to have incomplete responses, we decided to increase the sample size to 350.Data Management ::: Materials and MethodsData were exported from the Google Forms to Microsoft Excel (Microsoft Corporation, Redmond, Washington, USA, 2016) spreadsheet and coded.", [["largest", "OBSERVATION_MODIFIER", 16, 23]]], ["Statistical analyses were performed using Statistical Package for Social Sciences (SPSS) Statistics for Windows, Version 20.0 (IBM Corp., USA, 2011).Statistical Analysis Plan ::: Materials and MethodsDemographic characteristics were summarized using descriptive statistics such as frequency and percentages in case of discrete data, or mean and standard deviation (SD) in the case of continuous data.", [["Statistical analyses", "TEST", 0, 20], ["discrete data", "TEST", 318, 331]]], ["Prevalence rates of high-level stress, anxiety symptoms requiring further evaluation, and depressive symptoms requiring treatment were expressed as proportions with 95% confidence intervals (CI).", [["anxiety", "DISEASE", 39, 46], ["depressive symptoms", "DISEASE", 90, 109], ["high-level stress", "PROBLEM", 20, 37], ["anxiety symptoms", "PROBLEM", 39, 55], ["further evaluation", "TEST", 66, 84], ["depressive symptoms", "PROBLEM", 90, 109], ["treatment", "TREATMENT", 120, 129], ["CI", "TEST", 191, 193]]], ["The hypothesized factors/predictors to each of these conditions, namely stress, anxiety, and depression, such as age, gender, being a doctor, years of experience, hostel/ temporary accommodation, history of mental illness, presence of comorbidities, perceived inability to distress, and employment in the government sector, were subjected to univariate binary logistic regression.", [["anxiety", "DISEASE", 80, 87], ["depression", "DISEASE", 93, 103], ["illness", "DISEASE", 214, 221], ["anxiety", "PROBLEM", 80, 87], ["depression", "PROBLEM", 93, 103], ["mental illness", "PROBLEM", 207, 221], ["comorbidities", "PROBLEM", 235, 248], ["perceived inability to distress", "PROBLEM", 250, 281]]], ["Those with a significance of P < 0.2 in the univariate analysis were included in the multivariate binary logistic regression model.ResultsA total of 433 responses were received.", [["the univariate analysis", "TEST", 40, 63]]], ["Of these, 83 respondents were not involved in any of the COVID-19 related activities and hence were excluded.", [["the COVID", "TEST", 53, 62]]], ["The remaining 350 from across ten states and one union territory were included in the analysis.", [["the analysis", "TEST", 82, 94]]], ["A total of 344 participants had disclosed their institutions of affiliation, and the number of participating institutions totaled to 98.", [["participants", "ORGANISM", 15, 27], ["participants", "SPECIES", 15, 27]]], ["Of the 350 participants, 84.3% (n = 295/350) were doctors and the remaining 15.7% (n = 55/350) were nurses.", [["participants", "SPECIES", 11, 23]]], ["The mean (SD) age of the participants was 30.21 (5.22) years.", [["participants", "ORGANISM", 25, 37], ["participants", "SPECIES", 25, 37]]], ["The demographic characteristics are summarized in Table 1.ResultsThe details regarding the occupation of participants are given in Table 2.", [["participants", "SPECIES", 105, 117]]], ["The mean (SD) years of experience of the participants were 5.52 (4.79).", [["participants", "SPECIES", 41, 53]]]]}